incivo works by reducing the amount of the virus that causes hepatitis c infection . incivo is used for the treatment of chronic hepatitis c in adults and adolescents from 1865 years of age and older . it is used in combination with peginterferon alfa , ribavirin and telaprevir , which are medicines called ns3 - 4a protease inhibitors . the ns3 + 4a protein inhibitor stops hepatitis c virus from multiplying and multiplying . it also inhibits the ability of peginerferonalfa and ribavir to reproduce themselves . incovis is used to treat adults and children from 18 years
do not take incivo if you are allergic to telaprevir or any of the other ingredients of this medicine ( listed in section 6 ). if you have been taking peginterferon alfa or ribavirin for a long time . warnings and precautions talk to your doctor or pharmacist before taking incivo . if you take peginerferon ava or ribvirin , tell your doctor . incivo should not be taken with the following medicines : - if you suffer from severe side effects 56 if you currently take the medicine alfuzosin , which is used to treat symptoms of an enlarged prostate
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage the recommended dose regimen is one tablet once a day . the recommended dosage regimen is 3 mg twice a day ( 6 mg twice daily ) taken with 2 or 8 tablets per day ( 8 mg twice per day ). you should take incivo for as long as your physician continues to prescribe it for you . your doctor will check that you have both hepatitis c virus infection and human immunodeficiency virus infection ( hiv infection ). your doctor may prescribe incivo together with efavirenz . the
like all medicines , this medicine can cause side effects , although not everybody gets them . rash : if you get an itchy skin rash , stop using incivo and seek medical help immediately . the rash may progress to other symptoms . the severity of a severe skin reaction may be life - threatening . tell your doctor immediately if you develop a skin rash . if your rash does not go away or other symptoms get worse , tell your physician . a rash may be accompanied by fever , tiredness , swelling of the face , swelling or lymph glands , a wide - spread rash with peeling skin , fever , flu - like symptoms , painful
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and carton after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . incivo tablets should be kept in the bottle tightly closed in order to protect from moisture . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what incivo contains - the active substance is telaprevir . each tablet of incivo contain 375 mg telaprentir . - the other ingredients are tablet core hypromellose acetate succinate , calcium hydrogen phosphate ( anhydrous ), microcrystalline cellulose , silica colloidal anhydrated , sodium lauryl sulphate , croscarmellose sodium , sodium stearyl fumarate . film - coat polyvinyl alcohol , macrogol , talc , titanium dioxide ( e171 ), iron oxide yellow ( e172 ). what incivo looks like and contents of the pack
zinbryta contains the active substance daclizumab beta , a monoclonal antibody . how zinbryt works zininbrysta is used to treat multiple sclerosis ( ms ) in adults . it is used as therapy for two ms treatment followed by other treatments . inflammation destroys the protective sheath around the nerves in the central nervous system ( brain and spinal cord ). this loss of myelin ( demyelination ) can lead to relapsing ms , which can lead sometimes to repeated attacks ( relapses ). symptoms may occur mainly in the nerves around the spinal cord . these symptoms may
do not take zinbryta : if you have previously had a serious allergic reaction to daclizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you suffer from liver problems . warnings and precautions talk to your doctor , pharmacist or nurse before taking zinibryta . if you are suffering from any other autoimmune disorders . if any of these apply to you , tell your doctor . if your doctor has told you to take any other medicines , including herbal supplements . if this applies to you ( or you are not sure ), tell your physician or pharmacist before taking any medicines
your doctor will decide how much zinbryta you need and how often you need to take this medicine . the recommended dose of zinba is 150 mg once a day . your doctor will ask you to have a blood test to check how well your liver is working . the usual dose of your dose of one zinbagryta is 40 mg once daily . your dose may be adjusted depending on the results of this blood test . your next dose may need to be adjusted . your first dose of a bloodtest will be given at the same time as your first . injecting yourself zinbinba is given under the
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with zinbryta : tell your doctor straight away if you notice any of the following serious side effects : liver problems : very common ( may affect more than 1 in 10 people ) unexplained nausea ( feeling sick ) vomiting ( being sick ) stomach pain increased tiredness loss of appetite ( anorexia ) your skin or whites of your eyes turn yellow dark ( tea - coloured ) urine 41 uncommon ( may affects up to 1 in 100 people ) severe inflammation of the liver may lead to death . tell your liver
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the syringe label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the zinbryta pre - filled syringe in its original package in order to protect from light . before you start using a new syringe / pen , use a refrigerator to remove the pre - fill syringe from the refrigerator . zin bryta syringes / pens should be stored in
what zinbryta contains the active substance is daclizumab beta . each pre - filled syringe contains 150 mg of dacluzumabbeta . 1 ml of solution for injection contains 150mg of dlizumb beta . 1ml of solution contains sodium succinate , succinic acid , sodium chloride , polysorbate 80 ( see section 2 ' zin bryta contain sodium '). what zinbaryta looks like and contents of the pack zinbinbryt is a clear to slightly yellow solution for injecting in a syringe / pen ( pre -filled pen
wilzin belongs to a group of medicines called metabolism products . wilson ' s disease is due to a rare inherited defect in copper excretion , which affects the liver , eyes and brain . this defect causes liver damage and neurological disorders . wilzin works by attaching to copper in the intestine and slowing its further accumulation in the body . wilston ' s diseases has been associated with the development of certain types of liver damage , neurological disorders and with the destruction of the intestine from the original structure and its further accumulation in the organ . the development and spread of wilson ', s disease has been linked to the development or worsening of
do not use wilzin - if you are allergic ( hypersensitive ) to zinc or any of the other ingredients of wilzin ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using wilzin wilzin is used for initial therapy in adults who have signs and symptoms of wilson ' s disease . if you currently receive another anti - copper agent , penicillamine , wilzin may be used for the initial treatment in combination with other anti - copper agents . penicillinamine may be more effective in reducing your symptoms . your doctor will monitor the treatment closely , especially blood and
always take the different dose regimens exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual starting dose is 25 mg / 50 mg . the recommended dose is 1 mg wilzin 50 mg twice a day . the dose is 2 mg wilin 25 mg twice daily . the doctor may increase the dose to 25 mg once a day , depending on your response to wilzin . the daily dose is 50 mg once daily , depending upon your response . the dosage is 2mg wilzin 25 mg per day . this dose is 3 mg wilz 25 mg two times a day (
like all medicines , wilzin can cause side effects , although not everybody gets them . the following side effects have been reported : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) rare ( affects less than 1 users in 10 , 000 ), very rare ( affecting less than1 user in 1, 000 ) not known ( frequency cannot be estimated from the available data ): very common : may affect more than1 in 10 people not known : frequency cannot been estimated from available data . very common ): may affect less than one in
keep out of the reach and sight of children . do not use wilzin after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . do this after the first day of the month . store below 25 . do away with the blister and keep the blister tightly closed in order to protect from moisture . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what wilzin contains the active substance is zinc . each hard capsule contains 25 mg of zinc ( equivalent to 83 . 92 mg of z zinc acetate dihydrate ). each 50 mg hard capsule delivers 50 mg of the active substances ( equivalent of 167 . 84 mg of oz zinc acetates dihydrated ). the other ingredients are magnesium stearate . the capsule shell contains gelatin , titanium dioxide ( e171 ) and brilliant blue fcf ( e110 ). what wilzin looks like and contents of the pack wilzin 25 mg hard capsules are white to off - white , oblong , printed with " wilzin 50 mg "
biktarvy contains the active substance bictegravir , an antiretroviral medicine known as an integrase strand transfer inhibitor . it is also known as emtricitabine , an antiviral medicine ( known as a nucleoside reverse transcriptase inhibitor ( nrti ) tenofovir alafenamide , an antiiretviral medicine called a nucleotide reverse transcriptases inhibitor ( trti ). biktarv is used for the treatment of human immunodeficiency virus 1 ( hiv - 1 ) infection in adults . biktrelir reduces the
do not take biktarvy if you are allergic to bictegravir , emtricitabine , tenofovir alafenamide or any of the other ingredients of this medicine ( listed in section 6 ). if you take any of any of these , ask your doctor for advice . if you have recently taken any of your following medicines : - rifampicin , which is used to treat some bacterial infections such as tuberculosis - st . john ' s wort ( hypericum perforatum ), a herbal remedy used to help you sleep and / or relieve depression and anxiety . warnings and
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . your doctor may also prescribe antacids to help prevent stomach ulcers , heartburn and acid reflux . your dose may need to be adjusted by your doctor . your daily dose should be taken in combination with aluminium and magnesium hydroxide mineral supplements , vitamins , magnesium and iron . see section 2 " taking these medicines with biktarvy ". if you take more biktorvy than you should if you accidentally take too many tablets , contact your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following serious side effects : inflammation or infection in patients with advanced hiv infection ( aids ) or opportunistic infections ( infections caused by a weak immune system ). symptoms of inflammation from previous infections may occur during hiv treatment . these symptoms may be due to an improvement in the body ' s immune response , which is needed to fight infections . there are no obvious symptoms of autoimmune disorders , in which the immune system attacks specific parts of the body tissue . medicines given to treat hiv infected patients with autoimmune
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the seal tightly closed in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what biktarvy contains - the active substances are bictegravir , emtricitabine and tenofovir alafenamide . each biktorvy tablet contains bic tegravira sodium equivalent to 50 mg bicchegravirin , 200 mg emtritabine , tenofovel alcohol and magnesium stearate . - the other ingredients are tablet core microcrystalline cellulose , croscarmellose sodium and magnesiumstearate in the core and film - coating polyvinyl alcohol , titanium dioxide ( e171 ), macrogol , tal
novarorm is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancrea does not produce enough insulin to control the sugar in your blood or where your body is not able to use the insulin it produces effectively . novonorm is used to treat type 2abetes in adults . treatment is usually started with diet and exercise and weight reduction . your blood pressure should be controlled when you are on novonor or metformin alone . diabetes novonors can help control the blood sugar ,
do not take novonorm if you are allergic to repaglinide or any of the other ingredients of novonor ( listed in section 6 ). if you have type 1 diabetes . if the acid level in your blood is too low ( diabetic ketoacidosis ). if your doctor has told you that you have a severe liver disease . if you take gemfibrozil ( a medicine used to lower increased fat levels in the blood ). warnings and precautions 47 if you suffer from liver problems . novonere should not be used in patients with moderate liver disease , as novonOR may not be suitable for you
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 0 . 5 mg once a day . swallow the tablet whole with a glass of water . you can take novonorm with or without food . the maximum recommended dose for adults is 30 mg once daily for 4 weeks . the dose may be increased to 30 mg twice daily for 16 weeks . your doctor will monitor your blood sugar regularly . do not try to increase the dose yourself . if you take more novonor than you should if you have taken too many tablets , talk to a
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most common side effect of novonorm is hypoglycasemia ( may affect up to 1 in 10 people ). if you have a hypo in section 2 , hypoglycemic reactions are generally mild / moderate . however , hypocemic unconsciousness may lead to coma . allergy allergy ( may occur in up to1 in 10 , 000 people ) symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy or sweating ( anaphylactic reaction ). other side effects include : common ( may effect up
what novonorm contains - the active substance is repaglinide . - the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate anhydrous , maize starch , polacrilin potassium , povidone ( polyvidone ), glycerol , magnesium stearate , meglumine , poloxamer , iron oxide yellow ( e172 ), iron oxide red ( e 172 ) and water for injections ( see section 2 " novonor contains sodium "). what novonors looks like and contents of the pack novonom tablets are white , round , flat , with " 0 .
pumarix is a vaccine used in adults ( aged 18 years and older ) to prevent pandemic flu ( influenza ). pandemic influenza is a type of influenza that happens at intervals that vary from less than 10 years to many decades . pandemicflu is similar to ordinary flu but may be more serious . the vaccine works by helping your body to produce its own protection ( antibodies ) against the disease . none of the ingredients in the vaccine can cause flu . as with all vaccines , pumarix may not fully protect all persons who are vaccinated .
you should not receive pumarix : if you have had a sudden life - threatening allergic reaction to any ingredient of this vaccine ( listed in section 6 ) or to any of the ingredients that may be present in trace amounts as follows : egg , chicken protein , ovalbumin , formaldehyde and sodium deoxycholate . signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of the face or tongue . if you notice any of these , stop administering the vaccine and seek medical treatment immediately . an allergic response to any ingredients of pumarip may occur after receiving this vaccine . 33 warnings and
pumarix is for use in adults aged 18 years and older . pumarix contains a similar h5n1 as03 to those from 18 years of age and older , but is not recommended for use . pumix is a vaccine for use by children aged 3 - 9 years . pumanix is not for use for children aged 10 - 17 years . how pumarik is given pumarax is given as an injection into a muscle in the upper arm . if you have any further questions on the use of this vaccine , ask your doctor or pharmacist .
like all medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions allergic reactions may lead to dangerously low blood pressure , shock and emergency treatment . the following side effects have been reported with pumarix : very common ( may affect more than 1 in 10 people pain where the injection is given headache feeling tired aching muscles joint pain common ( might affect up to 1 in every 10 people redness or swelling where thejection is given fever sweating shivering diarrhoea feeling sick uncommon ( may affects up to1 in every 100 people ) bruising where the injections are given bruising a hard lump , itching or warmth
keep this vaccine out of the sight and reach of children . do not use this vaccine after the expiry date which is stated on the carton and the label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . after preparation of the vaccine , the suspension should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 - 30 . do away with the suspension once it has been thawed . do throw away any medicines via
what pumarix contains the active substance is split influenza virus ( a / 2005 , pr8 - ibcdc - rg2 ) in 0 . 5 ml . the other ingredient is haemagglutinin , which is used to treat the pandemic . the vaccine contains an ' adjuvant ' as03 . this adjuvant contains squalene , dl - α - tocopherol , polysorbate 80 and adjuvants are included to help to protect the vaccine . the ingredients in the suspension are sodium chloride , disodium hydrogen phosphate , potassium dihydrogen phosphate , water and
somakit t is a radiopharmaceutical product containing the active substance edotreotide . the powder contains a radioactive substance called gallium ( 68ga ) chloride . the active ingredient is gallium (" 68ga ") edotreaotide . during this procedure , the doctor will dissolve the remaining gallium and edotreeotide in a vein or body areas . somakit to is used for a medical imaging procedure called positron emission tomography ( ptom ) ( pet scan ). this medical procedure is to obtain images of the abnormal cells and tumours in your disease . the use of somakiton t
do not take somakittoc if you are allergic to edotreotide or any of the other ingredients of this medicine ( listed in section 6 ). if you have experienced allergic reaction to any of these ingredients , see section 4 " warnings and precautions ". warnings and risks talk to your doctor or pharmacist before taking somakttoc if : you have kidney or liver problems you have renal or hepatic disease you are under 18 years of age . you have dehydration . your doctor will discuss this with you during the examination . 28 you have or have had others medical conditions that affect the way your body works ( e . g .
there are strict laws on the use , handling and disposal of radiopharmaceutical products . somakittoc will only be handled and given to you by people who are trained and qualified to use it safely . they will keep you informed of their actions and will keep your informed of any changes . they are responsible for the correct disposal of radioactivity and for the safe disposal of radioactive materials . they should not use somakiton to treat or prevent radioactivity . they must take special care with somakttoc 29 during and after the procedure . after radiolabelling , somakitastoc is given as a single injection (
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are allergic reactions ( hypersensitivity ) which have been reported in patients receiving somakit to have symptoms such as warm flush , redness of the skin , swelling , itching , nausea and difficulty breathing . allergic reactions may also include stinging at the injection site due to ionising radiation , cancer and hereditary abnormalities . reporting of side effects if you get any side effects talk to your nuclear medicine doctor . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only : radiolabelling will be done by the specialist . somakit t will be stored at a temperature not above 4 ºc and below 25 ºcs . do not freeze . do away with the vial . do this if you notice any visible signs of deterioration of radioactive products . do throw away any medicines via wastewater or household waste . ask your pharmacist how
what somakit t contains - the active substance is edotreotide . each vial of powder contains 40 mg of edotREotide ( as 10 - phenanthroline ). - the other ingredients are gentisic acid , mannitol , formic acid ( e421 ), sodium hydroxide , water for injections , sodium and radiolabelling . the solution contains hydrochloric acid . what somakIT t looks like and contents of the pack somakiton t is presented as a kit for radiopharmaceutical preparation . it is supplied as a glass vial with black flip - off cap .
afinitor is an anticancer medicine that contains the active substance everolimus . everolim slows the growth and spread of cancer cells . afinitor inhibits the activity of hormone receptor - positive advanced breast cancer in postmenopausal women , when non - steroidal arthroscatase inhibitors ( such as non - steroids ) have failed to control the disease under control . afinavitor is used in combination with a medicine called exemestane ( a steroid osteroidal arthroatase inhibitor ) with hormonal anticancer therapy to treat advanced tumours ( neuroendocrine tumours that affect the stomach , bowels
do not take afinitor if you are undergoing cancer treatment . warnings and precautions talk to your doctor or pharmacist before taking afinit : if you have been previously treated with afinin . if you think you may be allergic to everolimus , sirolimus , temsirolimuses or any of the other ingredients of this medicine ( listed in section 6 ). if you suspect you may also be allergic , ask your doctor for advice . warnings , precautions and precautions tell your doctor before taking this medicine if you : - are allergic to afiniser . - have any problems with your liver . - had any
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet of 10 mg of afinitor once a day . if you have liver problems , your doctor may prescribe a lower dose of afginitor ( 5 mg ) once a week . your doctor will tell you how many tablets of 5 mg or 7 . 5 mg to take . if certain side effects occur , your dose may be reduced . your dose of the tablet may be increased or decreased depending on how you respond to treatment . if these effects occur your doctor should decide to reduce
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking afinitor and tell your doctor straight away if you experience an allergic reaction including : difficulty breathing or swallowing swelling of the face , lips , tongue or throat severe itching of the skin with a red rash or raised bumps if you notice any of the following side effects stop taking the medicine and tell a doctor straightaway : very common ( may affect more than 1 in 10 people ) - increased temperature - chills ( signs of infection ) - fever - coughing - difficulty breathing - wheezing - inflammation of the lung ( pneumonitis 46
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . do open the blister to remove the tablets from the blister . do this once a day . donot use this medication if you notice any visible sign of tampering . do so immediately after opening the blister , even if the tablets are still in the blister and are otherwise free of moisture . do use this product if you suspect there is tampering . if you have any further questions on the
what afinitor contains the active substance is everolimus . afinit 2 . 5 mg : each tablet contains 2 . 75 mg of everolim . afinnitor 5 mg tablet : each film - coated tablet contains 5 mg of Everolimus in one tablet . afincitor 10 mg tablet: each film film - coating contains 10 mg of of everlimus in two tablets . the other ingredients are butylhydroxytoluene , magnesium stearate , lactose monohydrate , hypromellose , crospovidone and lactose anhydrous . what afinitors looks like
what laventair ellipta is the active substance of lavent air ellipta ( umeclidinium bromide ) and vilanterol belong to a group of medicines called bronchodilators . what laventAir ellipta looks like and contents of the pack laventairy ellipta comes as a low - dose inhalation . it is used to treat chronic obstructive pulmonary disease ( copd ). copd is a long - term condition characterised by breathing difficulties that occur every day . in copd the muscles around the airways tighten . this medicine blocks the tightening of these muscles in the lungs
do not use laventair ellipta 31 - if you are allergic to umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine : - if your asthma is getting worse . warnings and precaution talk to the doctor or nurse before using lavent air ellipta : - asthma - heart problems - high blood pressure - an eye problem called narrow - angle glaucoma ( an enlarged prostate , difficulty passing urine , or a blockage in your bladder ). - epilepsy - thyroid gland problems .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours at the same time each day . do not use more than your doctor tells you to use . use laventair ellipta every day , at the usual time . if you use more lavent air ellipta than you should if you have used more lavents than you have been told to use , contact your doctor immediately . symptoms of using too much laventour ellipta include a sudden attack of breath
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions if you experience any of the following symptoms stop using laventair ellipta and contact your doctor immediately : uncommon side effects ( may affect up to 1 in 100 people ): skin rash ( hives ) and redness rare side effects : may affect upto 1 in 1 , 000 people : swelling mainly of the face or mouth ( angioedema ), which may make you feel very wheezy , coughing , having difficulty in breathing , feeling weak or light headed , collapse or loss of consciousness . immediate breathing difficulties should be immediately .
what laventair ellipta contains - the active substances are umeclidinium bromide and vilanterol . each delivered dose contains 55 micrograms umeklidinia ( equivalent to 65 microgram of umelidiniol bromides ) and 22 microgram s of vilancerol ( equivalent of trifenatate ). - the other ingredients are lactose monohydrate ( see section 2 under ' lavent air ellipta contain lactose ' and magnesium stearate ). what laventAir ellipta looks like and contents of the pack laventAIR ellipta is
tovfya contains the active substance guselkumab , which is a monoclonal antibody . this medicine works by attaching to a protein called il - 23 , which helps to improve the condition on the skin . tremfya is used to treat adults with moderate to severe " plaque psoriasis " an inflammatory condition on skin that affects nails . it is used in adults to improve how the condition is treated on the surface of skin and to reduce symptoms such as scaling , shedding , flaking , itching , pain and burning .
do not use tremfya if you are allergic to guselkumab or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before using tremfia if you have an active infection or active tuberculosis warnings and precaution talk to the doctor or nurse before using the vaccine . tremfYA may cause an infection or an infection with tuberculosis . tuberculosis is a serious infection that can affect up to 36 people . if you develop an infection , symptoms of an infection may be severe . infections and allergic
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . tremfya 100 mg solution for injection ( 1 pre - filled syringe ) is given under the skin ( subcutaneous injection ) every 4 to 8 weeks . you should not change the time of injection unless your doctor tells you to . if you have any further questions on the use of this product , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side effect : signs of serious allergic reaction : difficulty breathing or swallowing , swelling of the face , lips , tongue or throat , severe itching of the skin , a red rash or raised bumps other side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . some side effects may be serious ( may affect up to 1 in 10 people ): upper respiratory infections common side effects ( may effect up
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . do do not give this medicine if you notice that the solution is cloudy or contains large particles . do away with the refrigerator and the pre -- filled syringes within 30 days . do this medicine as your doctor has told you . donot throw
what tremfya contains - the active substance is guselkumab . each pre - filled syringe contains 100 mg of gusel kumab in 1 ml solution . - the other ingredients are histidine , histidine monohydrochloride monohydrate , polysorbate 80 , sucrose , water for injections . what tremfYA looks like and contents of the pack solution for injection in tremfia is a clear , colourless solution . tremfyna is supplied as a carton pack containing one single - dose glass syringe and a multipack containing 2 packs of 1 pack of single - set pre
the active substance of trepulmix is treprostinil . treprostsinil belongs to a group of medicines called prostacyclins , a hormone that lowers blood pressure by relaxing blood vessels . prostacycylins prevent blood from clotting . trepulemix is used to treat inoperable chronic thromboembolic pulmonary hypertension ( cteph ). it is used when persistent or recurrent ctph is not treated with surgical treatment or exercise capacity . symptoms of the disease are similar to those of chronic thromeboembololic pulmonary hypertension ( but may occur more often ). in chronic th
do not take trepulmix - if you are allergic to treprostinil or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has a disease called " pulmonary veno - occlusive disease ". this is a disease in which the blood vessels in the lungs become swollen , leading to a higher pressure in the blood arteries between the heart and the lungs . - if the child has severe liver disease . - tell your doctor if your baby has a heart problem . - have had a heart attack ( myocardial infarction ) in the last six months . - suffer from
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . trepulmix is intended for a continuous subcutaneous infusion ( subcutaneously ) under the skin through a small tube ( cannula ) in the abdomen or thigh . trepanmix is supplied in a pouch or a portable pump . you can use your treprostinil either directly or by pushing the pump through the infusion line to prevent accidental overdose . the recommended dose is 1 mg , 2 . 5 mg , 5 mg or 10 mg per infusion . the infusion rate will be adjusted depending
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): widening of blood vessels pain at the infusion site reaction at the site bleeding or bruising at the infusion site headaches nausea diarrhoea jaw pain common ( might affect up to 1 in every 10 people ) dizziness light - headedness fainting low blood pressure skin rashes muscle pain ( myalgia ) joint pain ( arthralgia ) swelling of feet , ankles , legs ( fluid retention ) hot flush pain in arms and / or legs 36 uncommon ( may effect up to
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . do away with the vials after reconstitution . trepulmix may be used if it is not clear , if it has been stored for a single period of less than 30 days , or if it contains visible signs of discolouration or
what trepulmix contains - the active substance is treprostinil . trepulemix 1 mg : each vial contains 1 mg treprostail ( as sodium salt ). each 10 ml vial of 10 ml solution contains 10 mg trepristinila ( as water for injections ). each 2 . 5 ml vials of 2 . 25 ml solution contain 10 mg of treproprostineil ( sodium salt ) . each 10ml vial also contains 25 mg of the active substances treprosticinil ( so water for injection ). each 50 ml vray of trepulesmix contains 10
the active substance of thorinane is enoxaparin sodium . it is a low molecular weight heparin ( lmwh ). the active substance in thorinanes is enalaparin . it works in two ways : 1 ) to prevent existing blood clots from forming . 2 ) stopping blood clumps from forming in your blood . thorinan is used to prevent blood clubs from forming within your blood during or after an operation . it can be used : - if you have an acute illness called unstable angina ( where the heart cannot pump blood enough ) - if your heart cannot pumping blood enough ( which
do not use thorinane if you are allergic to enoxaparin sodium or any of the other ingredients of this medicine ( listed in section 6 ). signs of an allergic reaction may include rash , swallowing or breathing problems , swelling of your lips , face , throat or tongue . if you think you may be allergic to heparin or other low molecular weight heparins ( e . g . nadroparin , tinzaparin , dalteparin ), tell your doctor immediately . if a reaction occurs with heparrin , you may experience a severe drop in the number of your clotting cells ( platelets
like other similar medicines ( medicines to prevent blood clotting ), thorinane is used to prevent bleeding . it works by blocking the blood supply to the bleeding . if you experience any bleeding event that does not stop immediately , including exceptional weakness , tiredness , paleness , dizziness , headache and unexplained swelling , stop taking your medicine and contact your doctor immediately . if any of these apply to you , stop using your medicine immediately and contact a doctor or the nearest hospital straight away . if your doctor thinks that you may have a severe allergic reaction , including difficulty breathing , swelling of the lips , mouth , throat or eyes , or block
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store below 25 . after dilution the solution should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 8 hours at 2ºc to 8ºc . do away with this medicine if you notice that the thorinane pre - filled syringes are damaged or have not been stored
what thorinane contains the active substance is enoxaparin sodium . one ml contains 100 mg of enoxapearin sodium in each pre - filled syringe . each 0 . 2 ml syringe contains 2 , 000 mg of the active ingredient enoxafarin sodium and / or water for injections . each vial contains 0 . 02 ml of solution . what thorinanes looks like and contents of the pack thorinANE is a clear , colourless type i neutral glass syringe barrel with fixed needle and needle shield , with chlorobutyl rubber stopper and a blue polypropylene plunger rod . each
the active substances in senstend are lidocaine and prilocaine . both belong to a group of medicines called local anaesthetics . senstends is used to prevent lifelong premature ejaculation in adult men . it works by attaching itself to the head of the penis , which allows ejaculation to be completed .
do not use senstend if you are allergic to lidocaine , prilocaine or any of the other ingredients of this medicine ( listed in section 6 ). if you have a history of allergy or sensitivity to local anaesthetics ( amide - type local anaesthesia ). if your doctor has told you that you have or have had a genetic disease or other condition that affects your red blood cells ( glucose and phosphate deficiency ), such as anaemia ( methaemoglobinaemia ). if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor before using this medicine . do not
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use the recommended dose of senstend is 3 sprays ( 3 sprabs per day ) in the morning and evening . the first dose is 1 spray into the head of your penis . after 3 weeks , the second dose is 24 sprays per day . the third dose is 4 sprays in the evening . how to use use the spray container before using the pump mechanism . gently squeeze the valve to prevent contact with eyes , nose , mouth and ears . the
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : common ( may affect up to 1 in 10 people ) inability to develop or maintain an erection in the penis feeling of burning in the area of the penis uncommon ( may affects up to1 in 100 people ) headache local irritation of the throat and irritation of any part of the skin redness failure to ejaculate during sexual intercourse abnormal orgasm tingling in the part of your penis pain or discomfort in the place of the penis itching in the space of your vagina a high temperature other side effects very
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the metal container after exp . the exp date refers to the last day of that month . store below 25 . store in the original package in order to protect from light . after first opening , use within 12 hours . do away with the metalcontainer and puncture or burn it . do this if you notice any particles in it . these measures will help to protect the environment .
what senstend contains - the active substances are lidocaine and prilocaine . each ml of solution contains 150 mg lidocain and 50 mg prilacaine . one spray container contains 50 ml of lidocane and 7 . 5 ml of prilucaine . - each spray container provides 2 . 5 mg of prlocaine per ml . what senstends looks like and contents of the pack each spraycontainer contains 6 . 5 to 20 ml of clear , colourless to light yellow cutaneous spray . each spray containers contains 5 or 12 sprays . each pack contains an aluminium spray container with
opdivo is a medicine used to treat advanced melanoma ( a type of skin cancer ) in adults melanoma that has not responded to complete resection in adults ( treatment may be surgery or adjuvant therapy ). advanced non - small cell lung cancer ( advanced renal cell carcinoma ) advanced kidney cancer in adults classical hodgkin lymphoma , when previous therapies have not worked or have not been able to provide an autologous stem - cell transplant . advanced kidney disease in adults advanced lymphoid , head and neck or bladder cancer in patients who have not received previous therapies , including an autologic stem - stem - transplant
do not use opdivo if you are allergic to nivolumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before using opdivor if you : - have problems with your heart , such as a change in the rhythm or the heartbeat , or an abnormal heart rhythm . - have any problems with any of your lungs , such breathing difficulties or cough . - had inflammation of the lungs ( pneumonitis or interstitial lung disease ). - have diarrhoea , watery , loose or soft stools . - any symptoms of inflammation of any intestines
opdivo is available in two strengths : opdivo 240 mg in each 2 ml vial and 480 mg in the 4 ml vials . opdivor is also available in combination with ipilimumab for the treatment of skin cancer . op divo is given in combination to 1 mg of nivolumab per kilogram of your body weight . the recommended dose is 4 mg per kil kilogram body weight , given once a week . opiodo 240mg in each 3 ml vinal and 480mg in the 14 ml vals administration is also possible . the dose is based on your bodyweight .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the exp date refers to the last day of that month . store below 25 and transport refrigerated ( 2 - 8 ). do not freeze . after dilution , chemical and physical in - use stability has been demonstrated for 48 hours at refrigerated temperature . the infusion solution should be used immediately . any unused medicine or waste material should be disposed of in accordance with local requirements .
what opdivo contains the active substance is nivolumab . each ml of concentrate for solution for infusion contains 10 mg of nivlumab ( as 40 mg / ml ). each 4 ml vial contains 100 mg of 10 mg or 240 mg of 24 mg of the nivlonumab as 40mg / ml . the other ingredients are sodium citrate dihydrate , sodium chloride ( see section 2 " opdivos contains sodium "), mannitol ( e421 ), pentetic acid , polysorbate 80 , sodium hydroxide , hydrochloric acid and water for injections . what
clopidogrel tad contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopridogrelTad is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombogenesis , which can lead to atherostrombotic events (
do not take clopidogrel tad 30 if you are allergic to clopiprel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , or if you think any of this applies to you ), tell your doctor before taking clopridogrel tart . warnings and precautions the following apply to all people taking clapidogl tud : if you : have a risk of bleeding such a medical
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clapidogl to be given orally once at the start of each 75 - day course of treatment .
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what clopidogrel tad contains the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopidaogrel ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone , macrogol 6000 and hydrogenated castor oil in the tablet core and polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide , talc and macrogola 3000 in the film - coating . what clopidiogrel tetad looks like and contents
tacrolimus contains the active substance tacrolimos . it is an immunosuppressant . after your organ transplant ( liver and kidney ), your body ' s immune system will try to reject the new organ . tacforius is used to prevent rejection of transplanted organs by the liver and kidneys , and to reduce the effects of any previous treatment that was not able to control the rejection of the transplanted organ after your transplantation .
do not take tacforius if you are allergic to tacrolimus or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . if you have been taking sirolimus , any macrolide ( antibiotic ), erythromycin , clarithromycin or josamycin . tacrolin immediate release capsules ( e . g . , tacnier ). tacforia prolonged - release capsules are not available . tacrulimus prolonged -release capsules are available . if any of these apply to you , tell your doctor
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this medicine should only be prescribed by a doctor experienced in the treatment of transplant patients . you should take the same tacrolimus medicine as your transplant patient . however , if you have been given a different tacrosimus medicine , your doctor may change the dose of this medicine . your doctor will check that you are taking the right medicine to prevent the rejection of your transplanted organ . the usual dose for adults is based on your body weight . the recommended dose for transplantation is 0 . 10 mg
like all medicines , this medicine can cause side effects , although not everybody gets them . infections you will be monitored for infections while you are being treated with tacforius . severe effects may occur , including allergic and anaphylactic reactions , benign and malignant tumours which may be fatal during tacforia treatment . pure red cell aplasia ( a very severe reduction in red blood cell counts ), agranulocytosis ( a severely lowered number of white blood cells ), haemolytic anaemia ( decreased number of red blood cells due to abnormal breakdown ), febrile neutropenia ( a reduced
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). discard all the prolonged - release hard capsules within 1 month after opening the aluminium wrapping . do away with the foil . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what tacforius contains the active substance is tacrolimus . tacforiu 0 . 5 mg : each capsule contains 0 . 25 mg of tacrolamus ( as monohydrate ). tacforio 1 mg : one capsule contains 1 mg of ticrolimum ( asmonohydrate ). each capsule of tacforios 3 mg : three capsules contain 3 mg of tartrolimas ( asohydrate ). the other ingredients are : tacforiet 5 mg capsule contains 5 mg of titrolimos ( as carbohydrate ). capsule content hypromellose 2910 , ethylcellulose , lactose , magnesium
clopidogrel zentiva contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopIDogrelzentiva is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombogenesis , which can lead to atherostrombotic
do not take clopidogrel zentiva : if you are allergic ( hypersensitive ) to clopipidogl or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , tell your doctor before taking clopridogrelzentiva . warnings and precautions the following apply to all patients taking clapidogel zentive : if any risk of bleeding is considered , including : - if
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel zentiva per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clapidogl zenta ( 4 tablets of 75 mg ) once at
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the blister tightly closed in order to protect from light . do use clopidogrel zentiva in aluminium blisters after the first 30 . do this to protect the tablets from moisture . doxorbed on aluminium blays : do not store above 25 . do xorbed upon aluminium blinks : dox or on
what clopidogrel zentiva contains the active substance is clopridogrel . each tablet contains 75 mg of clopidaogrel ( as hydrogen sulphate ). ( see section 2 ' clopiderel zenta contains lactose ' and ' clogidogl zentive contains hydrogenated castor oil '). the other ingredients are mannitol ( e421 ), hydrogenatedcastor oil , microcrystalline cellulose , macrogol 6000 , low - substituted hydroxypropylcellulose , lactose monohydrate ( milk sugar ), hypromellose ( e464 ),
yttriga is a radioactive medicine that is stored in a hospital or clinic . it is stored either in the original package or in a separate container . when yttrigba is prepared as another medicine , it is prepared in tiny radiolabelled medicinal product .
do not use yttriga - if you are allergic ( hypersensitive ) to chloride or any of the other ingredients of yttiga - you are pregnant or think you may be pregnant . warnings and precautions talk to your nuclear medicine doctor before using yttrada - yttrida is a radioactive medicine . it is used as another medicinal product in the processing of radiopharmaceuticals . yttarga contains radioactive material . radioactive medicinal products are stored at 2 to 16 in the outer layer of the vial . other medicines and yttoga tell your nuclear medicines doctor if you or your child are
the treatment will be supervised by a doctor experienced in the diagnosis and treatment of medicinal products . method of administration yttriga is for radiolabelling of medicinal product . it is used for specific diseases . if you have been prescribed yttrada for you , you should inform your doctor immediately . if overdose occurs , your doctor will determine the appropriate treatment .
like all medicines , yttriga can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
yttriga will be stored under the responsibility of the specialist in appropriate premises . storage will be in accordance with local regulations on radioactive substances . any unused product or waste material should be disposed of in accordancewith local requirements .
what yttriga contains - the active substance is chloride . 1 ml sterile solution contains 1 mg of hydrochloric acid ( equivalent to 3 mg / ml ). what yttiga looks like and contents of the pack yttarga is a clear , colourless type i glass vial with a flip bottom and a silicon stopper and an aluminium seal .
ciambra is a medicine used in the treatment of cancer . ciambra contains the active substance cisplatin , another anti - cancer medicine , which is used as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , which has not responded to prior chemotherapy . cimbra is also used in combination with cisplin for the initial treatment of patients with advanced stage of lung cancer . how ciamBra works patients with lung cancer are at risk of developing your disease if treatment is not considered appropriate after initial chemotherapy . how it works ciamba is a treatment
do not use ciambra - if you are allergic ( hypersensitive ) to pemetrexed or any of the other ingredients of ciamb . warnings and precautions talk to your doctor , pharmacist or nurse before using ciamBra . children and adolescents ciamba is not recommended for use in children and young children below 6 years of age . breast - feeding should be avoided during treatment with ciamra . if you have recently received or are about to receive a vaccine against yellow fever , tell your doctor before using this medicine . ciambre is not intended for use if you suffer from problems with your kidneys . before
the recommended dose of ciambra is 500 micrograms for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your whole body . your doctor will work out this body surface area using your body surface surface area as a whole . your dose and duration of treatment will depend on your blood cell counts and on your general condition . your healthcare professional will have mixed the ciamra powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution before it is given to you . ciamBra will be given to your doctor by infusion into one of your
like all medicines , this medicine can cause side effects , although not everybody gets them . 52 tell your doctor immediately if you experience : fever or infection ( common ) with a temperature of 38ºc or greater sweating ( common ). infection ( uncommon ) with less white blood cells than normal ( very common ). this can lead to infection ( sepsis ) and death . if you have chest pain ( common ), with a fast heart rate ( common ); pain , redness , swelling or sores in your mouth ( uncommon ). allergic reaction ( common ): skin rash ( common , may include burning or prickling sensation ) or fever ( common
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the expiratory date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . store below 25 . do away with the reconstituted solution . do this immediately after preparation . the infusion solution should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 -
what ciambra contains the active substance is pemetrexed . ciamba 100 mg : each vial contains 100 mg of pemetreed ( as pemetereed disodium hemipentahydrate ). ciamBra 500 mg : one vial delivers 500 mg of the active ingredient pemetreoned (as pemetired dis sodium hemipertahydrates ). after reconstitution , the solution contains 25 mg / ml of pemrexed without further dilution . the other ingredients are mannitol ( e421 ), hydrochloric acid ( for ph adjustment ), sodium hydrox
immunogam belongs to a group of medicines called immunoglobulins ( antibodies ). immunoglubulins help to control certain infections in your blood . immunogam can be used to prevent increased levels of human hepatitis b immunoglutins ( immunoglobin g ( ig )) in blood plasma of screened adults . immunoglogam is used to treat adults . your doctor will test for the presence of immunogams in patients who have previously been treated with hepatitis b virus in haemodialysed patients . vaccination may be delayed or stopped if you are a hepatitis birus carrier . immunovogam
you should not be given immunogam : if you have ever had an allergic reaction to human immunoglobulins or other blood products . if you suffer from an iga deficiency . if this applies to you , tell your doctor . if an allergic response occurs to iga containing products . children and adolescents immunogamer is not recommended for use in children and teenagers under 18 years of age . immunogloglobulin can cause adverse reactions such as chills , headache , fever and vomiting . allergic reactions may also be severe ( nausea , arthralgia ), joint pain , low blood pressure and moderate low back pain
immunogam is intended for vaccination against hepatitis b virus . the first vaccine dose will be given in combination with human hepatitis b immunoglobulin ( hbv ). administration prevention the recommended dose for hepatitis b in individuals who have not previously received 500 hbcv is : one 500 hcv dose given 24 to 72 hours after the last dose of hepatitis b . the recommended recommended dose of immunogam in haemodialysed patients is : 500 hdcv given 2 hours after vaccination with hepatitis b by a hepatitis birus carrier . the hepatitis b antigen administration and seroconversion following vaccination courses should be
like all medicines , immunogam can cause side effects , although not everybody gets them . the following side effects have been reported with immunogams : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) rare ( affects less than 1 users in 10 , 000 ), not known ( frequency cannot be estimated from the available data ) very rare ( affecting less than1 user in 100 ), not applicable ( frequency not known ) very serious adverse effects have occurred during clinical trials with immunoglobulin . the injection site is usually a
keep out of the reach and sight of children . do not use immunogam after the expiry date which is stated on the carton and on the label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . donot use immunongam if the solution is cloudy or contains deposits . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what immunogam contains - the active substance is human hepatitis b immunoglobulin . one ml of immunogams contains 1 or 5 mg of human plasma protein ( equivalent to 96 mg / ml ). - the other ingredients are polysorbate 80 . what immunogum looks like and contents of the pack immunogamer is a solution for injection in a glass vial . it is a clear to slightly opalescent , colourless to pale yellow liquid . each pack contains 1 vial of immunoglubulin .
remicade contains the active substance infliximab . inflixumab is a monoclonal antibody a type of protein that recognises and attaches to a specific target in the body called tumour necrosis factor ( tnfα ). remicade belongs to a group of medicines called ' tnfs blockers '. it is used to treat the following inflammatory diseases : rheumatoid arthritis , psoriatic arthritis , ankylosing spondylitis ( bechterew ' s disease ) and psoriasis . remicades is used in adults , adolescents and children aged 6 years and older
do not take remicade if you are allergic to infliximab or any of the other ingredients of remicades ( listed in section 6 ) if you think you may be allergic ( hypersensitive ) to any of these active substances if you have tuberculosis ( tb ) if your doctor has told you that you have another serious infection , such as pneumonia , sepsis or heart failure if you drink alcohol before or during remicada . if you feel that the effect of reminade is too strong or too weak , talk to your doctor . warnings and precautions talk to you doctor or pharmacist before taking remic
the recommended dose for adults is : rheumatoid arthritis : 3 mg for every kg of body weight . psoriatic arthritis , ankylosing spondylitis ( bechterew ' s disease ), psoriasis , ulcerative colitis and crohn ' s diseases : 5 mg for each kg of skin weight . how remicade is given remicine is given as an infusion ( drip ) over 2 hours into one of your veins ( usually in your arm ). the third treatment will be given after a gap of at least 1 month . how much remicad is given your doctor will decide
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some patients may experience serious side effects and require treatment . tell your doctor straight away if you notice any of the following side effects during or after your treatment with remicade : - if you have an allergic reaction , including swelling of your face , lips , mouth or throat , which may cause difficulty in swallowing or breathing , skin rash , hives and swelling of the hands , feet or ankles . these reactions are rare but can be life threatening . an allergic response can occur in up to 2 in
keep this medicine out of the sight and reach of children . do not use remicade after the expiry date which is stated on the carton and vial label after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . store in a refrigerator ( 2 8 ). do not freeze . remicad may be used for infusion after 3 weeks when stored at 2 8 or 28 . if stored at room temperature for an additional 24 hours , it may be stored at 25 for a single period of up to six months . do away with remicades if you notice
what remicade contains the active substance is infliximab . each vial contains 100 mg of inflixumab . after reconstitution , each ml contains 10 mg of infiximb . the other ingredients are sucrose , polysorbate 80 , monobasic sodium phosphate and dibasicodium phosphate . what remicada looks like and contents of the pack remicad is supplied as a glass vial containing a powder for concentrate for solution for infusion . the powder is white to off - white . remicades is supplied in packs of 1 , 2 , 3 , 4 or 5
rasagiline mylan is used to treat parkinson ' s disease in adults . it is used in combination with levodopa ( another medicine used to control parkinson '. in parkinson's disease , there is a loss of cells that produce dopamine in the brain . dopamine is a chemical in the body that is important for movement control . rasagilinea mylan works by increasing the amount of dopamine that is produced in the cells . this helps to increase the amount that dopamine is produced throughout the brain and helps to maintain movement control throughout the day and night . raspagilmine mylan increases the amount dopamine
do not take rasagiline mylan - if you are allergic to rasaga or any of the other ingredients of this medicine ( listed in section 6 ). - if severe liver problems . warnings and precautions talk to your doctor or pharmacist before taking the following medicines : rasaline mylan contains monoamine oxidase ( mao ) inhibitors , used to treat depression and parkinson ' s disease . it is also a medicinal ( natural products ) form of st . john ' s wort . pethidine is a strong pain killer . children and adolescents rasaggiline melan treatment should be stopped or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 tablet once a day by mouth . take rasagiline mylan at about the same time each day . you should take rascagilrine mylan every day until your doctor tells you otherwise . if you take more rasgiline than you should if you accidentally take too many tablets , contact your doctor immediately . take the rasaga mylan carton with you so that you can easily describe what you have taken . if possible take rrasagil
like all medicines , this medicine can cause side effects , although not everybody gets them . side effects of rasagiline mylan are similar to those of placebo . the frequency of possible side effects is defined using the following convention : very common abnormal movements ( dyskinesia ) headache common abdominal pain rare rare cases of fall allergy fever flu ( influenza ) feeling of being unwell neck pain chest pain ( angina pectoris ) low blood pressure with symptoms such as light headedness ( orthostatic hypotension ) decreased appetite , constipation , dry mouth , nausea and vomiting flatulence abnormal results of blood ( leuc
what rasagiline mylan contains - the active substance is rasagailine . each tablet contains rasageiline tartrate equivalent to 1 mg rasgailine - the other ingredients are microcrystalline cellulose , tartric acid , maize starch , pregelatinized maize starch and talc , stearic acid . what rasaggiline Mylan looks like and contents of the pack rasaginiline tablets are 11 . 5 mm x 6 mm , white to off - white , biconvex tablets debossed with " r " on one side and "
do not use hulio - if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has a severe infection , including tuberculosis ( see " warnings and precautions "). symptoms of infections may include fever , wounds , feeling tired , dental problems . - if the child has moderate or severe heart failure . - tell your doctor if the patient has a serious heart condition . warnings and symptoms of allergic reaction some patients have experienced allergic reactions with symptoms such as chest tightness , wheezing , dizziness , swelling or a rash . the severity of these reactions
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . polyarticular juvenile idiopathic arthritis in adults and adolescents from 2 to 17 years old weighing 10 kg or more : the usual dose is 30 mg once a day . hulio is 20 mg once daily . in children from 2 - 17 years of age weighing 30 kg or less : the dose is 40 mg once weekly . enthesitis - related arthritis in children and adolescents 6 to 17 months of age and weighing 15 kg or greater : the doctor will prescribe you a 30 mg dose . h
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate and may be of concern to you . you may need urgent medical treatment if you notice any of the following side effects ( see section 4 of this leaflet ): after the last hulio injection , you may experience allergic reaction or heart failure severe rash or hives swollen face , hands or feet trouble breathing or swallowing pale complexion , dizziness persistent fever , bruising or bleeding . signs and symptoms of infection such as fever , feeling sick , wounds , dental problems , burning on urination , feeling weak or tired
what hulio contains - the active substance is adalimumab . - the other ingredients are monosodium glutumate , sorbitol , methionine , polysorbate 80 , hydrochloric acid and water for injections . what hulios looks like and contents of the pack hulIO 40 mg is a sterile solution for injection in a vial containing 40 mg of adalimimumab in 0 . 8 ml of solution . the solution is clear to slightly opalescent and has a rubber stopper . hullio is available in packs containing 1 , 2 , 1 , 1 sterile injection
the active substance of yellox is bromfenac . it belongs to a group of medicines called non - steroidal anti - inflammatory drugs ( nsaids ), which reduce inflammation . yellox has been prescribed for the treatment of eye inflammation following cataract surgery in adults .
do not use yellox - if you are allergic to bromfenac or any of the other ingredients of this medicine ( listed in section 6 ). - if your asthma ( skin allergy ) is severe . - if there is intense inflammation in your nose . warnings and precautions talk to your doctor or pharmacist before using yellox . other nsaids are acetylsalicylic acid , ibuprofen , ketoprofen and diclofenac . this medicine may be used with topical steroids such as cortisone which may increase unwanted side effects . - bleeding problems if you have had haemophilia
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose of yellox is one drop in the affected eye ( s ) twice a day . the recommended daily dose is one dose in the eye (s ) twice daily , for 2 weeks . the drops should be used on the next day after your cataract surgery . method of administration yellox is for oral use . wash your hands before using the eye drops . remove the bottle cap from the bottle . hold the bottle , pointing down , between your thumb and fingers .
what yellox contains - the active substance is bromfenac . each ml of solution contains bromenac ( as sodium sesquihydrate ). each vial contains 33 mg of bromnac . - the other ingredients are boric acid , borax , sodium sulphite anhydrous , benzalkonium chloride , tyloxapol , povidone ( k30 ), disodium edetate , sodium hydroxide to maintain acidity levels . what yellox looks like and contents of the pack yellox is a clear yellow liquid ( solution ) supplied in a glass v
duzveo contains sufentanil , which belongs to a group of strong painkillers called opioids . sufENTanil is used to treat sudden moderate - to - severe pain in adults .
do not take dzuveo - if you are allergic to sufentanil or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have a serious lung or breathing problem . warnings and precautions talk to your doctor or pharmacist before taking dzuvoo - tell your doctor if you have any condition affecting your breathing ( such as asthma , wheezing or shortness of breath ). dzuveco may affect your breathing during treatment . - tell a doctor if : - you have recently suffered a head injury - you suffer from brain tumour - you
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the single - dose administration device is for oral use only . swallow the tablet whole with a glass of water . you can take this medication with or without food . dzuveo must be taken with strong painkillers such as sufentanil . the recommended dose is 30 mg once daily . the sublingual tablet should be taken in the morning with or with food . the disposable single -dose applicator should be inserted into the tablet tray . the applicator must be inserted under the tongue .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects : severe breathing problems , slow and shallow breathing . if you get any of these side effects contact your doctor immediately . very common side effects ( may affect more than 1 in 10 people ): nausea , feeling sick , vomiting , being sick and feeling hot . common side side effect ( may effect up to 1 in every 10 people ) : inability or difficulty sleeping , feeling anxious or confused , dizziness , headache , drowsiness , feeling sleepy , increased heart
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . do use this product if you notice any visible signs of deterioration . do this if you are concerned that the solution may have been accidentally frozen . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help protect the environment .
what dzuveo contains - the active substance is sufentanil . each tablet contains 30 mg sufantanil ( as citrate ). - the other ingredients are mannitol ( e421 ), dicalcium phosphate , hypromellose , croscarmellose sodium , indigo carmine ( e132 ), stearic acid , magnesium stearate . what dzuvoo looks like and contents of the pack dzu veo is a white to off - white , round oval tablet with " 30 " debossed on one side and " 3 " debottled on the other
erveada is a cancer medicine that contains the active substance apalutamide . it is used to treat adult men with prostate cancer that has spread to other parts of the body and cannot be treated with surgical treatments . it also treats adult men who have sensitive prostate cancer which has spread beyond the original body and has not responded to surgical treatment with testosterone . it has been shown to reduce the number of resistant prostate cancer cells . erleada also works by blocking the action of androgens , which are involved in the growth of the cancer . by blocking androgens from the blood , apalotamide stops prostate cancer from growing and dividing
do not take erleada - if you are allergic to apalutamide or any of the other ingredients of this medicine ( listed in section 6 ). - if if you think you may be pregnant or are planning to become pregnant . ( it is also better to avoid erleade in early pregnancy see pregnancy and contraception section ). if you have any further questions on the use of this medication , ask your doctor or pharmacist . warnings and precautions talk to your doctor before taking this medicine . this medicine should not be given to children under the age of 18 years . if you take any medicines that may increase the risk of blood cl
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 240 mg once a day . your doctor may increase your dose to 60 mg once daily depending on how you respond to erleada . take this leaflet with you . this medicine is for oral use . it is taken by mouth . if you take more erleade than you should if you accidentally take too many tablets , contact your doctor immediately . taking other medicines if you forget to take erlea if you miss a dose , take it as soon as you remember . if it
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking erleada and see a doctor immediately if you have any of the following symptoms : reddish , non - elevated , target - like , circular patches on the trunk , central blisters , skin peeling , ulcers of mouth , throat , nose , genitals and eyes . these serious skin rashes may be accompanied by fever and flu - like symptoms . toxic epidermal necrolysis ( dress ) ( dress ). serious side effects tell your doctor straight away if you notice any of these serious sideeffects : fits ( seizure )
what erleada contains - the active substance is apalutamide . each film - coated tablet contains 60 mg of apalectamide . - the other ingredients are colloidal anhydrous silica , croscarmellose sodium , hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose , silicified microcrystine cellulosa . - in addition , the film - coating contains iron oxide black ( e172 ), iron oxide yellow ( e 172 ), macrogol , polyvinyl alcohol , talc , and titanium dioxide ( e 171 ). what erlead
this medicine is a radiopharmaceutical product . axumin contains the active ingredient fluciclovine . it is used to perform a type of scan called a pet scan . it may be used : - if you have previously had treatment for prostate cancer . - if other tests have shown prostate specific antigen ( psa ) in the blood . - when the cancer has spread . an axumin pet scan may show the cancer that has spread to the prostate . the scan will be recorded on the patient alert card . your doctor or nurse will record the name of the patient and batch number of the product that you are using . your
do not use axumin - if you are allergic to fluciclovine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using axumin . - if your doctor has told you that you have kidney problems . - you should follow a low sodium diet . - axumin is given once a day for a day . the axumin scan will last approximately 4 hours . during the scan , you will be given your usual medicines to take for the latest 60 minutes . - during the 60 minutes after the axus injection , you should urinate at least
there are strict laws on the use , handling and disposal of radiopharmaceutical products . axumin will only be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this medicine and will keep you informed of their actions . the nuclear medicine doctor supervising the procedure will decide the quantity of axumin to be used . the usual dose is 370 megabecquerel per kilogram of body weight . axon will be given to your child by a doctor or nurse . the doctor will decide how much axumin you should receive . during
like all medicines , this medicine can cause side effects , although not everybody gets them . in clinical studies , the following side effects were reported : common ( affects 1 to 100 patients ): the medicine may cause side effect when used with axumin . uncommon ( affects less than 1 to100 patients ): pain , rash , altered taste in the mouth , altered sense of smell . this radiopharmaceutical emits low amounts of ionising radiation which can cause the body to produce its own protection against cancer and hereditary abnormalities . reporting of side effects if you get any side effects talk to your nuclear medicine doctor . this includes any possible side effects not listed
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only : axumin will be stored under protection from light .
what axumin contains - the active substance is fluciclovine . axumin 1600 mg : each vial contains 1600 mg of fluciniclovine ( as besilate ). each 1600 mg vial of 16000 mg axumin 3200 mg : one vial containing 3200mg of fluciiclovin ( as mesilate ) ( as resilate ), each 3200 ml vial delivers 32000 mg of the active substances . - the other ingredients are sodium citrate , concentrated hydrochloric acid and sodium hydroxide ( see section 2 " axumin with sodium "). what axumin
azopt contains brinzolamide which belongs to a group of medicines called carbonic anhydrase inhibitors . it works by reducing pressure within the eye . azopt eye drops are used to treat high pressure in the eye , an illness called glaucoma . the pressure in your eye increases , which can damage your sight .
do not take azopt if you have severe kidney problems . if you are allergic to brinzolamide or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to medicines containing sulphonamides ( medicines used to treat diabetes or infections ). if any of these apply to you , tell your doctor before taking azopt . warnings and precautions talk to your doctor or pharmacist before taking this medicine if you : have had the same allergy before . have too much acidity in your blood ( hyperchloraemic acidosis ). your doctor may need to adjust your dose of az
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . azopt is used for the eyes only . use azopt in both eyes . use in both the eyes : 1 drop in each eye , 1 drop of the colourless liquid in each nostril , and 1 drop drop of a colourless fluid in each eyelid , approximately 3 hours apart . remove the azopt bottle . wash your hands before using it . remove from the cap . remove one side of the cap with a snap collar . hold the bottle with your thumb or finger , pointing down towards your
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with azopt : common side effects ( may affect up to 1 in 10 people ) - effects in the eye : blurred vision , eye irritation , eye pain , eye discharge , itchy eye , dry eye , abnormal eye sensation , redness of the eye . other side effects : bad taste . uncommon side effects - effects ( might affect up up to1 in 100 people ) ) - effect in the inside of theeye : sensitivity to light , inflammation or infection of the conjunctiva , eye swelling , eyel
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and bottle after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . to prevent infections , a pack containing a single bottle should be used immediately .
what azopt contains - the active substance is brinzolamide . each ml contains 10 mg of brinzaolamide ( as benzalkonium chloride ). - the other ingredients are carbomer 974p , edetate disodium , mannitol , purified water , sodium chloride , tyloxapol , hydrochloric acid and sodium hydroxide ( to increase acidity levels and ph levels ). what azopt looks like and contents of the pack azopt is a milky liquid ( a suspension ) supplied in a 5 ml plastic ( droptainer ) bottle with a screw cap . a pack
the active substance of forxiga , dapagliflozin , belongs to a group of medicines called " oral medicines ". it belongs to the group of " oral " medicines which are taken by mouth . forxigo is used to treat diabetes by lowering the amount of sugar in your blood . it is used in adults ( aged 18 years and older ) and adolescents ( 12 years and above ). forxige is used for diabetes in adults . type 1 diabetes is a problem that occurs when your body does not make enough insulin or if your body is not able to use the insulin it produces effectively . diabetes occurs mainly in women
do not take forxiga - if you are allergic to dapagliflozin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking forxigo : - if any of these apply to you , tell your doctor straight away : - feeling sick or being sick , stomach pain , excessive thirst , fast and deep breathing , confusion , unusual sleepiness or tiredness , a sweet smell to your breath , asweet or metallic taste in your mouth , a different odour to your urine or sweat , rapid weight loss . contact your doctor immediately if
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of forxiga for type 2 diabetes is 10 mg once a day ( 5 mg twice a day ). if you have a liver problem , your doctor may lower your dose of the tablet . your doctor will tell you how many tablets of for xiga to take . for type 1 diabetes the recommended starting dose is 5 mg once daily . your dose may be increased if you take more tablets than you should . your physician will tell how many capsules to take and how often to take them . if
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are angioedema ( seen very rarely , may affect up to 1 in 10 , 000 people ). angioEDema is swelling of the face , tongue or throat which may cause difficulties swallowing , hives and breathing problems . diabetic ketoacidosis ( seen commonly , may affects up to1 in 10 people ) is a complication of type 2 diabetes . it is rare , but may affect 1 in 1 , 000 to 1 , 10 people . diabeticketoacidemia may occur with increased levels of " ketone
what forxiga contains - the active substance is dapagliflozin . each forxigo 5 mg film - coated tablet ( tablet ) contains dapapagllozin propanediol monohydrate equivalent to 5 mg dapablifloin . - the other ingredients are : tablet core : microcrystalline cellulose ( e460i ), lactose ( see section 2 under ' forxigiga contains lactose '), crospovidone , silicon dioxide ( e171 ), magnesium stearate . film - coating : polyvinyl alcohol ( partially hydrolysed ), titanium dioxide ( i
mifamurtide is a medicine that blocks the activity of certain bacteria in the immune system . mepact is used to treat osteosarcoma ( bone cancer ) in adults and adolescents aged 2 and 30 years . it is used when surgery is not possible to remove the tumour and is given alone or together with chemotherapy which stops cancer cells from growing and cancer is likely to come back .
do not take mepact if you are allergic to mifamurtide or any of the other ingredients of this medicine ( listed in section 6 ). if you take medicines containing ciclosporin or other cineurin inhibitors ( non - steroidal - anti - inflammatory drugs ). nsaids may cause problems with your heart or blood vessels such as blood clots ( thrombosis ), bleeding ( haemorrhage ), inflammation of the veins ( vasculitis ). warnings and precautions talk to your doctor or pharmacist before taking mepactor if any of these apply to you . some of the effects
treatment mepact will be given to you by a doctor or nurse . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of mepACT is 2 mg mifamurtide once a day . your doctor will decide how many doses you need . the dose may be increased every 12 hours or 24 hours . your dose may need to be adjusted by your doctor . your physician will decide on the right dose for you . your chemotherapy schedule will depend on your chemotherapy and on how you respond to it . the maximum dose you should take is
like all medicines , mepact can cause side effects , although not everybody gets them . chills , fever and fatigue have been reported in patients taking mepacts ( transient ) paracetamol . fever has been reported during treatment with mepACT . if you have stomach problems ( nausea , vomiting , loss of appetite ) during chemotherapy , tell your doctor immediately . continuing fever and chills have been seen in patients receiving up to 8 doses of mepacting . if any of the following apply to you , tell the doctor immediately : - if you develop an infection ( rash ), - if any problems breathing , wheezing
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in outer carton in order to protect from light . reconstituted suspension may be stored at ambient room temperature ( up to 25 ) for a single period of up to 9 days . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not
what mepact contains the active substance is mifamurtide . one vial contains 4 mg of mifamanurtide ( as besilate ). after reconstitution and suspension , each ml contains 0 . 08 mg mifmurtide per ml . the other ingredients are 1 - palmitoyl - 2 - oleoyl- sn - glycero - 3 - phosphocholine ( see section 2 under ' mepacts contains lactose ') 2 - dileoyls - sn - glyco - 5 - sodium monosodium salt ( see also section 2 " mepACT
mirvaso contains the active substance brimonidine which belongs to a group of medicines called alpha agonists . it is used on the skin of the face to reduce redness ( rosacea ) and redness of theface . rosica is caused by high levels of blood flow in theacial skin and enlargement ( dilution ) of the small blood vessels of the skin . mirvaso acts by blocking the blood vessels which prevent the excess blood flow and reding of the area .
do not take mirvaso - if you are allergic to brimonidine or any of the other ingredients of this medicine ( listed in section 6 ) warnings and precautions talk to your doctor or pharmacist before taking mirvasos if you have had any of these conditions : - if your doctor has prescribed mirvasoe for you , as it may increase the risk of side effects . - if the medicine is given under the skin ( for example , in combination with certain medicines used to treat depression or parkinson ' s disease ) - if a person is taking monoamine oxidase ( mao ) inhibitors such as selegiline
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . mirvaso is applied to the skin or on the face . this medicine is applied on the surface of your body . it is applied in the same area as the body faces . it should only be applied to your eyes , mouth , nose or vagina . if you have any further questions on the use of mirvasos , ask your doctor , pharmacist or nurse . if necessary , your doctor may change the dose of mirviso mirvasoe is applied only to the face once a day . the
like all medicines , this medicine can cause side effects , although not everybody gets them . uncommon side effects : severe skin irritation or inflammation , skin rash , skin pain or discomfort , dry skin , warm skin sensation , tingling , sensation of pins and needles or swelling . common side effects that may be worsening of rosacea are : worsening of the treatment with symptoms ( see section 2 " warnings and precautions "). contact allergy : allergic reaction including rash and rare angioedema ( a serious allergic reaction with swelling mainly of the face , mouth and tongue ). if you are given mirvaso stop using mirvasoa and tell
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and tube and pump after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do away with the tube and pumps that are damaged or shows signs of tampering . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what mirvaso contains - the active substance is brimonidine . each ml of gel contains 3 . 3 mg of brimonine . each vial contains 5 mg of the active ingredient brimonidine tartrate . - the other ingredients are carbomer , methylparahydroxybenzoate , phenoxyethanol , glycerol , titanium dioxide ( e171 ), propylene glycol , sodium hydroxide , purified water ( see section 2 " mirvasos contains methylparahsydroxy benzoate "), propylene Glycol . what mirvasoa looks like and contents of the pack mirvas
mvasi contains the active substance bevacizumab , which is a humanised monoclonal antibody ( a type of protein that recognises and attaches to a specific target in the immune system , the body ' s natural defences ). it is used to defend the body against infection and cancer . bevacsizumb binds to a protein called human vascular endothelial growth factor ( vegf ), which is found in large amounts on the lymph vessels of the body . the veg f protein is found on blood vessels that provide blood with nutrients and oxygen . bevagacizumaab prevents tumour growth
do not use this medicine if you are allergic ( hypersensitive ) to bevacizumab or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic ( allergic or hypersensitive ), to chinese hamster ovary ( cho ) cell products if you or your child are pregnant . warnings and precautions talk to your doctor or pharmacist before using mvasi . if you have any of these conditions , please tell your doctor before using this medicine . if any of them apply to you , tell your physician before using it . if your doctor thinks you may have an increased risk
dose and frequency of administration your doctor will work out the dose of mvasi you will receive based on your body weight and the type of cancer . the usual dose is 5 mg , 7 . 5 mg or 10 mg per kg of body weight , given once every 15 days . your doctor may adjust the dose depending on your general condition and on your size of tumour . your dose of either mvasic once a day or once a week will be decided by your doctor . you will usually receive mvasis once a month for 2 or 3 weeks . your number of infusions may be increased depending on how you respond to
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with mvasi : side effects that may occur during treatment with mvai are similar to those of chemotherapy . these side effects are usually mild to moderate and usually disappear after a few days . if you notice any of these side effect , stop using mvasis and seek medical advice immediately . allergic reactions tell your doctor straight away if you have an allergic reaction including : difficulty in breathing , chest pain , redness and flushing of the skin , a rash , chills or shivering , feeling sick ( nausea
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outercarton in order to protect from light . infusion solutions should be used immediately after dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 8 and below 30 . do away
what mvasi contains the active substance is bevacizumab . each ml contains 25 mg of bevackizumumab in 1 . 4 ml or 16 . 5 ml of solution . each 4 ml vial contains 100 mg of the active substances bevaconizumb in 1. 4 ml of water . each 16 ml vials contains 400 mg of of bevoacizumaab in 16 .5 ml of solvent . the other ingredients are trehalose dihydrate , sodium phosphate , polysorbate 20 and water for injections . what mvasis looks like and contents of the
tecartus is a gene therapy medicine used to treat mantle cell lymphoma . it is used in adults , adolescents and children who are not able to take other medicines . it works by inhibiting the growth of refractory mantle cell lipoma ( b - lymphocytes ) in your own white blood cells . tecartus contains autologous anti - cd19 - transduced cd3 + cells . mantle cell cancer is a cancer that affects the immune system , which can cause the body to produce b - cells . in mantle cell lysisoma , b - lipocytes multiply in an uncontrolled way and accumulate in lymph tissue
do not use tecartus if you are allergic to any of the ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before using tecartuse if you have : - a problem with the number of white blood cells in your blood ( lymphodepleting chemotherapy ) ( see section 3 ) - a shortage of white cells due to autologous use ( see " other medicines and tecartuses "). tests and checks your doctor will do before you start using teCartus : - check your lungs , heart , kidney
tecartus contains your own white blood cells . your cells will be collected and given to you by a doctor or nurse . your doctor or nurses will take care to keep your cells alive . tecartus is given by catheter placed in your vein ( a procedure call leukapheresis ). your white blood cell will be taken from your blood and given into a vein over 3 to 6 hours . the number of your white white blood blood cells will then be taken up to 2 or 3 times per week . medicines given before tecartuse treatment ( lymphodepleting chemotherapy ) the modified white bloodcells will be given
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss your side effects with you and will explain the risks and benefits of taking tecartus . if you notice any of the following side effects you may need urgent medical attention : very common side effects during the tecartu infusion ( may affect more than 1 in 10 people ): fever , chills , reduced blood pressure . symptoms may include dizziness , lightheadedness , fluid in the lungs . all symptoms could be signs of a condition called cytokine release syndrome ( loss of consciousness ). decreased level of consciousness may be associated with confusion
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . infusion bag contains liquid nitrogen equivalent to 150 mg / ml . this medicine contains genetically modified human blood cells and human - derived material . the product is stable for 36 hours at 2 to 8 .
what tecartus contains the active substance is autologous anti - cd19 - transduced cd3 + cells . each specific single infusion bag contains a dispersion of anti - cd19 car t cells equivalent to 68 cd3 cells per 2 ml of solution . the concentration is 106 cd3 / ml . the other ingredients are anti - dcp19 , sodium chloride , human albumin ( see section 2 " tecartuses contains sodium "). what tecartu looks like and contents of the pack tecartub is a concentrate for solution for infusion . it is supplied as an infusion bag packed in a metal cassette
januvia contains the active substance sitagliptin which belongs to a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4 inhibitor ) that lowers blood sugar levels in adult patients with type 2 diabetes mellitus . this medicine helps to increase the levels of insulin produced after a meal and decreases the amount of sugar made by the body . your doctor has prescribed this medicine to help lower your blood sugar , which is too high because of your type 2abetes . this medication can be used alone or with certain other medicines ( insulin , metformin , sulphonylureas , or gl
do not take januvia - if you are allergic to sitagliptin or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has prescribed januvi for you because of inflammation of the pancreas ( pancreatitis ). warnings and precautions talk to your doctor or pharmacist before taking januva if you have : - blistering of the skin ( bullous pemphigoid ) janura is not recommended if you suffer from a disease of the pancreatreas called pancreatitis . - gallstones . - alcohol dependence . - very high levels of triglycerides ( a
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 100 mg film - coated tablet 63 once daily by mouth . if you have kidney problems , your doctor may prescribe a lower dose of 25 mg or 50 mg . your doctor will tell you the dose to take . you should take this tablet once daily . if your doctor advises you to take this medication alone , you should continue with this medicine as long as your physician prescribes certain other medicines that lower blood sugar . diet and exercise can help your body use its blood sugar better . if
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking januvia and contact a doctor immediately if you notice any of the following serious side effects : severe and persistent pain in the abdomen ( stomach area ) which might reach through to your back , with or without nausea and vomiting , as these could be signs of an inflamed pancreas ( pancreatitis ). if you have a serious allergic reaction ( frequency not known ), including rash , hives , blisters on the skin , peeling skin , swelling of the face , lips , tongue , and throat that may cause difficulty in breathing or
what januvia contains - the active substance is sitagliptin . each film - coated tablet ( tablet ) contains sitaglptin phosphate monohydrate equivalent to 25 mg of sitaglioptin . - the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate , croscarmellose sodium , magnesium stearate and sodium stearyl fumarate . the tablet film - coating contains poly ( vinyl alcohol ), macrogol 3350 , talc , titanium dioxide ( e171 ), red iron oxide ( e172 ) and yellow iron oxide . what januva looks like and contents of the pack
xultophy works by lowering blood glucose . it is used to treat type 2 diabetes mellitus in adults . diabetes is when your body does not make enough insulin to control the level of sugar in your blood . the insulin that your body produces does not work as well as it should . this results in an increase in blood sugar . insulin degludec ( a long - acting basal insulin ) helps your body to increase its blood sugar levels . liraglutide ( a glp - 1 analogue ) is a type of insulin that is used for the treatment of diabetes . it works by helping your body make better use
do not take xultophy if you are allergic to insulin degludec , liraglutide or any of the other ingredients of this medicine ( listed in section 6 ). if you 39 are taking a sulfonylurea such as glimepiride or glibenclamide . your doctor will monitor your sulfonylation dose and will adjust your blood sugar levels if necessary . warnings and precautions talk to your doctor or pharmacist before taking xulturo if you have type 1 diabetes mellitus or ' ketoacidosis '. this is a condition which can occur when you take xulinophy . if
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if you have been blind or have poor eyesight , your doctor may need to adjust your blood sugar level . the recommended dose of xultophy is 41 mg once a day . you should take xultose for 8 consecutive days . you can take xupophy with or without food . xultide is supplied in a pre - filled dial - a - dose pen . the dose counter shows the dose to be taken as follows : 1 mg insulin degludec 0 . 063 mg lir
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are low blood sugar ( very common may affect more than 1 in 10 people ). if your blood sugar level gets low you may pass out or become unconscious . serious hypoglycaemia ( may cause brain damage ) can occur with low blood glucose . if yourblood sugar level is too low , you may need to stop taking xultophy and see a doctor straight away . if you have low blood sugars , hypoglycasemia may occur . see section " warnings and precautions " for more information . serious allergic reaction ( an
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after first opening : do not store above 30 . after opening : store in the original package in order to protect from light . after dilution : use within 8 hours or 21 hours at room temperature ( 20 - 25 ). do away with the preservative after 21 hours . do away from direct heat or direct light . do throw away
what xultophy contains the active substances are insulin degludec and liraglutide . each ml contains 100 units of insulin degluudec 3 . 6 mg liragolutime in 3 ml solution . each vial contains 300 units of the active substance in insulin deglusudec 10 . 8 mg liraagluteide . the other ingredients are glycerol , phenol , zinc acetate , hydrochloric acid and sodium hydroxide ( for ph adjustment ) and water for injections . see section 2 " xultphil contains sodium ". what xultos looks like and
giotrif is a medicine that contains the active substance afatinib . it works by blocking two proteins called egfr [ epidermal growth factor receptor - 1 ] ( egfr1 ) and her2 [ erbb2 ] ( erbb3 ). these proteins are involved in the growth of cancer cells . this medicine works by stopping the growth and spread of cancer proteins . this is important as it prevents the growth or spread of these proteins . giotriff is used to treat cancer cells in adults . this type of cancer of the lung ( non - small cell lung cancer ) giotrienif is used as
do not take giotrif if you are allergic to afatinib or any of the other ingredients of this medicine ( listed in section 6 ) if you have low body weight ( less than 50 kg ) if your doctor has told you that you have kidney problems if you suffer from side effects associated with lung inflammation ( interstitial lung disease ) if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor before taking giotrinif if any other conditions apply to your child . your doctor may need to change your dose . if you know that you suffer or have had liver problems , your doctor
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 40 mg tablet once a day . you should take this tablet at the same time each day . giotrif can be taken with or without food . swallow the tablet whole with a glass of water . you can take this medication with or just after food . you may take this this medicine with or with food . if you take more giotrinif than you should if you accidentally take too many tablets , contact your doctor immediately . if possible , take this leaflet with you
like all medicines , giotrif can cause side effects , although not everybody gets them . the most serious side effects are usually mild to moderate and of a short duration . during treatment , diarrhoea may occur . this is common ( may affect up to 1 in 10 people ). diarrhoehoea is usually mild and usually goes away within 2 hours . severe diarrhoee with or without fluid loss is common . this may affect 1 in every 10 people . if you have low blood potassium or worsening kidney function , your doctor may decide to reduce your dose of giotrinif . if diarrhoeation occurs , contact your
what giotrif contains - the active substance is afatinib . each film - coated tablet contains 20 mg of afatinin . - the other ingredients are lactose monohydrate , microcrystalline cellulose , colloidal anhydrous silica , crospovidone , magnesium stearate , hypromellose , macrogol 400 , titanium dioxide ( e171 ), polysorbate 80 , water for injections . what giotraif looks like and contents of the pack giotratif 20 mg film - coating tablets are white , round , biconvex , with " gsi
orkambi contains two active substances called lumacaftor and ivacaftOR . it is a medicine used for long - term treatment of cystic fibrosis ( cf ) in patients aged 6 years and older . f508del mutation ( a type of cyst fibrosis transmembrane conductance regulator ) is a protein that carries oxygen from the lungs to the cells in the body . the mutation causes an abnormal cftr protein . lumacafor and / or ivacafir work together to remove the abnormal cFTr protein and replace it with lumacaptor . lumackaftor allows
do not take orkambi if you are allergic to lumacaftor or ivacaftour or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking orkammi . if you have been told that you have the f508del mutation , your doctor may need to change your dose of orkandemi . talk to a doctor if you suffer from liver or kidney disease . your doctor will monitor the dose of andkambie . if any of these apply to you , tell your doctor . abnormal blood tests of the liver may be
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 6 mg tablet twice a day for the first 12 hours . your doctor will tell you how many tablets to take . the usual dose of orkambi is one ork2 tablet twice daily for the next 6 to 11 hours . the maximum recommended dose of eitherkambsi is 100 mg twice a week for the second 2 weeks . your daily dose is 2 tablets twice a morning for the third week . your dose may be increased to 12 mg twice daily . your usual dose
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects are usually mild to moderate . if you are given orkambi with ivacaftor , you may experience some of the following : serious side effects that may occur with orkammi : raised levels of liver enzymes in the blood , which may increase the risk of liver injury in patients with pre - existing severe liver disease . the worsening of liver function . other side effects include : uncommon ( may affect up to 1 in 100 people ): pain or discomfort in the upper right stomach ( abdominal ) area yellowing of your skin
what orkambi contains the active substances are lumacaftor and ivacaftir . orkammi 100 mg film - coated tablets each tablet contains either 125 mg lumacafor or 125 mg ivacafir . each orkamberi 200 mg film film - coating each tablet contain either 200 mg lumiacaftor or 250 mg iviacaftir ( see section 2 " orkabambi 100mg film - coat "). orkmbi 200mg film film coating each tablets contain either 125mg lumacftor or 150 mg ivicaftor ( see also " or kamb
what lynparza is lynparaz contains the active substance olaparib . olaparaib is a type of cancer medicine known as a parp inhibitor ( poly [ adenosine diphosphate - ribose ] polymerase inhibitor ). it works by stopping the growth of mutations ( changes ) in a gene called brca ( breast cancer gene ). cancer patients with parp inhibitors have a risk of death because they have a problem with an enzyme that helps repair dna . what lynparz is used for lynparZA is used to treat adult patients with ovarian cancer called brcas ( mutated ovarian cancer ). it
you must not be given lynparza if you are allergic to olaparib or any of the other ingredients of this medicine ( listed in section 6 ). if you think this applies to you , tell your doctor before you are given it . children and adolescents do not give this medicine to children and young children below 2 years of age . other medicines and lynparz tell your nuclear medicine doctor if you have any questions about how lynparaz works or why this medicine has been prescribed for you . if you use more lynparze than you should if you accidentally use too much of this product , tell the nuclear medicine physician or
always take lynparza capsules exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of lynparz is 100 mg once a day . your doctor may increase your dose to 150 mg once daily . the doses of lynperza capsules are usually taken in combination with tablets . if you take more than a capsule of lynpalza once a night , you may experience side effects for up to 8 hours . take the tablet by mouth . in the evening take the same dose as usual . if possible take the next dose at the usual time . if necessary , take the
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): feeling short of breath , feeling very tired , pale skin , fast heart beat . these may be symptoms of a decrease in the number of red blood cells ( anaemia ). uncommon ( may affects up to 1 in 100 people ): allergic reactions such as hives , difficulty breathing or swallowing , dizziness . if you notice any of these , tell your doctor immediately . signs and symptoms of hypersensitivity reactions are listed below . other side effects very common : may affect less than 1in 10 people
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store the blister in the original package in order to protect from light . do this after the first opening of the blister . do away with any lynparza capsules that are damaged or have been frozen . lynparZA capsules may be stored at room temperature ( up to 30 ) for a maximum period of 3 days . do discard any capsules that
what lynparza contains - the active substance is olaparib . each hard capsule contains 50 mg olaparaib . - the other ingredients are lauroyl macrogol - 32 glycerides , hypromellose , titanium dioxide ( e171 ), gellan gum , potassium acetate , iron oxide black ( e172 ). what lynparz looks like and contents of the pack white , opaque , hard capsule with " olaparatib 50 mg " imprinted on one side and " astrazeneca logo on the other . lynparZA is available in packs containing 112 hard capsules or 448 hard
this medicine contains the active substance naloxone . nalxone is used to treat opioids such as heroin , methadone , fentanyl , oxycodone , buprenorphine and morphine in adults . nyxoid is also used as a nasal spray for the emergency treatment of opioid overdose in adults , adolescents and children . opioid overdose is a serious , life - threatening , and can be fatal in some cases . it is usually fatal within 14 days . overdose may cause breathing problems and severe sleepiness . if you have an opioid overdose , you should immediately contact your doctor or get emergency medical care .
do not use nyxoid if you are allergic to naloxone or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using nyxoids . you may need emergency medical care or emergency services if you have an opioid overdose . the signs and symptoms of an opioid dose may be similar to those of an overdose . if you use more nyxid than you should contact your doctor immediately . if possible , use this nasal spray 2 to 3 times a day . you can use a new nasal spray at any time of the day . if this
always use nyxoid nasal spray exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 . use the nasal spray as instructed by your doctor . do not use more than once a day . do this if you have symptoms such as : shoulders , ears , breastbone , sternum , or inside the ear . fingernail . clear the mouth and nose of any blockages . do that by pushing the nose harder . 1 . breathe is the chest moving . if you hear breathing sounds , or breath on the cheek , you should contact your doctor immediately .
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : stop taking nyxoid and seek medical help immediately if you experience acute withdrawal symptoms from opioid drugs . symptoms include fast heart rate , high blood pressure body aches , stomach cramps , feeling sick , vomiting , diarrhoea , sweating , fever , goose bumps , shivering , trembling changes in behaviour , including violent behaviour , nervousness , anxiety , excitement , restlessness , irritability unpleasant or uncomfortable mood increased skin sensitivity difficulty in sleeping . acute withdrawal reactions may affect up to 1 in 100 people
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nyxoid contains the active substance is naloxone . each nasal spray contains 1 . 8 mg of nalxone ( as hydrochloride dihydrate ). the other ingredients are trisodium citrate dihydrates , sodium chloride , hydrochloric acid , sodium hydroxide and purified water . the amount of nloxone in 0 . 1 ml solution for injection in a pre - filled nasal spray is supplied as a single dose container . nyxoids is available in a carton containing 2 nasal sprays in blisters . each spray contains one dose of ndaloxone ( 4 mg
what ovaleap is ovaleape contains the active substance follitropin alfa , which is a gonadotropin ( a type of hormone that is produced naturally in the body ). follitroin ala is a hormone produced by the body called fsh . it is involved in the growth and development of the sacs ( follicles ) in the ovaries . follicle - stimulating hormone ( fsh ) is involved for the production of sperm and a premature egg cell . ovaleaps is used in women who are not ovulating and who are undergoing treatment with a medicine called " clomifene cit
do not use ovaleap if you are allergic to follitropin alfa , follicle stimulating hormone or any of the other ingredients of this medicine ( listed in section 6 ) if you have a tumour in your hypothalamus or pituitary gland ( the brain ). if you think you may have large ovaries or sacs of fluids that contain the ovaries . if you know that you have ovarian cysts . if unexplained vaginal bleeding . if any of these apply to you . if your doctor thinks you may be at risk of cancer in your ovaries , womb or breasts . if there is any condition that makes
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this medicine is given as an injection into the tissue just under the skin ( subcutaneous injection ). if you have irregular periods , you should not use this medication for the first 7 days of your menstrual cycle . the medicine should be used every day . this is to make sure that you are taking the medicine as prescribed . the usual dose is one 75 mg tablet ( tablet ) once a day . the maximum recommended dose is 150 mg . you should use this this medicine every day for 7 days , for 14
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with ovaleap : serious side effects : - women allergic reactions such as skin rash and raised itchy areas of skin . severe allergic reactions may cause weakness , drop in blood pressure , difficulty breathing and swelling of the face . 37 rare ( may affect up to 1 in 10 , 000 people ) this type of reaction occurs rarely . if you notice this typeof reaction after your ovaleop injection , stop using it and contact your doctor immediately . serious sideeffects in women lower stomach ache ( nausea ) and vomiting
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the cartridge after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the cartridge in the outer carton in order to protect from light . this medicine may be stored for a maximum of 3 days below 25 . do this medicine if it is stored at room temperature ( up to 30 ) for a single period of not more than 3 days . once the cartridge has been removed from the refrigerator and has
what ovaleap contains the active substance is follitropin alfa . ovaleop 300 iu / 0 . 5 ml : each cartridge contains 300 iiu ( 22 micrograms ) follitroin ala in 0 . 05 ml . ovalesap 450 iu : each cartridges contains 450 iiu 33 microgram ( 23 microgram ) follitonropin alpha in 0. 75 ml . what ovaleaps looks like and contents of the pack ovaleape 300 i iu solution for injection ( injection ) is a clear , colourless solution . each cartridge has a diameter of 900 iu (
voriconazole accord contains the active substance voriconazol . voricoazole is an antifungal medicine that works by killing or stopping the growth of the fungi that cause infections . it is used in adults and children from the age of 2 years to treat invasive aspergillosis ( a type of fungal infection caused by aspergonillus sp .) and candidaemia ( a form of fun fungal illness caused by candida sp .) in non - neutropenic patients ( patients with abnormally low white blood cells count ). candida spores infections are caused by the fungus fluconaz
do not take voriconazole accord - if you are allergic to voricoazole or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you are taking any other medicines , including herbal medicines . the medicines listed below are taken before voricazole accord treatment : 46 terfenadine ( used to treat allergy ) astemizole ( used for allergy ) cisapride ( used in stomach problems ) pimozide ( used against mental illness ) quinidine ( used if you have irregular heart beat ) rifampicin (
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will work out your dose based on your weight and the type of infection you have . the usual starting dose is 40 mg once a day . this is increased to 40 mg twice a day for 24 hours . your dose may be increased to 400 mg once daily for 12 hours . this will be given as a single dose in the morning and evening . this 24 hour dose may also be increased by 200 mg once every 24 hours for 24 weeks . your daily dose may increase to 100 mg once per day
like all medicines , this medicine can cause side effects , although not everybody gets them . if any side effects occur , you should contact your doctor immediately . serious side effects stop taking voriconazole accord and tell your doctor straight away : rash , jaundice ( changes in blood tests of liver function ) and pancreatitis . other side effects include : very common ( may affect more than 1 in 10 people ): visual impairment ( change in vision , blurred vision , visual color alterations , abnormal intolerance to visual perception of light , colour blindness , eye disorder , halo vision , night blindness , swinging vision , seeing sparks , visual aura
what voriconazole accord contains the active substance is voricazole . each tablet contains 50 mg voricleazole ( as besilate ). voricoazole accord 50 mg film - coated tablets : each tablet has 200 mg vorbiconazose ( as mesilate ) voronazoleaccord 200 mg film : the other ingredients are lactose monohydrate , pregelatinised starch , croscarmellose sodium , povidone , magnesium stearate , hypromellose , titanium dioxide ( e171 ), lactosemonohydrate and triacetin
mvabea is a vaccine to protect you against ebola virus disease in the future . adults and children from 1 year of age and older who have been exposed to ebola can receive a 2 - dose course of vaccinations . the active substances in this vaccine are the zaire ebolavirus and filovirus . this vaccine stops the spread of filov virus and gives the whole ebolairus away . it does not give you ebola disease . warnings and precautions talk to your doctor or nurse before you are given mvabeas . vaccinations you will receive two types of zabdeno vaccine about 8 weeks later
your doctor or nurse will supervise the vaccination course . before you are given the vaccine , tell your doctor or pharmacist if you have had a severe allergic reaction to any of the ingredients in section 6 . if you had asevere allergic reaction , to an antibiotic called ' gentamicin ', or any of those other ingredients of the vaccine ( listed in section 7 ). if you think you may have had such a severe allergy , tell the doctor or healthcare professional . warnings and precautions talk to your doctor , pharmacist or nurse before you receive mvabea if you : have had or have ever had a severely allergic reaction before to
the recommended dose of vaccine is given by injection into a muscle ( intramuscular injection ) in the upper arm , thigh or blood vessel . the first dose of vaccination with zabdeno vaccine is administered 8 weeks later . the second vaccine will be given at least two weeks after the first . the third dose of the vaccine is scheduled to be given two weeks later after the second dose . the fourth dose of a vaccine is recommended . primary vaccination first vaccination with a zab deno red cap vial ( 0 . 5 ml ) second vaccination with mvabea yellow cap vials ( 0. 5 ml ). the
like all medicines , this vaccine can cause side effects , although not everybody gets them . the following side effects may happen with mvabea : very common ( may affect more than 1 in 10 people ): pain , warmth and swelling where the injection is given feeling very tired muscle ache joint pain common ( might affect up to 1 in every 10 people ) being sick ( vomiting ) itching where the vaccine is given uncommon ( may affects up to1 in every 100 people ): redness and skin hardness where thejection is given generalised itching . the most common side effects are : common ( likely to affect up in 1 in 1 ,
what mvabea contains the active substance is zaire ebolavirus 29 produced inactivated by recombinant dna technology inactivated with tai forest ebolovirus nucleoprotein marburg equivalent to 0 . 7 mg / 108 micrograms . the other ingredients are : chicken embryo fibroblast cells . this vaccine contains trace residues of gentamicin , sodium chloride , trometamol , water for injections , and hydrochloric acid ( for ph adjustment ). what mvabaa looks like and contents of the pack mvaraa is a suspension for injection in a single - dose glass v
ondronat contains the active substance ibandronic acid . this belongs to a group of medicines called bisphosphonates . bondronat is used to treat breast cancer that has spread to your bones ( called ' bone ametastases '). it helps to prevent your bones from breaking ( fractures ). it also helps to reduce the risk of other bone problems that may need surgery or radiotherapy bondronAT is used if you have a raised calcium level in your blood due to a tumour . this helps to stop calcium being lost from your bones . it also reduces the risk that your bones become weaker .
do not take bondronat if you are allergic to ibandronic acid or any of the other ingredients of this medicine ( listed in section 6 ) if you have low levels of calcium in your blood . warnings and precautions talk to your doctor or pharmacist before taking this medicine if any of these apply to you . warnings , precautions and precautions a side effect called osteonecrosis of the jaw ( onj ) has been reported in patients receiving bondronatin . it is believed that bone damage in the jaw caused by the use of bondronit is due to cancer or related conditions . onj can occur many years after stopping
this medicine is given to you by a doctor or nurse with experience in the treatment of cancer . it is given as an infusion into your vein . your doctor will carry out regular blood tests to check how well you are being treated with bondronat . your dose of this medicine depends on your illness . if you have breast cancer that has spread to your bones , it may take 3 to 3 weeks ( depending on how you respond to the medicine ) before you are given an infusion in your vein , which may take up to 15 minutes . if there is a raised calcium level in your blood , it can be given as a single dose
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following serious side effects you may need urgent medical treatment : rare ( may affect up to 1 in 1 , 000 people ): persistent eye pain or inflammation new pain , weakness or discomfort in your thigh , hip or groin . this may be a sign of unusual fracture of the thigh bone . very rare ( might affect up in 1 to 10 , 000 users ): pain or sore in your mouth or jaw . this could be a symptom of severe jaw problems called necrosis ( dead bone tissue ) in the jaw
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . after dilution the infusion solution should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2ºc to 8ºc . do away with this medicine if you notice any particles in the solution . do throw away any medicines
what bondronat contains - the active substance is ibandronic acid . each vial contains 2 mg ibandronat . after reconstitution , a concentrate for solution for infusion contains 2mg ibandor acid . - the other ingredients are sodium monohydrate , sodium chloride , acetic acid , sodium acetate , water for injections . what bondronAT looks like and contents of the pack 1 vial and 2 vials are white to off - white , round , bromobutyl rubber stopper .
what zeposia is zeposeia belongs to a group of medicines that affect the number of white blood cells ( lymphocytes ). what zeposa is used for zepoesia is used to treat relapsing remitting multiple sclerosis ( rrms ), a rare but active disease that affects the nerves of the brain and spinal cord . symptoms include numbness , difficulty in walking and problems with vision and balance . relapsING remitting rel sclerosis is attacks on the nerve cells . the symptoms disappear for a few days or weeks , but for periods of time some problems can remain . how zeposesia works
do not take zeposia if you are allergic to ozanimod or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severely weakened immune system . if you had a heart attack , angina , stroke , mini - stroke or transient ischemic attack ( tia ). if severe heart failure has occurred within the last 6 months . if your heartbeats ( arrhythmia ) are not normal . if any of these apply to you , tell your doctor before treatment . if the patient has severe infection such as hepatitis , tuberculosis or cancer . if he / she has severe liver
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take your doctor will work out the dose of zeposia you need and will work on your heart rate . your doctor may prescribe you a ' treatment initiation pack ' with different doses . the initiation pack is for adults . the first 4 doses are 0 . 23 mg ozanimod per day . the second 1 dose is 0 . 4 mg ozamanod per morning . the third 4 doses will be 0 . 45 mg ozmod per afternoon . the recommended dose is one capsule per
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects the following side effects may happen with zeposia : very common ( may affect more than 1 in 10 people ): slow heart rate urinary tract infection ( raised blood pressure ) uncommon ( may affects up to 1 in 100 people ): allergic reaction . the signs may include a rash . other side effects include : very rare ( may effect more than one in 10 , 000 people ): infections of the nose or nostrils , nasal cavity , mouth , throat ( pharynx ) and voice box ( larynx ). viruses and a type
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . do this medicine in the original package in order to protect from moisture . do away with this medicine if you notice any damage or signs of tampering to the pack . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what zeposia contains the active substance is ozanimod . zeposeia 0 . 23 mg : each capsule contains 0 . 22 mg ozanimog ( as hydrochloride ). zepoesia 0 , 46 mg : one capsule contains approximately 0 . 46 mg ozimod ( as hydrometrochloride ) and zeposesia 0. 92 mg : two capsules contain approximately 0.92 mg ozmod (as hydrochlorine ). the other ingredients are microcrystalline cellulose , silica , colloidal anhydrous , croscarmellose sodium , magnesium stearate
what temybric ellipta is temybaellipta contains two active substances , fluticasone furoate and umeclidinium bromide , vilanterol . fluticusone furaate belongs to a group of medicines called corticosteroids ( steroids ). umecylidinia bromine and vilansterol belong to agroup of medicines known as bronchodilators . what temybarric elliptoe is used for temyborric elliptoma is used to treat chronic obstructive pulmonary disease ( copd ). copd is a long -
do not use temybric ellipta - if you are allergic to fluticasone furoate , umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using temy bric elliptia - if your child has asthma . warnings and precaution talk to the doctor , nurse or pharmacist before using this medicine : - if the child has ever had asthma . temyberric ellipte should not be used in children with asthma . - if any of these apply to your child
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours at the same time each day . try to use temybric ellipta at the start of each day and continue to use it until your doctor tells you otherwise . if you use more temybiric ellipte than you should if you have used more tembric ellipta than you need , contact your doctor immediately . symptoms of temybubric elliptoe may include a sudden attack of
like all medicines , this medicine can cause side effects , although not everybody gets them . immediate breathing difficulties : if your breathing is not working properly or you are wheezing , stop taking this medicine and seek medical help straight away . pneumonia ( infection of the lung ) in copd patients the most common side effect of temybric ellipta is symptoms of a lung infection such as fever and chills . increased mucus production , change in mucus colour , increased cough and increased breathing difficulties common side effects ( may affect up to 1 in 10 people ) are sore , raised patches in the mouth or throat . this may be
what temybric ellipta contains - the active substances are fluticasone furoate , umeclidinium bromide and vilanterol . each delivered dose contains 92 micrograms of flutic asone firoate , 65 microgram of umelidinum bromate and 55 microgram ( 23 microgram ) of umclidine ( 22 microgram ), vilancerol and trifenatate . - the other ingredients are lactose monohydrate ( see section 2 under ' temy bric elliptas contains lactose '), magnesium stear
zinforo is an antibiotic medicine that contains the active substance cefaroline fosamil . it belongs to a group of medicines called 'cephalosporin antibiotics '. zinforo works by killing certain bacteria that cause serious infections . zin foro is used to treat adults and children who have infections of the skin or the tissues below the skin . it is also used to prevent an infection of the lungs called ' pneumonia '. how zin Foro works zininforoe works by stopping the body from killing certain cells that cause some serious infections that may be life - threatening .
do not take zinforo if you are allergic to ceftaroline fosamil or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to othercephalosporin antibiotics . if you have had previous severe allergic reactions to other antibiotics ( such as penicillin or carbapenem ). warnings and precautions talk to your doctor or pharmacist before taking zin foro . tell your doctor if you : have kidney problems have had seizures or convulsions have had any non - severe allergic reaction to otheriotics ( such such as pensicillin and carb
the recommended dose of zinforo is 600 mg once a day . your doctor will tell you how many capsules to take . the recommended dose is one 600 mg capsule once a week . the dose may be increased to 600 mg every 8 weeks for some infections . the maximum recommended dose for 8 to 12 weeks is one capsule once daily . it is given as a drip into a vein ( intravenously ) over a period of 5 minutes . your dose may later be increased up to 60 mg or 120 mg . your physician will tell if you need an increased dose . the duration of treatment is 5 to 14 days . if you have
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following side effects . if you get any of these symptoms , you may need urgent medical treatment : sudden swelling of your lips , face , throat or tongue , a severe rash , swallowing or breathing problems , asevere allergic reaction ( anaphylaxis ), diarrhoea , stool , blood or mucus . treatment with zinforo may be interrupted or stopped , or medicines may slow bowel movement ( see section 1 ). you will have a blood test called a ' coombs test ' to check
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 30 . store in the original package in order to protect from moisture . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zinforo contains the active substance is ceftaroline fosamil . the other ingredients are arginine and water for injections . what zinofo looks like and contents of the pack zinforto is a pale yellowish to light yellow powder for concentrate for solution for infusion in a vial . it is supplied in packs containing 10 vials .
pregabalin pfizer belongs to a group of medicines used to treat epilepsy , neuropathic pain and generalised anxiety disorder ( gad ) in adults . peripheral and central neuropathicpain : pregabalin pumpfizer is used to relieve long lasting pain caused by damage to the nerves . a variety of diseases can cause peripheral neuropathic arthritis , such as diabetes or shingles . pain sensations may be described as hot , burning , throbbing , shooting , stabbing , sharp , cramping , aching , tingling , numbness , pins and needles . peripheral or central neuropathy pain may also be associated with
do not take pregabalin pfizer - if you are allergic to pregagalin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking preggabal pfiser . some patients taking pregaabalin pumpfizer have reported symptoms suggesting an allergic reaction . these symptoms include swelling of the face , lips , tongue , and throat and diffuse skin rash . should you experience any of these reactions , you should contact your doctor immediately . pregibalin has been associated with dizziness and somnolence , which may
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . pregabalin pfizer is for oral use . peripheral and central neuropathic pain , epilepsy and generalised anxiety disorder : the usual dose is 150 mg once a day . your doctor may increase your dose to 600 mg once daily depending on your response to pregagalin pafizer . you should take pregafalin pfeizer once in the morning and once inthe evening . for 59 patients , the usual dosing schedule is one tablet once a morning , once in a day ,
like all medicines , this medicine can cause side effects , although not everybody gets them . very common : may affect more than 1 in 10 people dizziness , drowsiness , headache . common : might affect up to 1 in every 10 people increased appetite , feeling of elation , confusion , disorientation , decrease in sexual interest , irritability , disturbance in attention , clumsiness , memory impairment , loss of memory , tremor , difficulty with speaking , tingling feeling , numbness , sedation , lethargy , insomnia , fatigue , feeling abnormal , blurred vision , double vision , vertigo , problems with balance
what pregabalin pfizer contains the active substance is pregibalin . each hard capsule contains 25 mg , 50 mg , 75 mg , 100 mg , 150 mg , 200 mg , 225 mg or 300 mg of pregagalin . the other ingredients are lactose monohydrate , maize starch , talc , gelatine , titanium dioxide ( e171 ), sodium laurilsulphate , anhydrous colloidal silica . the printing ink contains black ink , shellac , black iron oxide ( e172 ), propylene glycol , potassium hydroxide ). the 75 mg capsules contain 100 mg
xadago is a medicine that contains the active substance safinamide . it works by increasing the levels of dopamine in the brain . this is a chemical that is important in the movement of the brain , and is important for parkinson ' s disease . xadago helps to control parkinson ', a condition that causes sudden swings in the ability to move . this can lead to difficulties moving . xADago is used in combination with levodopa ( other medicines used to treat parkinson' s disease ).
do not take xadago - if you are allergic to safinamide or any of the other ingredients of this medicine ( listed in section 6 ). - if your child is taking any of any of : - monoamine oxidase ( mao ) inhibitors such as selegiline , rasagiline and moclobemide . - phenelzine , isocarboxazid and tranylcypromine . these are all used in treatment of parkinson ' s disease and depression . - pethidine , a strong pain killer . it is usually taken at least 7 hours before or at the
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of xadago is 50 mg once a day . the dose may be increased to 100 mg once daily by mouth . your doctor will tell you the dose of the medicine to take . if you have moderately reduced liver function , your doctor may prescribe a lower dose of 50 mg . take xadadago at the same time each day . swallow the tablet whole with a glass of water . xadagon can be taken with or without food . if taking more xadade than you should
like all medicines , this medicine can cause side effects , although not everybody gets them . hypertensive crisis ( very high blood pressure that may lead to collapse ) has been reported very commonly in patients with neuroleptic malignant syndrome ( see section 2 ). signs include confusion , sweating , muscle rigidity , hyperthermia ( increase level of enzyme creatine kinase in your blood ), serotonin syndrome ( confusion , hypertension , muscle stiffness , hallucinations and hypotension ). the following side effects have been reported in patients treated with parkinson ' s disease , when used in combination with safinamide or levodopa . other medicines and xadago
what xadago contains - the active substance is safinamide . each tablet contains 50 mg or 100 mg safinam . - the other ingredients are methansulfonate , microcrystalline cellulose , crospovidone type a , magnesium stearate , silica colloidal anhydrous - tablet coating contains hypromellose , macrogol , titanium dioxide ( e171 ), iron oxide red ( e172 ). what xadadago looks like and contents of the pack xadagon 50 mg film - coated tablets of 7 mm diameter with metallic gloss are engraved with ' gsi '
zytiga is a medicine containing abiraterone acetate that is used to treat prostate cancer that has spread to other parts of the body . zytiga reduces the amount of testosterone in the blood in men who have prostate cancer . ztiga is used in patients who have disease that has not responded to hormone therapy or who are not able to take a treatment that lowers testosterone ( androgen deprivation therapy ). it is used with another medicine called prednisone . prednisolone is used for high blood pressure in adult patients whose body is not able effectively to absorb the medicine effectively . it reduces fluid retention in
do not take zytiga - if you are allergic to abiraterone acetate or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor thinks you may be pregnant . warnings and precautions talk to your doctor or pharmacist before taking zytigo - if any of these apply to you . - if there is severe liver damage or prostate cancer . this medicine should not be used in combination with this medicine . - tell your doctor if any other side effects of this medication are listed below . - talk to a doctor or nurse before taking this medicine - if the patient has liver problems such as
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 , 000 mg once a day . you should take this tablet at the same time each day . this medicine should be taken by mouth . swallow the tablet whole with a glass of water . do not chew or crush the tablet . if you take more zytiga than you should if you accidentally take too many tablets , contact your doctor immediately . if possible take zytige with food . if more than 2 hours have passed since you accidentally took too many , contact a doctor or the
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking zytiga and contact your doctor immediately if you experience : muscle weakness , muscle twitches , a pounding heart beat or palpitations . your doctor may decide that the level of potassium in your blood is low . your dose of potassium may need to be adjusted . other side effects include : very common ( may affect more than 1 in 10 people ): fluid in your legs or feet ( see section 2 ). low blood potassium ( seen on liver function test ). high blood pressure . urinary tract infection . diarrhoea . common ( might affect
what zytiga contains - the active substance is abiraterone acetate . each tablet contains 250 mg abirate acetate - the other ingredients are microcrystalline cellulose , croscarmellose sodium , lactose monohydrate , magnesium stearate , povidone ( k32 ), colloidal anhydrous silica , sodium laurilsulfate . see section 2 " zytigo contains lactose ". what zytig looks like and contents of the pack - zytinge tablets are white to off - white , round tablets with " gsi " debossed on one side
hefiya contains the active substance adalimumab , a medicine used for the treatment of inflammatory diseases in adults : polyarticular juvenile idiopathic arthritis , enthesitis - related arthritis , paediatric plaque psoriasis and paediatric crohn ' s disease . paediatric non - infectious uveitis : adalumab is a monoclonal antibody . monoclabs are proteins that recognise and bind to other unique proteins in the body . mononlonal antibodies attach to specific proteins in tumour necrosis factor ( tnfα ), a protein involved in the inflammatory diseases and in reducing
do not take hefiya if your child is allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). if your or your child ' s child has a severe infection , including tuberculosis , sepsis ( blood poisoning ), or other opportunistic infections . if your / your child has unusual infections , or if your doctor suspects that your or his child ' ll have a weakened immune system . symptoms of infections may include fever , wounds , feeling tired , dental problems . if you / your son has moderate or severe heart failure . if he / yourchild has a serious heart condition . warnings
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 40 mg tablet once a day . your doctor may prescribe a different dose for you . your child ' s doctor may decide to increase the dose to a maximum of 20 mg once a week . your newborn ' s physician may prescribe the dose of 20mg once a month . your infant ' s surgeon may prescribe an alternative dose of 40 mg once daily . your baby ' s dentist may prescribe this dose for your newborn if your child is not responsive to the 40 mg dose . your children
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . tell your doctor immediately if you notice any of the following side effects ( see section 4 , " warnings and precautions "): after the last hefiya injection , you may experience allergic reaction ( including heart failure ). severe rash , hives , swollen face , hands , feet , trouble breathing , swallowing , shortness of breath and swelling of the feet . tell a doctor immediately , if you have any of these signs and symptoms of infection such as fever , feeling
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . after first opening , the product may be stored at room temperature ( up to 25 ) for a maximum period of 14 days . once removed from the refrigerator for room temperature storage , your pre -filled syringe may be used for a single period of
what hefiya contains - the active substance is adalimumab . each pre - filled syringe contains 20 mg of adalimab in 0 . 4 ml of solution . - the other ingredients are adipic acid , citric acid monohydrate , sodium chloride , mannitol , polysorbate 80 , hydrochloric acid and sodium hydroxide and water for injections . what hefiYA looks like and contents of the pack hefiah 20 mg / 0 . 04 ml solution for injection is a clear to slightly opalescent , colourless to slightly yellowish solution . it is supplied in a clear
what ritemvia is ritemv contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a type called a white blood cell called " b - lymphocyte ". when ritukimab sticks to this surface , it stops the cell from growing and dividing . what ritemva is used for ritemvir is used to treat adults for the treatment of : a ) non - hodgkin ' s lymphoma this is an uncommon form of a disease of the lymph tissue that affects the immune system . it affects
do not take ritemvia if you are allergic to rituximab , other proteins that are similar to ritonuximabs or any of the other ingredients of this medicine ( listed in section 6 ) if you have a severe active infection if you suffer from a weak immune system if you suffered from severe heart failure or severe uncontrolled heart disease if you know that you have granulomatosis , polyangiitis , microscopic polyangis or pemphigus vulgaris ( see section " warnings and precautions "). warnings and risks talk to your doctor before taking ritemvi if you : have ever had
how much ritemvia is given your doctor will decide how much ritemvia you will receive and how often you will need this treatment . always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . if you have any side effects , your doctor may decide to change your dose . how ritemv is given ritemva is given as a drip ( intravenous infusion ). medicines given before each ritema administration you will be given ritamvia together with other medicines ( pre - medication ) to reduce the risk of side effects . your doctor or nurse will decide on
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion you may experience fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number
what ritemvia contains the active substance is rituximab . each ml of concentrate contains 100 mg of ritukimab ( as besilate ). each vial of concentrate contents contains 10 mg of the active ingredient in ritiximab ). the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what ritemutil looks like and contents of the pack ritemicon is a clear , colourless solution for infusion in a glass vial . pack size of 2 vials .
capecitabine teva belongs to a group of medicines called " cytostatic medicines ", which stop the growth of cancer cells . capecitabrine teva contains capecitibine , which itself is not a cytostatics medicine . only after being absorbed by the body is it changed into an active anti - cancer medicine . capecabine ti is used in the treatment of colon , rectal , gastric , or breast cancers . furthermore , capecitabiline teeva is used to prevent new occurrence of colon cancer after complete removal of the tumour by surgery . cape citabineteva may be used
do not take capecitabine teva if you are allergic to capecitabiline or any of the other ingredients of this medicine ( listed in section 6 ) if you have an allergy to any of these ingredients or any other ingredients , or to any other ingredient of this vaccine ( listed under section 6 ). if you suffer from severe reactions to fluoropyrimidine therapy ( a group of anticancer medicines containing fluorouracil ) if your pregnant or breast - feeding is not being treated if you : have low levels of white cells or platelets in the blood ( leucopenia , neutropenia or throm
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . capecitabine should only be prescribed by a doctor experienced in the use of anticancer medicines . your doctor will prescribe a dose and treatment regimen that is right for you . the dose of capecitabe teva depends on your body surface area ( height and weight ). the usual dose for adults is 1250 mg / m2 of body surface surface area taken once daily . this is equivalent to a daily dose of body weight of 64 kg . your child ' s height is 1 . 64 m has a
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking capecitabine teva and contact your doctor immediately if you have any of these symptoms : diarrhoea : if you experience an increase of 4 or more bowel movements compared to your normal bowel movements , or any diarrhoehoea at night . vomiting : if vomiting is more severe than nausea . if you lose your appetite . stomatitis : if pain , redness , swelling or sores in your mouth and / or throat . hand and foot skin - reaction : if your doctor feels that you have pain , swelling ,
what capecitabine teva contains the active substance is capecitabiline . capecitabe teva 150 mg film - coated tablets each film - coating contains 150 mg capecitobine . furthermore , capecitaba teva 500 mg film film - coat contains 500 mg capecabine . the other ingredients are : tablet core : lactose , microcrystalline cellulose , hypromellose , croscarmellose sodium , magnesium stearate , macrogol 400 , hypromeellose, titanium dioxide ( e171 ), yellow iron oxide ( e172 ), red iron oxide red ( e 172
silodosin recordati contains silodosino recordati . it belongs to a group of medicines called alpha1a - adrenoreceptor blockers . silodosein recordat is used to lower the pressure in the prostate , bladder and urethra . it helps to maintain smooth muscle in these tissues . this helps to reduce your symptoms . silosin Recordati is used in adults to treat the urinary symptoms associated with benign enlargement of the prostate ( prostatic hyperplasia ), such as difficulty in starting to pass water , and a feeling of not completely emptying the bladder .
do not use silodosin recordati - if you are allergic to silodnosin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using silodousin recordi - if your child is undergoing eye surgery to reduce cloudiness of the lens in the eye during cataract surgery 26 - if the child is being treated for a surgery to remove a muscle tone in the iris ( the coloured part of the eye ). before a surgery , your doctor will take appropriate precautions , including the use of medicine and surgical techniques . silodose
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one capsule of silodosin recordati taken once a day , with or without food . the maximum recommended dose for adults is 8 capsules . if you have kidney problems if you suffer from moderate kidney problems , your doctor may prescribe a lower dose . for this purpose silodosein recordat is taken once daily , with food . if your daily dose is less than 4 capsules of silosinrecordati , you may feel dizzy or feel weak . if this happens , take
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions swelling of the face or throat , difficulty in breathing , feeling faint , itchy skin or hives are the most common side effect of silodosin recordati . dizziness . dizzy and occasionally fainting may occur when standing up or when standing or walking up . if you feel weak or dizzy , tell your doctor . the symptoms may include dizziness and faints . if any of the above occur , tell the doctor or pharmacist . if they occur , stop taking silodosiin recordat and seek
what silodosin recordati contains the active substance is silodosein . each capsule contains 8 mg silodofin . the other ingredients are : capsule content : silodusin , mannitol , magnesium stearate , sodium laurilsulfate , gelatin , titanium dioxide ( e171 ). capsule shell : silosin filmati 4 mg silosino , mannaitol , magnitol ( e421 ), magnesium stearingate , and sodium lurilsulfATE . capsule shell printing ink : gelatin , stainless dioxide ( i171 ), yellow iron oxide ( e172 ). what silodosi
kinzalmono belongs to a class of medicines known as angiotensin ii receptor antagonists . angiotENSin ii is a substance produced in the body which causes your blood vessels to narrow , thus increasing your blood pressure . kinzalono blocks the effect of angiotenin ii so that the blood vessels relax , and your bloodpressure is lowered . kinzonmono is used to treat essential hypertension ( high blood pressure ) in adults . the high blood blood pressure is not caused by any other condition . high bloodpressure , if not treated , can damage blood vessels in several organs , which could lead sometimes
do not take kinzalmono - if you are allergic to telmisartan or any of the other ingredients of this medicine ( listed in section 6 ). - if , at least 3 months pregnant , you are breast - feeding . ( it is also better to avoid kinzdalmono in early pregnancy see pregnancy section .) - if your doctor has told you that you have severe liver problems ( such as cholestasis or biliary obstruction ) that are not well controlled by drainage of the bile from the liver and gall bladder . - if any other severe liver disease . - have diabetes or impaired kidney function and
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . the tablets should be taken with or without food . try to take the tablet at the same time each day . you can take kinzalmono with or just after food . if you take more kinzdalmono than you should if you have taken more tablets than you have been told to , talk to a doctor or go to a hospital straight away . if possible , take the tablets with a glass of water . if necessary , take your tablet at
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects could be serious and need immediate medical attention : sepsis ( often called " blood poisoning "), a severe infection with whole - body inflammatory response , rapid swelling of the skin and mucosa ( angioedema ). these side effects are rare ( may affect up to 1 in 1 , 000 people ). other side effects of kinzalmono common side effects ( may effect up to1 in 10 people ): low blood pressure ( hypotension ) cardiovascular events uncommon side effects : uncommon side effect ( may impact up to one in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . once your medicine has been taken out of your refrigerator , it must be used within one week . do this by referring to the new expiry calendar printed on the blister . do away with the blister and write the date on the outer carton to make sure it is first used . donot throw away any medicines via wastewater or household waste . ask your
what kinzalmono contains - the active substance is telmisartan . each tablet contains 20 mg telmisantan . - the other ingredients are povidone , meglumine , sodium hydroxide , sorbitol ( e420 ), magnesium stearate . what kinzalao looks like and contents of the pack kinzalanmono 20 mg tablets are white to off - white , round tablets with " pfizer " debossed on one side and " nvr " debottled on the other side . kinzaloo is available in blister packs of 14 , 28
afstyla is a human clotting ( coagulation ) factor viii product produced by recombinant dna technology in the manufacturing process in the laboratory of lonoctocog alfa . afstylfa is used to treat bleeding episodes in patients with haemophilia a ( inborn factor v iii deficiency ). factor vii is a naturally occurring constituent of blood clotting . it helps blood to clot . patients with an increased tendency to bleed have been more likely to develop factor v ii in the past than patients with a lack of factor v viii . afostyla helps blood in the blood to
do not use afstyla if you have had an allergic reaction to afstylea or any of the other ingredients of afstrya ( listed in section 6 ). if you are allergic to hamster proteins 46 warnings and precautions talk to your doctor , pharmacist or nurse before using afstya . the batch number and frequency of administration are recorded in your treatment diary . do not use more afstilea than your doctor has recommended . allergic ( hypersensitivity ) reactions are possible with afstreea . symptoms of allergic reactions may include allergic reactions such as hives , generalised skin rash , tightness
your treatment will be overseen by a doctor experienced in the treatment of blood clotting disorders . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage the recommended dose of afstyla is one vial per day . dose and duration of treatment depending on your disease the site and the bleeding your clinical condition will be determined by your doctor . reconstitution and administration general instructions the powder and the solvent ( liquid ) should be mixed in a glass vial to form a seal . if you have aseptic conditions , you may be given afstst
like all medicines , afstyla can cause side effects , although not everybody gets them . symptoms of allergic reactions allergic reactions may include hives , generalised urticaria ( itchy rash ), tightness of the chest , difficulty in breathing , wheezing , low blood pressure , dizziness , anaphylaxis ( bleeding caused by factor viii medicines ) and inhibitor antibodies ( see section 2 ). very common ( may affect more than 1 in 10 people ) patients who have received previous treatment with factor v iii ( more than 150 days of treatment ) and who were treated with less than 100 days of medicines for persistent bleeding
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiratory date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the afstyla powder in the outer carton in order to protect from light . after reconstitution , the product may be stored at room temperature ( up to 25 ) for a maximum period of 3 days . keep afstylea in theouter carton to protect it from light and moisture . the reconst
what afstyla contains the active substance is lonoctocog alfa . each vial contains 250 iu ( 2 . 5 mg / ml ). after reconstitution with 2 .5 mg of lonoectocog aluminium , each vials contains 100 iu lonoactocog alpha . after reconstall with 2. 5 mg of injections the solution contains 200 iu of loroctocag alfa per ml . each 1000 iu / ml vial provides one injection . after administration with 2 , 5 mg injections the solutions contains 400 iu iu o lonoCTocog α
what praxbind is prax bind contains the active substance idarucizumab . idarukizumb is a recombal agent similar to dabigatran ( pradaxa ), a blood thinner medicine used to prevent blood clot formation . what praxBind is used for praxbinding is used to rapidlytrap dabigATran . how prax Bind works prax binds is used in combination with pradxa in adults who are undergoing emergency surgery or urgent procedures to control uncontrolled bleeding .
do not take praxbind if you are allergic to idarucizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a genetic disease called hereditary fructose intolerance ( hafid ). if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor before taking this medicine : if you develop serious adverse reactions after taking praxBind , stop taking this medication and tell your pharmacist . dabigatran ( other medicines to prevent blood clots ) dabigATran is naturally absorbed by the body and can form blood clumps . medicines to reduce
the recommended dose is 5 mg / kg body weight ( equivalent to 2 . 5 mg dabigatran ). this medicine will be given to you once a day . the recommended dose for adults is 5mg / kg ( equivalent of 5 mg ). this will be administered into a vein . your doctor will decide how much of this medicine you need . your treatment will be supervised by a doctor experienced in blood clot formation . your dose of dabigATran will be reduced by one dose per 24 hours . if you have any further questions on the use of this medication , ask your doctor or nurse . if this medicine has been used in
like all medicines , this medicine can cause side effects , although not everybody gets them . reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what praxbind contains - the active substance is idarucizumab . - the other ingredients are sodium acetate trihydrate , acetic acid , sorbitol ( e420 ), polysorbate 20 and water for injections . what prax bind looks like and contents of the pack praxbinding is a clear to slightly opalescent , colourless to slightly yellow solution supplied in a butyl rubber stopper and sealed with an aluminium cap .
temomedac contains a medicine called temozolomide . this medicine is an antitumour agent . temomedac is used to treat specific forms of brain tumours : - in adults with newly - diagnosed glioblastoma multiforme . temormac is first given together with radiotherapy ( concomitant phase of treatment ) and then together with monotherapy phase oftreatment . - in children 3 years of age and older and adult patients with malignant glioma , such as glioclastoma multipurpose or anaplastic astrocytoma . temmedac is given in combination
do not take temomedac - if you are allergic to temozolomide or any of the other ingredients of this medicine ( listed in section 6 ) - if your doctor has told you that you have had an allergic reaction to dacarbazine ( an anticancer medicine sometimes called dtic ). signs of allergic reaction include feeling itchy , breathlessness , wheezing , swelling of the face , lips , tongue or throat . - if certain kinds of blood cells are severely reduced ( myelosuppression ) - your white blood cell count and platelet count are severely decreased . these blood cells help fighting infection by
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage and duration of treatment your doctor will work out your dose of temomedac based on your height and weight . if you have a recurrent tumour that has not responded to chemotherapy treatment in the past and you are taking other medicines ( anti - emetics ) that are similar to temomedic ( see section " other medicines and temomedax "). you should take temomedacon to prevent nausea and vomiting . if your doctor determines that you have newly - diagnosed glioblastoma multiforme
like all medicines , this medicine can cause side effects , although not everybody gets them . if you have a severe allergic ( hypersensitive ) reaction , including hives , wheezing or other breathing difficulty , uncontrolled bleeding , seizures , convulsions , fever , chills and severe headache , stop temomedac treatment and contact your doctor immediately . there may be a reduction in certain kinds of blood cells . this may cause increased bruising or bleeding , anaemia ( reduced number of red blood cells ), fever and reduced resistance to infections . the reduction in blood cell counts is usually short - lived and can lead to anaemia (' apl
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store above 30 . do away with the capsules if you notice any change in the appearance of the capsules . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what temomedac contains - the active substance is temozolomide . temomedic 5 mg : each capsule contains 5 mg of temozolsomide ( as mesolomides ). temomedoc 20 mg :each capsule contains 20 mg of Temozolomonide (as mesolomonomide ). temmedac 100 mg : one capsule contains 100 mg of the active ingredient temozolaomide , as mesoledomide. temomedacon 140 mg : two capsules contain 140 mg of a substance called temozoledomides ( as temoledac ). temarthac 180 mg : three capsules
cialis is a treatment for adult men with erectile dysfunction . this is when a man cannot get , or keep a hard , erect penis suitable for sexual activity . cialis allows a hard erect penis to last long enough for you to satisfactorily complete sexual activity and to achieve a sexual climax . cialsis contains the active substance tadalafil which belongs to a group of medicines called phosphodiesterase type 5 inhibitors . calis works by helping the blood vessels in your penis to relax . this allows your penis stay hard and erect for a long enough period of time . erectile function is important for
do not take cialis - if you are allergic to tadalafil or any of the other ingredients of this medicine ( listed in section 6 ) - if your doctor has told you that you are intolerant of organic nitrate or nitric oxide donors such as amyl nitrite ( a group of medicines (" nitrates ") used to treat angina pectoris (" chest pain ")). warnings and precautions talk to your doctor before taking ciali if you : - are taking any of these medicines ( see section " other medicines and cialises ") - have serious heart disease - recently had a heart
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . cialis tablets are for oral use . swallow the tablets whole with a glass of water . the tablets can be taken with or without food . the usual dose is 5 mg twice a day ( approximately 2 . 5 mg per day ). if you take more cialises than you should if you accidentally take too many tablets , contact your doctor . if you forget to take ciali if you miss a dose , take it as soon as you remember . if
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with the medicine : allergic reactions ( rashes ) ( frequency not known ) chest pain ( common ) nitrates ( frequency unknown ) priapsim may cause a prolonged and possibly painful erection . stop taking cialis and seek medical help immediately if you experience such an erection . see section 4 , " warnings and precautions ". sudden loss of vision ( frequency cannot be estimated from the available data ). other side effects very common ( may affect more than 1 in 10 people ) uncommon ( may affects up to 1 in 100 people
what cialis contains - the active substance is tadalafil . each tablet contains 2 . 5 mg of tadalabil . - the other ingredients are : tablet core : lactose monohydrate ( see section 2 ' cialises contains lactose '), croscarmellose sodium , hydroxypropylcellulose , microcrystalline cellulose , sodium laurilsulfate , magnesium stearate . film - coating : lactate monohydrate , hypromellose , triacetin , titanium dioxide ( e171 ), iron oxide yellow ( e172 ), ironoxide red ( e 172 ),
enyglid is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancrea does not produce enough insulin to control the sugar in your blood or where your body is not able to use the insulin it produces effectively . enyglide helps control the level of sugar in the blood when you have type 2abetes by helping your pancry make better use of its insulin . treatment is usually started with diet and exercise and weight reduction . your blood glucose may be increased when enylid
do not take enyglid : if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). if you have type 1 diabetes . if the acid level in your blood is too low ( diabetic ketoacidosis ). if your doctor has told you that you have a severe liver disease . if you take gemfibrozil ( a medicine used to lower increased fat levels ). if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor before taking eny glid : - if you suffer from liver problems . if your physician
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 0 . 5 mg tablet once a day . swallow the tablet whole with a glass of water . you can take enyglid with or without food . the maximum recommended dose for adults is 30 mg once a week for 4 weeks . your doctor may increase your dose to 30 mg every 16 weeks . if you take more enylid than you should if you accidentally take too many enygelid tablets , or if someone else accidentally takes your medicine , contact your doctor immediately
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most common side effect of enyglid is hypoglycasemia ( may affect up to 1 in 10 people ). hypoglycemic reactions are generally mild / moderate . hypocaemic unconsciousness may lead to coma . allergy allergy ( may occur in up to1 in 10 , 000 people ) symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating ( anaphylactic reaction ). other side effects may include : common ( may effect up to one in 10 users ): stomach pain diarr
what enyglid contains the active substance is repaglinide . each tablet contains 0 . 5 mg or 1 mg or 2 mg repagginide . the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate , anhydrous , croscarmellose sodium , povidone k25 , glycerol , magnesium stearate , meglumine , poloxamer , yellow iron oxide ( e172 ), red iron oxide (< e172 ) ( see section 2 " eny glid contains lactose "). what enyglyglid looks like and contents of the pack en
what azacitidine mylan is azacitonidine myl is an anti - cancer agent . what azac citidine myla is used for azaccitidine mylon is used to treat adults . what it is usedfor azacacitine mylan can be used in adults . azacididine mygal is used after a stem cell transplantation in adults with higher - risk myelodysplastic syndromes ( mds ). it is also used in adult patients with chronic myelomonocytic leukaemia ( cmml ). it can also be used for acute myeloid
do not use azacitidine mylan - if you are allergic to azaccitidine or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have advanced liver cancer . warnings and precautions talk to your doctor or pharmacist before using azacacitrix mylan : - if the patient has decreased counts of platelets , red or white blood cells . - if he / she has kidney disease . - tell your doctor if the person has liver disease . if the doctor has a heart condition such as heart attack or lung disease . blood test your doctor will do
before starting azacitidine mylan , you will be given another medicine to prevent nausea and vomiting . the recommended dose is 75 mg once a day . your doctor will tell you how much azacita mylan you need . your dose of this medicine will depend on your height and weight . your first dose of azaccitidine myl will be taken on an empty stomach ( tummy ) and will be repeated every 6 weeks . this medicine is given under the skin ( subcutaneously ) on the skin of your thigh , tummy or upper arm . if you have any further questions on the use of this product ,
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following serious side effects : drowsiness , shaking , jaundice ( abdominal bloating and easy bruising ), which may be symptoms of liver failure . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , reduced appetite , confusion , restlessness and fatigue , which may also be symptoms , of kidney failure . a fever , which might be a sign of an infection with low levels of white blood cells . chest pain
your doctor , pharmacist or nurse knows how to store azacitidine mylan properly . any unused azaccitidine myl must be disposed of in accordance with local requirements . this medicine is for single use only . this medicinal product does not require any special storage conditions . once the suspension has been mixed with water , it should be used immediately . the suspension should be administered within 1 hour . the azacidine mylon suspension must be stored in a refrigerator ( 2 8 ). the suspension must not be stored outside the refrigerator ( 8 8 ). if the azackitidine melan suspension has not been mixed in a fridge
what azacitidine mylan contains - the active substance is azacinidine . one vial of powder contains 100 mg of azacacitine . after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / ml azacita . - the other ingredient is mannitol . what azacituidine myl looks like and contents of the pack azaccitidine mylon is a white powder for suspension for injection in a glass vial containing 100 mg azacididine . pack sizes of 1 and 7 vials . not all pack sizes may be marketed
duotrav eye drop solution contains two active substances , travoprost and timolol . travaprost is a prostaglandin analogue in the eye . timololine is a beta blocker that reduces fluid within the eye and reduces pressure within theeye . duotraveye drops are used to treat high pressure in theeye in adults with an illness called glaucoma .
do not take duotrav - if you are allergic to travoprost , prostaglandins , timolol , beta blockers or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has respiratory problems such as asthma , severe chronic obstructive bronchitis or severe lung disease . - if the child has wheeziness , difficulty in breathing , long - standing cough , breathing problems or severe hay fever . - tell your doctor if your baby has a slow heartbeat . - warnings and precautions talk to your doctor before taking duotra : - if he / she has heart failure (
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one drop in each eye once a day . do not use duotrav in both eyes . use duhotrav in the morning and evening . do this at about the same time each day . use in children and adolescents do not try to use duosrav in children or adolescents . the effects of duotrev in children are not known . the amount of eye drops that are used in children is 1 drop in the affected eye , 3 times a day , for 4 weeks . a
like all medicines , this medicine can cause side effects , although not everybody gets them . the drops should be swallowed whole with water . duotrav can cause very common side effects ( may affect more than 1 in 10 people ) effects on the eye eye redness . common side effect ( may effect up to 1 in every 10 people ), effects on how the eye surface inflammation ( surface damage ) can cause eye pain , blurred vision , abnormal vision , dry eye , itchy eye and eye discomfort . signs and symptoms may include eye irritation , burning or stinging . uncommon side effects( may affect up to1 in 100 people )effects
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 30 . store in the original package in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what duotrav contains the active substances are travoprost and timolol . each ml contains 40 mg of travaprost and 5 mg of timololine ( as timolole maleate ). the other ingredients are polyquaternium - 1 , mannitol , propylene glycol , polyoxyethylene hydrogenated castor oil 40 mg . the other ingredient is boric acid , sodium chloride , sodium hydroxide , hydrochloric acid , purified water , sodiumhydroxide and hydrochlorIC acid . acidity levels are measured at ph levels . what duotra looks like and contents
nplate ' s active ingredient is romiplostim . it is a protein used to reduce low platelet counts in the immune ( idiopathic ) thrombocytopenic purpura ( itp ). itp is a disease in which your body ' s immune system does not produce enough platelets . platelets are important in controlling the number of blood clots . very low platelets can lead to bruising and serious bleeding . nplate is used in adults ( aged 1 year and older ) who have had their spleen removed and who have chronic itp . itp has been previously treated with cortic
do not take nplate if you are allergic to romiplostim or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . if you have been previously treated with other medicines containing escherichia coli ( e . coli ). warnings and precautions some patients taking nplate have developed a low blood platelet count ( thrombocytopenia ). your doctor may reduce your dose of nplate or temporarily stop it . your doctor will monitor your platelet counts to check that you are having blood clots . if any of these apply to
nplate is given to adults and adolescents from 1 to 17 years of age . your doctor will decide how much nplate you need and how often you need to take nplate . nplate is usually given as an injection under the skin ( subcutaneous ) over a period of 1 hour . how often to take your dose of nplate depends on your platelet counts . your physician will take regular blood samples to check your platelets . your platelelet count will be checked regularly . your blood will be taken regularly to measure your platel count . the usual starting dose is 1 mg / kg body weight . your dose may
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with itp : common ( may affect up to 1 in 10 people ): headache , allergic reaction , upper respiratory tract infection . common ( might affect up in 1 in10 people ): bone marrow disorder , increased bone marrow fibres , trouble sleeping ( insomnia ), dizziness , tingling or numbness of the hands or feet ( paraesthesia ), migraine , redness ofthe skin , flushing , blood clot in a lung artery ( pulmonary embolism ), nausea , diarrhoea , abdominal pain , ind
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do store above 30 . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what nplate contains the active substance is romiplostim . nplate 125 mg powder for solution for injection contains 230 mg romipliplostime . each vial contains 125 mg romplostim in a deliverable amount of 0 . 25 ml solution . each single - dose vial provides 125 mg of romiploseim in the deliverable amounts . each multi - dose ampoule contains 375 mg romclostim and 250 mg of the active ingredient . each dual - dose ephedrine ampoules contains 250 mg romlostim ( in a deliveryable amountof 0 . 5 ml solution ). each
this medicine contains an active substance called glycopyrronium bromide which belongs to a group of medicines called bronchodilators . what tovanor breezhaler is used for this medicine is used to help to relieve breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten , making breathing difficult . this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the lungs . this means that it helps to keep the air in the air when you breathe . this helps to
do not use tovanor breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using tovanOR breez inhaler - kidney problems - an eye problem called narrow - angle glaucoma - difficulty passing urine during treatment with tovannor breezer . stop using this medicine and tell your doctor immediately if you get tightness of the chest , coughing , wheezing or breathlessness immediately after using toivanor breezer . this may be a
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much tovanor breezhaler to use the recommended dose of this medicine is one inhalation once a day . you should inhale this medicine at least 24 hours before or at least 75 minutes after food . you can use this medicinal product at any time of the day , with or without exercise . this medicine should be used every day . this is because it is easier to use it in the long term . how to use this leaflet for this medicine comes as an inhaler and capsules (
what tovanor breezhaler contains - the active substance is glycopyrronium bromide . each hard capsule contains 63 micrograms glycopirroniumbromide and 50 microgramms glycopyronium . the delivered dose ( the delivered amount that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgram of glycopYRronium per inhalation dose . - the other ingredients of the inhaled powder are lactose monohydrate and magnesium stearate . what tovanOR breez inhaler looks like and contents of the pack tovannor breezer 44
adasuve contains the active substance loxapine and belongs to a group of medicines called antipsychotics . it works by stimulating the brain to produce dopamine and serotonin which are important for calming effects and relieving aggressive behaviour . adasuve is used to treat acute symptoms of mild - to - moderate agitation in adults with schizophrenia and bipolar disorder . these are diseases characterised by symptoms such as ( schizophrenia ) hearing , seeing things which are not there , mistaken beliefs , incoherent speech and behaviour , emotional flatness , depressed , guilty , anxious , tense , and generally not being able to do anything . adasve can also
do not take adasuve if you are allergic to loxapine or any of the other ingredients of adasuvet ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking adasuves if you have symptoms of wheezing or shortness of breath , as these may be signs of lung problems like asthma , chronic obstructive pulmonary disease ( copd ), narrowing of the airways ( bronchospasm ), wheeze , cough , chest tightness or short shortnessof breath . children and adolescents adasuvest is not recommended for children and teenagers below 25 years of age .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 9 . 1 mg twice a day ( taken 2 to 4 weeks apart ) for a short period of time . your doctor may adjust your dose if your condition is not controlled by the hand or mouth or by the device . if you have any of the following symptoms : extreme tiredness , sleepiness , trouble breathing , low blood pressure , throat irritation and a bad taste in the mouth . if this happens , muscle or eye movements may get worse . if any of these apply to you ,
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you get any of the following side effects : - any breathing symptoms such as wheezing , cough , shortness of breath , chest tightness , irritating your airways ( asthma or copd ), light - headedness or fainting . these may be signs that your blood pressure is not being controlled properly . - worsening agitation , confusion , fever and muscle stiffness . these could be signs of a severe condition called neuroleptic malignant syndrome . the following other side effects have been reported : very common ( may affect
keep out of the sight and reach of children . do not use adasuve after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do use adasve if you notice any visible signs of physical damage . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what adasuve contains - the active substance is loxapine . each single - dose inhaler contains 5 mg of loxepine . adasuves delivers 4 . 5 mg loxpine . what adasuvet looks like and contents of the pack adasuvel 4 .5 mg is a white to off - white plastic inhaler , imprinted with " loxphine " on one side and " nvr " on the other side . each inhaler is packed in a sealed foil pouch . adasve 4 . 4 . 0 mg is available in packs containing 1 or 5 inhalers . not
what azacitidine betapharm is azacitonidine betabarm is an anti - cancer agent . it belongs to a group of medicines called ' anti - metabolites '. what azacididine betafarm is used for azacinidine betaparm is a stem cell transplantation for the treatment of : - higher - risk myelodysplastic syndromes ( mds ) - chronic myelomonocytic leukaemia ( cmml ) - acute myeloid leukaemic ( aml ). these are diseases that affect the bone marrow , which results in normal blood cell production .
do not use azacitidine betapharm - if you are allergic to azaccitidine or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have advanced liver cancer . warnings and precautions talk to your doctor or pharmacist before using azacacitrix betapham : - if the patient has decreased counts of platelets , red or white blood cells . - if he / she has kidney disease . - tell your doctor if the person has liver disease . if the doctor has a heart condition such as heart attack or lung disease . blood test your doctor
before starting azacitidine betapharm , you will be given another medicine to prevent nausea and vomiting . the recommended dose is 75 mg once a day . your doctor will tell you how much azacita betapham you need . your dose of this medicine will depend on your height and weight . azacacitine betapharms is given every 3 weeks as part of this " treatment cycle " ( cycle 4 , 6 ). this medicine is given under the skin ( subcutaneously ) on the skin of your thigh , tummy or upper arm . if you have any further questions on the use of this product ,
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following serious side effects : drowsiness , shaking , jaundice ( abdominal bloating and easy bruising ), which may be symptoms of liver failure . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , reduced appetite , confusion , restlessness and fatigue , which may also be symptoms , of kidney failure . a fever , which might be a sign of an infection with low levels of white blood cells . chest pain
your doctor , pharmacist or nurse knows how to store azacitidine betapharm properly . any unused azacituidine betabarm must be disposed of in accordance with local requirements . this medicine is for single use only . this medicinal product does not require any special storage conditions . the suspension must be administered within 45 minutes . the azaccitidine betafarm suspension must not be mixed with water for injections . the mixture must be stored in a refrigerator ( 2 8 ). the azackitidinebetapharm suspension should be stored within a refrigerator and not refrigerated . the solution must be used within 8 hours .
what azacitidine betapharm contains - the active substance is azacitonidine . each vial contains 100 mg azacinidine . after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / ml azacita . - the other ingredient is mannitol ( e421 ). what azacituidine betafarm looks like and contents of the pack azaccitidine betabarm is a white to off - white powder supplied in a glass vial containing 100 mg of azacilitidine .
ceberdelga contains the active substance eliglustat . it is used for the long term treatment of gaucher disease type 1 in adults . gaucher dementia type 1 is inherited condition in which a substance called glucosylceramide is not removed from the body . this substance is passed from the spleen , liver and bones . when eliglustAT is taken with glucoslceramide , it can cause your affected organs to become smaller . this medicine will be prescribed to you by a doctor or nurse . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not
do not take cerdelga if you are allergic to eliglustat or any of the other ingredients of this medicine ( listed in section 6 ). if you have been taking medicines called moderate cyp2d6 inhibitors ( e . g . quinidine , terbinafine ) 31 or moderate cyc3a inhibitors ( such as erythromycin or itraconazole ). these medicines are used to reduce your body ' s ability to absorb nutrients . do not take any of these medicines if any of them have been harmful to you . warnings and precautions talk to your doctor before taking cerdelg . if
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet twice a day with food . the amount of metaboliser that you need depends on your condition and body weight . the dose of metabolizer that you take is one 84 mg tablet twice daily . swallow the tablet whole with water . if you take more cerdelga than you should if you accidentally take too many tablets , contact your doctor straight away . how to take take the tablet once a day , with food , at about the same time each day . do not chew , crush
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): headache dizziness change in taste ( dysgeusia ) palpitations throat irritation heartburn ( dyspepsia ) feeling sick ( nausea ) diarrhoea constipation abdominal pain stomach ache ( upper abdominal pain ) acid reflux disease ( gastrooesophageal reflux diseases ) bloating ( abdominal distension ) inflammation of the stomach ( gastritis ) 34 difficulty swallowing ( dysphagia ) vomiting dry mouth gas ( flatulence ) dry skin hives ( ur
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and sleeve after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what cerdelga contains - the active substance is eliglustat . each capsule contains 84 mg of eliglustit . - the other ingredients are : capsule content : microcrystalline cellulose , lactose monohydrate ( see section 2 ' cerdelaga contains lactose '), hypromellose , glycerol dibehenate , gelatin , potassium aluminium silicate , titanium dioxide ( e171 ), yellow iron oxide ( e172 ), indigotine ( e132 ), shellac , black iron oxide , propylene glycol and ammonia solution . what cerdelg looks like and contents of the pack cerdelgi
the active substance in zoledronic acid hospira is zoledron acid , which belongs to a group of substances called bisphosphonates . zoledor acid works by attaching itself to the bone and slowing down the rate of bone change . it is used to prevent bone complications , e . g . fractures , in adult patients with bone metastases ( spread of cancer from primary site to the other bone ). it reduces the amount of calcium in the blood in adult people when : there is a tumour . tumours can accelerate normal bone change and this can lead to an increase in the level of calcium ( also known as
your doctor will carry out blood tests before you start treatment with zoledronic acid hospira and will check your response to treatment regularly during treatment . do not use zoledron acid hospir if you are allergic ( hypersensitive ) to zoledic acid , another bisphosphonate ( the substance to which zoledor acid belongs ). warnings and precautions talk to your doctor or pharmacist before using zoledoral acid hospire : if you think any of the above apply to you , or if you have been in close contact with someone who has , or has had , a kidney problem . if you experience pain , swelling
zoledronic acid hospira must only be given by healthcare professionals trained in administering bisphosphonates intravenously ( into a vein ) and under ' iv ' administration . in order to reduce the risk of dehydration , your doctor will tell you how much zoledronic acidic hospira you should take ( see section 4 " important information about some of the ingredients of zoledron acid hospir "). if you have a kidney problem , your dose of zolingronic acid hospira will be adjusted by your doctor . if you are not sure about the severity of your kidney problem talk to your doctor or pharmacist . z
like all medicines , zoledronic acid hospira can cause side effects , although not everybody gets them . the most common side effects are : common ( may affect up to 1 in 10 people ): severe kidney impairment ( will be determined by your doctor with certain blood tests ) low level of calcium in the blood uncommon ( may affects up to1 in 100 people ): pain in the mouth , teeth and / or jaw , swelling or non - healing sores inside the mouth ( jaw discharge ), numbness or a feeling of heaviness in the jaw , and loosening of a tooth . these could be signs of bone damage in the g
keep out of the reach and sight of children . do not use zoledronic acid hospira after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what zoledronic acid hospira contains the active substance is zoledron acid . one vial contains 4 mg zoledrine acid . the other ingredients are monohydrate , mannitol , sodium citrate and water for injections . what zoledic acid hospir looks like and contents of the pack zoledicle acid hospire is a liquid concentrate for solution for infusion ' s use . it is a clear , colourless to pale yellow to yellow concentrate . each pack contains one vials of concentrate .
varuby contains the active substance rolapitant . it is used to treat adults with cancer feeling sick ( nauseous ) or being sick ( vomiting ) when cancer treatment chemotherapy is used . chemotherapy destroys nerve cells in the brain that help you to fight off nausea and vomiting . when you are sick , rolapit works by killing these nerve cells . this can cause nausea and / or vomiting .
do not take varuby if you are allergic to rolapitant or any of the other ingredients of this medicine ( listed in section 6 ). if you take an herbal medicine called st john ' s wort ( hypericum performatum ). if your doctor has prescribed varubchy for you . if you have depression or difficulty sleeping ( see section 2 " warnings and precautions "). if you think any of these apply to you , tell your doctor before taking this medicine . warnings and risks 27 if you suffer from severe liver or kidney problems . if your dose of certain medicines ( e . g . rifampicin ,
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 180 mg once a day for up to 90 days . swallow the tablet whole with water . you can take varuby with or without food . you may take it with or just after food . it may be taken with or after a meal . you should take varubsy for 2 weeks before your chemotherapy cycle . you will receive chemotherapy to reduce sickness . if you take more varubys than you should if you have taken more medicine than you were told to , contact your doctor immediately
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with varuby : very rare ( may affect up to 1 in 1 , 000 people ) symptoms of an allergic reaction may include sudden shortness of breath , swelling of the lips or tongue , change in taste , swelling or skin or tissue , sudden rash , fever and faster heartbeats . tell your doctor immediately , and he or she may decide to stop the treatment . other side effects include : very common ( may affects more than 1 in 10 people ) headache constipation feeling tired uncommon ( may affecting up to
what varuby contains the active substance is rolapitant . each tablet contains 90 mg rolapit . the other ingredients are : tablet core : lactose monohydrate ( see section 2 under ' varubiy contains lactose '), pregelatinised starch , microcrystalline cellulose , povidone ( k - 30 ), croscarmellose sodium , colloidal silicon dioxide , magnesium stearate . film - coating : polyvinyl alcohol , titanium dioxide ( e171 ), macrogol , polysorbate 80 . what varubey looks like and contents of the pack varubdy
what enerzair breezhaler is enerzaire breez inhaler contains two active substances : indacaterol and glycopyrronium - mometasone furoate indacterol and microcopyrroneium belong to a group of medicines called bronchodilators . they relax the muscles in the small airways in the lungs . this makes it easier for air to get in and out of the lungs and makes it less likely that you will have to inhale it . mometsone fruate belongs to a class of medicines known as corticosteroids or steroids . cort
do not use enerzair breezhaler if you are allergic to indacaterol , glycopyrronium , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before using enerzir if you have : heart problems if you get an irregular or fast heartbeat if you suffer from thyroid gland problems if your family has diabetes , high blood sugar , seizures if you drink alcohol if you smoke if you know that you have severe kidney problems if any of these
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . the medicine should be inhaled once a morning . use enerzair breezhaler every day until your asthma is controlled and your symptoms improve . use in children and adolescents use in adolescents is the same as for adults . use with enerz air breez inhaler in children . how to use enerzeair breezehaler is for inhalation use only . you should use an inhaler and capsules that contain the medicine . the inhaler
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects could be serious stop using enerzair breezhaler and see a doctor straight away if you notice any of the following : very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips or face , skin rash , itching and hives . these may be signs of allergic reaction . other side effects other sideeffects include the following side effects : very commonly ( may affects more than1 in 10 users ): sore throat , runny nose , sudden difficulty breathing , feeling of tight
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store in the original package in order to protect from moisture . the capsules should be used within one month after first opening . do this if you notice any change in the appearance of the capsules . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the
what enerzair breezhaler contains the active substances are indacaterol ( as acetate ), glycopyrronium ( as bromide ), and mometasone furoate . each capsule contains 150 micrograms of indacate ( asacetate ), 63 microgram of glycopreyronium bromides , 50 microgram glycopirronium and 160 microgram mometsone furuate . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is 114 microgram indacatedol ( acetate ) , 58 microgram ( glycop
clopidogrel acino pharma gmbh contains the active ingredient clopidigrel which belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thromebosis ). clopidineogrelacino pharmae gmbhs is taken to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as athero
do not take clopidogrel acino pharma gmbh if you are allergic ( hypersensitive ) to clopiprel or any of the other ingredients of clopidineogrel aglodipride ( see section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , tell your doctor before taking clopridogrelacino pharmace kinase . if your doctor thinks that the effect of clapidogl acino pharma gmb h
always take clopidogrel acino pharma gmbh exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is one 75 mg tablet of clopridogrel aclara gmbhl per day to be taken orally with or without food . you can take clapidogl acino pi gmb h with or just after food . if you take more clopidoogrelacino pharmara gph than you should contact your doctor , pharmacist or the nearest hospital emergency department because of the increased risk of bleeding .
like all medicines , clopidogrel acino pharma gmbh can cause side effects , although not everybody gets them . the most common side effects are : common ( affects 1 to 10 users in 100 ) uncommon ( affects less than 1 user in 1 , 000 ) rare ( affects 2 to 10 user in 10 , 000 ). very rare ( affect less than1 user in 100 ). contact your doctor immediately if you experience : fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . signs of liver problems may include yellowing of the skin and / or the eyes (
store in the original blister in order to protect from moisture . keep out of the reach and sight of children . do not use clopidogrel acino pharma gmbh after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . donot use cloplidogl acino pharmaceutical gmbhl if you notice any visible sign of damage of blister or film - coated tablets . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will
what clopidogrel acino pharma gmbh contains the active substance is clopridogrel . each tablet contains 75 mg of clopidaogrel ( as besilate ). the other ingredients are : tablet core : macrogol 6000 cellulose , microcrystalline ( e460 ) crospovidone type a castor oil , hydrogenated film - coating : macromol 6000 ethylcellulose ( e462 ) titanium dioxide ( e 171 ) what clopidiogrelacino pharmha gmb h looks like and contents of the pack clopideogrel acute
delstrigo is used to treat hiv (' human immunodeficiency virus ') infection in adults who are taking medicines called ' antiretroviral medicines '. the active substances are doravirine ( a non - nucleoside reverse transcriptase inhibitor ( nnrti ), lamivudine ( also a nucleosides analogue reverse transcriptases inhibitor ( tnrtis ), tenofovir disoproxil ( also known as a nucleositide analogue reverse transcriptase inhibitor , nrti ). delstrigo can be used to control hiv infection in adult patients ( aged 18 years
do not take delstrigo if you are allergic to doravirine , lamivudine , tenofovir disoproxil or any of the other ingredients of this medicine listed in section 6 . if you take any of any of these medicines : carbamazepine , oxcarbazepine ( medicines to treat tuberculosis ), phenytoin ( medicines used to prevent seizure ), rifampicin , rifapentine ( medicine to treat anxiety ) products containing mitotane ( a medicine to help prevent cancer ), enzalutamide ( a medicines to help treat prostate cancer ), lumac
always take delstrigo exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is a complete regimen of one tablet a day . a single tablet is sufficient for the treatment of hiv infection . the dose is 1 tablet a night . your doctor may prescribe you certain medicines ( such as doravirine ). your doctor will tell you which medicines to take . taking this medicine swallow the tablet whole with a glass of water . you can take this medicine with or without food . if you take more delstriga than you should if you have taken more tablets than
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking this medicine and see a doctor immediately if you notice any of the following : very common ( may affect more than 1 in 10 people ): abnormal dreams difficulty in sleeping ( insomnia ) headache dizziness sleepiness cough nasal symptoms feeling sick ( nausea ) diarrhoea stomach pain vomiting wind ( flatulence ) hair loss rash muscle symptoms such as pain ( stiffness ) feeling tired fever blood tests increased levels in liver enzymes uncommon ( may effect up to 1 in 100 people ): nightmares , depression , anxiety , irritability , confusion , suicidal thoughts 45 trouble concentrating
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and carton after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . keep the bottle tightly closed in order to protect from moisture . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what delstrigo contains the active substances are : 100 mg doravirine , 300 mg lamivudine , 245 mg tenofovir disoproxil ( as fumarate ) the other ingredients are : tablet core : croscarmellose sodium e468 , hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose e460 , silica , colloidal anhydrous , sodium stearyl fumararate . a coating material : carnauba wax e903 , hyprogellose , iron oxide yellow ( e172 ), lactose mon
spravato contains esketamine . it belongs to a group of medicines called anti - depressants . this medicine helps to control your depression . it also helps to reduce the symptoms of depression such as feeling sad , anxious , worthless , sleeping difficulties , change in appetite , loss of interest in favourite activities and feeling of being slowed down . spravato is used in combination with another antidepressant in adults , adolescents and children aged 2 years and older . if you have any questions about antidepressant medicines , ask your doctor or pharmacist .
do not take spravato if you are allergic to esketamine , ketamine or any of the other ingredients of this medicine ( listed in section 6 ). if you have an aneurysm ( a weak spot in a blood vessel wall that bulges out due to bleeding in the brain ). if recently had a heart attack . within 6 weeks of starting treatment . a temporary increase in blood pressure can lead to serious complications in these conditions . if any of these apply to you , tell your doctor before taking spravo . warnings and precautions talk to your doctor or pharmacist before taking this medicine if you : have a heart
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much spravato to use the spravatos nasal spray is a clear , colourless liquid . the nasal spray device is only suitable for use in children and adolescents . the recommended dose is 1 spray ( 2 sprays ) per kg body weight . the maximum recommended dose for children is 3 spray devices ( 3 sprays ). one nasal spraydevice is used for 4 weeks . if you use more spravata than you should if you have used more spradato than you have been told to ,
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported : very common ( may affect more than 1 in 10 people ) feeling disconnected , feelings and things around you feeling dizzy headache change in sense of taste feeling sleepy decreased feeling or sensitivity to touch in the mouth area spinning sensation ( vertigo ) vomiting nausea common ( might affect up to 1 in every 10 people ): feeling extremely happy , euphoria , feeling agitated , feeling anxious , feeling in the eyes , ears or sense of touch are altered or mimicked irritable panic attacks change in perception 37 feeling , hearing ,
what spravato contains - the active substance is esketamine . each nasal spray device contains esketam hydrochloride equivalent to 28 mg esketine . - the other ingredients are citric acid monohydrate disodium edetate sodium hydroxide ( for ph adjustment ) water for injections what spravat looks like and contents of the pack spravatos is a nasal spray solution . this medicine is a clear , colourless solution supplied in a single - use nasal spraydevice . spravata is available in packs containing 1 , 2 , 3 or 6 nasal spray devices . eachnasay device is sealed in a
zerbboraf is an anticancer medicine that contains the active substance vemurafenib . it is used to treat melanoma that has spread to other parts of the body or cannot be removed by surgery . it can be caused by cancer caused by a change ( mutation ) in a gene called ' melanoma ' ( tk - 1 ). zelboraf targets proteins that are involved in the growth and spread of your cancer .
do not use zelboraf if you are allergic to vemurafenib or any of the other ingredients of this medicine ( listed in section 6 ) if symptoms of allergic reactions ( such as swelling of the face , lips or tongue , difficulty breathing , rash , or fainting sensation ) occur . if this happens , stop using zelberaf and tell your doctor immediately . allergic reactions if allergic reactions occur , stop taking zelbaraf and contact your doctor or seek medical help immediately . if you have any symptoms of an allergic reaction ( such : swelling ofthe face , lip or tongue ), difficulty breathing or rash
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 4 mg once a day for up to 8 weeks . your doctor may increase your dose to 4 mg twice a day if you experience side effects . your treatment will be continued until your doctor tells you otherwise . taking zelboraf with food you can take zelbaf with or without food . swallow the tablets whole with a glass of water . do not crush or chew the tablets . if you take more zelberaf than you should if you accidentally take too many tablets ,
like all medicines , zelboraf can cause side effects , although not everybody gets them . serious allergic reactions swelling of the face , lips or tongue difficulty breathing rash fainting sensation stop taking zelberaf and tell your doctor immediately if you notice any of the following symptoms : radiation treatment if you get any of these , tell your nuclear medicine doctor immediately . radiation may affect the skin , esophagus , bladder , liver , rectum , and lungs . tell your radiologist immediately if : you get skin rash , blistering , peeling or discoloration of the skin shortness of breath , a cough , fever
keep out of the reach and sight of children . do not use zelboraf after the expiry date which is stated on the carton and on the blister after exp . the expiratory date refers to the last day of that month . this medicine does not require any special storage conditions . do this after the first opening of the blister . do away with any blister that is damaged or shows signs of tampering . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what zelboraf contains the active substance is vemurafenib . each film - coated tablet contains 240 mg of vemurabenib ( as a co - precipitate of veMurafenb ). the other ingredients are : hypromellose acetate succinate , colloidal anhydrous silica , croscarmellose sodium , hydroxypropyl cellulose , magnesium stearate film - coating containing iron oxide , macrogol 3350 , polyvinyl alcohol , talc and titanium dioxide ( e171 ). what zelberaf looks like and contents of the pack zelb
duoplavin contains clopidogrel and acetylsalicylic acid (asa ). this belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood which clump together during blood clotting . by preventing this clumping , blood vessels relax . antiplatelets medicinal products reduce the chances of blood clots forming ( a process called atherothrombosis ). duoplavic is taken to prevent blood clumps forming in hardened arteries , a process known as atherostrombotic events , which can lead to stroke , heart attack , or death .
do not take duoplavin if you are allergic to clopidogrel , acetylsalicylic acid ( arsa ) or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic to other products called non - steroidal anti - inflammatory products if you have painful and / or inflammatory conditions of muscles or joints if you suffer from a medical condition ( such as asthma , nasal discharge , runny nose , polyps ( a type of growth in the nose ) if your doctor has told you that you have a medicalcondition that is currently causing bleeding such as a stomach
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . you should take duoplavin at the same time each day . your doctor will tell you how many tablets of your medicine to take . if you take more duoplin than you should if you have accidentally taken too many tablets , or if someone else has taken your tablets , contact your doctor immediately . if possible , take the tablet immediately and then go back to your regular schedule . if necessary , take your medicine pack with you . if a child swall
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . do store below 25 . do this medicine in the original package in order to protect from light . donot use this product if you notice any visible sign of deterioration . do so if you have any further questions on the use of this medicine , ask your pharmacist .
what duoplavin contains duoplin 75 mg film - coated tablets each tablet contains 46 mg of the active substances , clopidogrel , acetylsalicylic acid (asa ) and 75 mg of clopidoogrel ( hydrogen sulphate ). each tablet also contains 75 mg acetylSalicylicacid , mannitol , macrogol 6000 , microcrystalline cellulose , low substituted hydroxypropylcellulose , maize starch , hydrogenated castor oil ( see section 2 ' duopllin contains hydrogenatedcastor oil '), stearic acid and colloidal
simbrinza contains two active substances , brinzolamide and brimonidine tartrate . brin zolamide belongs to a group of medicines called carbonic anhydrase inhibitors . brimonididine tartrates belongs to the group of medicine called alpha - 2 adrenergic receptor agonists , which work by reducing pressure within the eye . simbrinz is used to treat pressure in the eyes in adults aged 18 years and older who have been previously treated for eye conditions such as glaucoma , ocular hypertension ( high pressure in one or both eyes ).
do not take simbrinza if you are allergic to brinzolamide , brimonidine tartrate or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic to sulphonamides if you have been taking medicines for diabetes or infections if you take diuretics ( water tablets ) or a monoamine oxidase ( mao ) inhibitors if you were taking medicines to treat depression or parkinson ' s disease if you do not take certain antidepressants if you know that you may have been misusing any antidepressant medicines you are taking if you suffer from severe kidney problems if
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . simbrinza should only be used in the eyes . avoid touching your eyes or eyes with your hands ( see section 1 , " how to use simbrinusza "). remove the cap and snap collar . hold the medicine with your fingers . tilt the bottle back . pull down the lower eyelid with a clean finger and insert a ' pocket ' between the eyelid and the eye . the drop will go in here . see section 2 , " important information about how to apply simbrins "
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : a reaction to the medicine ( frequency not known ): signs of an allergic reaction may include severe skin reactions , rash , redness , itching all over your body and / or eyes trouble breathing , chest pain , or irregular heart beat tell your doctor immediately extreme tiredness or dizziness . the other side effects that may occur with simbrinza are : common side effects ( may affect up to 1 in 10 people ) effects affecting the eye ( allergic conjunctivitis ) eye allergy eye surface inflammation
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the bottle tightly closed in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what simbrinza contains the active substances are brinzolamide and brimonidine tartrate . each ml of suspension contains 10 mg of brin zolamide ( corresponding to 2 mg of a brimonine tartrate equivalent to 1 . 3 mg of Brimonidine ). the other ingredients are benzalkonium chloride ( see section 2 " simbrinusza contains benzalkonic chloride "), propylene glycol , carbomer 974p , boric acid , mannitol , sodium chloride , tyloxapol , hydrochloric acid , sodium hydroxide , purified water , hydroch
what filgrastim ratiopharm is filgrasteim ratisopharm contains the active substance filgrastaim . filgrateim is a protein produced by biotechnology in bacteria called escherichia coli . it belongs to a group of proteins called cytokines and is very similar to a natural protein ( granulocyte - colony stimulating factor [ g - csf ]) produced by your own body . filfilgrastine stimulates the bone marrow to produce new blood cells . more blood cells are needed than white cells . white cells are important as they help your body fight infection . what filgratim
do not use filgrastim ratiopharm - if you are allergic ( hypersensitive ) to filgrasteim or any of the other ingredients of filgraspim ratisopharm . warnings and precautions talk to your doctor or pharmacist before using filgrateim ratitopharm if you have ever had a cough , fever or difficulty breathing . this may be a symptom of a pulmonary disorder . tell your doctor if you get any of these side effects . sickle cell disease 57 left upper abdominal pain or pain at the tip of your shoulder . this might be a sign of a spleen disorder . your
how much filgrastim ratiopharm is given the amount of filgrasteim ratisopharm you will receive will depend on your condition and on how well you respond to filgrasterim ratitopharm . your doctor will decide how much filgnastim ratiopharm to give you . filgrateim ratiotopharm treatment will be started by your doctor . the usual dose of fil grastim ratsion for adults undergoing chemotherapy is 0 . 5 mg / kg body weight once daily for 60 days . your treatment will last approximately 14 days . some disease types may be more severe .
you should not be given filgrastim ratiopharm if you have sickle cell disease 57 you should not have left upper abdominal pain or pain at the tip of your shoulder if you suffer from a spleen disorder . see section 4 . possible side effects your doctor will perform regular blood tests before and during treatment with filgrasterim ratisopharm to check the number of neutrophils ( a type of white blood cells ) in your blood . your doctor may also monitor your blood during treatment . other medicines and filgrasteim ratitopharm tell your doctor or pharmacist if you are taking , have
keep out of the reach and sight of children . do not use filgrastim ratiopharm after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . donot use filgrimastim piriopham if the solution is cloudy or contains particles . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what filgrastim ratiopharm contains - the active substance is filgrasterim . each ml of solution for infusion contains 60 mg of filgrateim . filgraspim ratisopharm 30 mg : each pre - filled syringe contains 0 . 5 ml of fil grastim in 0 . 05 ml solution . filgnastim ratiopharm 48 mg : one pre - drawn syringe containing 0 . 8 ml of filmgrastIM in 0. 8 ml solution for injection . - the other ingredients are sodium hydroxide , glacial acetic acid , sorbitol , poly
what riluzole zentiva is riluxole zenta contains a substance called rilusole which belongs to the nervous system . what rilizole zsentiva is used for rilustole zertiva is given to adults with amyotrophic lateral sclerosis ( amy ) motor neurone disease ( ms ). ms affects the nerve cells responsible for sending messages to muscles , causing weakness , muscle waste and paralysis . ms is caused by the destruction of nerve cells . motor neurONE disease may also cause too much glutamate ( a chemical messenger ) in the brain and spinal cord . rilzole zint
do not take riluzole zentiva - if you are allergic to rilizole or any of the other ingredients of this medicine ( listed in section 6 ). - if any liver disease has been reported . - if your doctor has noticed increased blood levels of some enzymes of the liver called transaminases . - tell your doctor if you think you may be pregnant . warnings and precautions talk to your doctor before taking rilzole zenta - if : you have any liver problems - you have yellowing of your skin or the whites of your eyes ( jaundice ) - you get itching , feeling sick or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . the tablets should be taken by mouth at least 12 hours apart . if you take more riluzole zentiva than you should contact your doctor , pharmacist or your nearest hospital emergency department immediately . if possible take rilzole zenta with food . if a child swallows some tablets , contact your physician immediately . do not take a double dose to make up for a forgotten dose . if your child swalloses more tablets than he / she should
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : fever ( increase in temperature ). during treatment with riluzole zentiva there may be a decrease in the number of white blood cells . this is shown in a blood sample . white blood cell counts are important for fighting infections . if you have any of the following symptoms : yellowing of your skin or the whites of your eyes ( jaundice ), itching , feeling sick or being sick . these may be signs of liver disease ( hepatitis ). your doctor will do regular blood tests before and during treatment
what riluzole zentiva contains the active substance is rilusole . the other ingredients are : tablet core : anhydrous dibasic calcium phosphate , micro crystalline cellulose , anhydrated colloidal silica , magnesium stearate , croscarmellose sodium , hypromellose , macrogol 6000 , titanium dioxide ( e171 ). what rilizole zenta looks like and contents of the pack the tablets are white to off - white , round and marked with " 50 " on one side and " rilzole 202 " on the other side . ril
emgality contains the active substance galcanezumab , a medicine that blocks the activity of a protein called calcitonin gene ( cgrp ). it is used to treat migraine in adults with increased levels of cgrm . emgality is used in adults to treat a type of migraine called migraine . it is indicated for use in patients 4 years of age and older and in adolescents with migraines that are not controlled with other treatments . emigality is indicated to reduce the frequency and severity of migraine headache and improve your quality of life .
do not use emgality if you are allergic to galcanezumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a serious cardiovascular disease . serious cardiovascular diseases can lead to allergic reactions emgally can cause serious allergic reactions . these reactions may occur within 40 minutes of a serious allergic reaction . you should see a doctor immediately if you notice such signs or possible side effects . see section 4 . children and adolescents emgali is not recommended for children and teenagers under the age of 18 years . other medicines and emgals tell your doctor or pharmacist if you use ,
always use emgality exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 240 mg once daily . emgally is given as an injection under your skin ( subcutaneous injection ). you may receive your emgalis injection at any time of the day , with or without proper training . if you use more emgico than you should if you forget to use emgonality if you miss a dose , inject the missed dose as soon as you remember . however , if it is almost time for your next dose , skip the missed missed dose and go
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects allergic reactions to emgality may include rash and itching . serious allergic reactions ( rare , may affect up to 1 in 1 , 000 people ) may include : difficulty breathing or swallowing , low blood pressure , dizziness or light - headedness , swelling of the neck , face , mouth , lips , tongue or throat , severe itching of the skin , a red rash with raised bumps . other side effects very common side effects ( may affect more than 1 in 10 people ) injection site pain injection site reactions may include red skin , itching
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after first opening use within 7 days or store below 30 . do this medicine if you notice any change in the appearance of the tablets . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what emgality contains - the active substance is galcanezumab . each pre - filled pen contains 120 mg of galcaneszumumab in 1 ml solution . - the other ingredients are l - histidine , l - ethidine hydrochloride monohydrate , polysorbate 80 , sodium chloride and water for injections . what emgalis looks like and contents of the pack emgally is a solution for injection in a clear glass syringe . the colour is clear to slightly yellow . the syringe is provided in single - dose pen packs of 1 , 2 , 3 or a multipack
defitelio is a medicine that contains the active substance defibrotide . it is used to treat a condition called hepatic veno - occlusive disease ( when the blood vessels in the liver are damaged ) in adult patients where blood clots are forming and patients cannot be given medicines prior to a stem cell transplantation . defibrorotide works by helping the blood to open and close the blood clasts . your doctor has prescribed this medicine for you because you have not been given it before .
do not use defitelio if you are allergic to defibrotide or any of the other ingredients of this medicine ( listed in section 6 ) if you have been taking other medicines to prevent blood clots ( tissue plasminogen activator warnings and precautions ) if any of these apply to you , tell your doctor before using this medicine . warnings and measures if you : have bleeding , especially heavy bleeding , if you need a blood transfusion or surgery if you suffer from problems with blood circulation or a constant blood pressure ( see section 1 " warnings and actions "). have recently taken other medicines ( medicines to reduce blood
the treatment with defitelio will be started by a doctor who is experienced in the use of stem cells transplantation . it will be given by infusion into one of your veins ( known as an ' intravenous infusion ') or drip . you will be monitored during this treatment for 21 days until your symptoms improve . if you have any further questions on the use this medicine , ask your doctor or nurse . if more than 18 hours have passed since you last received defiteloio , tell your doctor , nurse or pharmacist . if possible , take the next dose at the usual time . do not take a double dose to
like all medicines , defitelio can cause side effects , although not everybody gets them . stop taking defiteloio and see a doctor straight away if you notice any of the following side effects . if you get any of these side effects you should stop taking the medicine and contact your doctor immediately : very common ( may affect more than 1 in 10 people ) low blood pressure common ( might affect up to 1 in every 10 people ): bleeding in general bleeding including the nose bleeding from the brain bleeding from inside the gut vomiting blood bleeding from around the lungs bleeding from blood in the urine in the mouth bleeding from under the skin co
keep this medicine out of the sight and reach of children . do not use defitelio after the expiry date which is stated on the vial label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . do use definitelio if you notice that the infusion storage is not working properly , or if the solution is cloudy . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what defitelio contains the active substance is defibrotide . each ml of 2 . 5 ml solution contains 200 mg of defibrorotide ( as besilate ). each ml solution provides 80 mg of the active ingredient in defibotide . the other ingredients are sodium citrate dihydrate , hydrochloric acid , sodium hydroxide ( for ph - adjustment ), water for injections . what defitelsio looks like and contents of the pack 2 ml solution for infusion is a clear , colourless to pale yellow to yellow solution . each pack contains 10 ml of solution for injection ( 2 .
daklinza contains the active ingredient daclatasvir . hepatitis c is an infectious disease that affects the liver caused by the hepatitis c virus . this medicine works by stopping the hepatitisc virus from multiplying in your body . it reduces the amount of the virus in your blood . daklinz must not be used alone . other medicines and daklanza tell your doctor or pharmacist if you are taking , have recently taken or might take any other medicines . hepatitisc infection can spread rapidly in your community and can be life - threatening if the virus is in your bloodstream . dakinlinza may be used in
do not take daklinza if you are allergic to daclatasvir or any of the other ingredients of this medicine ( listed in section 6 ) if you take daclinza by mouth with the following medicines : phenytoin , carbamazepine , oxcarbazepine and phenobarbital used to treat epileptic seizures rifampicin , rifabutin and rifapentine antibiotics used to prevent tuberculosis dexamethasone , a steroid used to correct allergic and inflammatory diseases , medicines containing st . john ' s wort ( hypericum perforatum )
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of daklinza is 60 mg once a day . do not take more than this dose once a week . do this to avoid unpleasant taste . your doctor may tell you to take dakinza with some other medicines . if you take more daklanza than you should if you have taken more dailinza than your doctor tells you to , talk to your doctor . if possible , take these medicines as directed by your doctor , as directed . your daily dose of t
like all medicines , this medicine can cause side effects , although not everybody gets them . daklinza in combination with sofosbuvir or ribavirin has been associated with the following side effects : very common ( may affect more than 1 in 10 people ): headache fatigue common ( might affect up to 1 in every 10 people ) difficulty sleeping dizziness migraine nausea ( feeling sick ) diarrhoea abdominal pain joint pain aching or tender muscles when taking dakinza in tandem with sofsosbuv or ribvirin the following other side effects have been associated : common ( likely to affect up in every 1
what daklinza contains - the active substance is daclatasvir . each film - coated tablet contains 30 mg or 60 mg of daclasvir ( as dihydrochloride ). - the other ingredients are : tablet core : anhydrous lactose , microcrystalline cellulose , croscarmellose sodium , silicon dioxide , magnesium stearate . tablet coating : hypromellose , titanium dioxide ( e171 ), macrogol 400 , indigo carmine aluminum lake ( e132 ), yellow iron oxide ( e172 ) and 51 what daklineza looks like and contents
proquad is a vaccine against measles , mumps , rubella and chickenpox ( varicella ) viruses . when a person is given the vaccine , the body will make antibodies against the measles , rubles , rubell and varicelluses . the antibodies help prevent diseases caused by these viruses . proquad is used to prevent measles , which may be caused by mumps or rubella or chickenpox (" varicelli ). the vaccine is given to infants 12 months of age and older . pro quad is used in children and adolescents 9 months of old and older who are already receiving national vaccination schedules . measles is
do not use proquad - if you are allergic to any varicella vaccine , measles , mumps or rubella vaccine , or any of the other ingredients of this vaccine ( listed in section 6 ) - if your doctor has told you that you have neomycin - if any of these apply to you - if the child has a blood disorder or type of cancer that affects the immune system - if treatment with medications that weaken the immunesystem ( e . g . low - dose corticosteroid therapy , asthma or replacement therapy ) - a weakened immune system ( including aids ) - congenital or hereditary immunodeficiency
proquad is given by injection into the muscle or under the skin ( usually in the thigh or upper arm ). injections will be given into the upper muscle or thigh area or into the arm area . if you have a blood clotting disorder or low levels of platelets , the vaccine should not be given under the sun . injecting under the same skin will not reduce bleeding . proquad will not be injected into a blood vessel . pro quad is given as an injection into a 9 mm diameter . adults and adolescents from 9 years of age and older : proquad is recommended for use in children and adolescents aged 9 years and older who have
like all vaccines and medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions ( hives ) may occur . these reactions may cause difficulty in breathing or swallowing . if you have an allergic reaction , stop taking proquad and seek medical help immediately . other side effects that have been reported with proquad include : uncommon ( may affect up to 1 in 100 people ): seizures ( fits ) with a fever rare ( may effect up to1 in 1 , 000 people ): bronchiolitis ( difficulty breathing , cough , unsteadiness with walking ). the following side effects have been observed with pro quad : very
what proquad contains the active substances are : measles virus1 , edmonston strain , 3 . 00 mg mumps virus1 ( jeryllynn™ level b ) strain , 4 . 30 mg rubella virus2 , strain , 6 . 00mg varicella virus3 , merck strain , 9 . 99 mg mrc . the other ingredients are : tissue culture : plaque - forming units ( mrc ), 1 , chickembryo cells ( fibroblasts ), mrc , powder sucrose , hydrolysed gelatin , urea , sodium chloride , sorbitol ( e420 ), monosodium glutamate
jylamvo is a substance that is absorbed by the body and is an anticancer medicine that reduces unwanted reactions . it is an immunosuppressive agent . it acts on the body ' s own inflammatory system . jylamv is used to treat rheumatic and skin diseases : active rheumatoid arthritis ( where polyarthritic forms form in the joints ) and severe juvenile idiopathic arthritis ( jia ) in children and adolescents ( 3 years of age and older ) who have not previously used non - steroidal anti - inflammatory drugs ( nsaids ) and who have inadequate o severe or disabling
do not use jylamvo - if you are allergic to methotrexate or any of the other ingredients of this medicine ( listed in section 6 ) - if your doctor has told you that you have a severe kidney impairment - if the doctor has prescribed a lower dose - if a liver impairment is not controlled - if any of these apply to you - if there are certain blood disorders called bone marrow hypoplasia , leukopenia or thrombocytopenia - if this is the case - if patients have significant anaemia 34 - if they have a weakened immune system - if someone else has a serious
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . jylamvo can cause severe side effects , sometimes leading to even death . your doctor will determine the dose you need and will adjust the dose depending on your response to the treatment . rheumatoid arthritis , severe juvenile idiopathic arthritis , and severe psoriasis . in severe psoriatic arthritis , jylimvo is used as a long - term treatment . jyslamvo is also used for rheumatic and skin diseases , such as jia , psorism and
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : wheeziness , difficulty in breathing , swelling of the eyelids , face or lips , rash or itching affecting your whole body . other possible side effects include breathing problems , feeling of illness , dry , irritating cough , shortness of breath , difficulty or breathing , chest pain ( fever ), spitting or coughing blood , serious peeling or blistering of the skin unusual bleeding ( vomiting blood ), bruising nose bleeds nausea , vomiting , abdominal discomfort , severe diarrhoea mouth ulcers , black or tarry st
keep this medicine out of the sight and reach of children . do not use the medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . do store below 25 . do this to protect the medicine from accidental spillage . do away with the vial within 3 days . do no reuse of the vials . any unused medicine or waste material should be disposed of in accordance with local requirements for cytotoxic products .
what jylamvo contains - the active substance is methotrexate . each ml of solution contains 2 mg of methotexate . - the other ingredients are macrogol 400 , glycerol , orange flavour , sucralose , ethyl parahydroxybenzoate ( e218 ), sodium methyl parahhydroxybenzzoate , citric acid , tri - sodium citrate , purified water ( see section 2 " jylimvo contains ethyl paraahydhydroxy benzoate and sodium methyl paraahhydrobenzoates "). what jyamelvo looks like and
this medicine contains glycopyrronium bromide which belongs to a group of medicines called bronchodilators . this medicine is used to help breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten . this makes breathing difficult . this medication blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the lungs . this helps to reduce the effects of this medicine on copd .
do not use enurev breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have kidney problems . - if the doctor has given you an eye problem called narrow - angle glaucoma ( difficulty passing urine ). warnings and precautions talk to your doctor or pharmacist before using treatment with enurevi breez inhaler . stop using this medicine and contact your doctor immediately if you get tightness of the chest , coughing , wheezing or breathlessness immediately after using
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours at a temperature of 75 to 75˚ c . you can use this medication at any time of the day , with or without food . this medicine is for inhalation use only . you must use this product only once a week . this leaflet contains instructions for use , which are included in the pack . how to use this leafleting this medicine comes as an inhaler
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects can be serious : uncommon ( may affect up to 1 in 100 people ) irregular heart beat high level of blood sugar ( hyperglycaemia ). typical symptoms are excessive thirst , hunger and frequent urination ) rash , itching , hives , difficulty breathing or swallowing , dizziness . allergic reaction including swelling mainly of the tongue , lips , face or throat ( angioedema ). other side effects include some side effect that may be serious ( frequency cannot be estimated from the available data ). the following side effects have been reported with en
what enurev breezhaler contains - the active substance is glycopyrronium bromide . each hard capsule contains 63 micrograms of glycopirroniumbromide ( equivalent to 50 microgram of glyopyrronia ). - the delivered dose ( the delivered amount that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgram glycopYRronium . - the other ingredients of the inhaled powder are lactose monohydrate and magnesium stearate . what enurevan breez inhaler looks like and contents of the pack enurevo breezker 44 micro
what riximyo is riximusyo contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to a specific target in a type called a white blood cell called " b - lymphocyte ". when ritukimab sticks to the target of this target , it stops the cell from growing and dividing . what rixima is used for rixiemyo is used to treat adults with two different types of lymphoma : a ) non - hodgkin ' s lymphoma this is an illness of the lymph tissue that affects
do not use riximyo if you are allergic to rituximab , other proteins that are similar to ritonuximib , or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severe active infection at the moment . if you suffer from a weak immune system . if your doctor has told you that you have severe heart failure or severe uncontrolled heart disease ( granulomatosis , polyangiitis , microscopic polyangiaritis or pemphigus vulgaris ). warnings and precautions talk to your doctor or pharmacist before using rixima . if any
your doctor will decide how much riximyo you will receive and how often you will need this treatment . always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . if you have any side effects , your doctor may decide to change your dose . riximeyo is given as a drip ( intra - venous infusion ). medicines given before each riximusyo administration you will be given rixima in combination with other medicines ( premedication ) to reduce the risk of side effects . your doctor will determine the dose you need and will adjust your treatment accordingly . for
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion you may experience fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number
what riximyo contains the active substance is rituximab . each 10 ml vial contains 100 mg of ritukimab ( 10 mg / ml ). each 50 ml vials contains 500 mg of the active ingredient in ritiximab , 10 mg per ml . the other ingredients are sodium citrate , polysorbate 80 , sodium chloride , sodium hydroxide and hydrochloric acid ( see section 2 " rixima contains sodium "). what riximusyo looks like and contents of the pack rixamyo is a clear to slightly yellowish solution for infusion . it
topotecan actavis contains the active substance topotecin . topotecaan actis is used to treat small cell lung cancer that has come back after chemotherapy . it is also used to prevent advanced cervical cancer that cannot be treated by surgery or radiotherapy . in this case topotican activ treatment is combined with medicines containing cisplatin .
do not use topotecan actavis - if you are allergic to topotecaan or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using topotocan activ . your doctor will check your blood cell counts if they are too low . your dose of topotican actis may need to be adjusted . - if your doctor has told you that you have any kidney problems . your treatment with topotchean actez should be carefully supervised . warnings and risks talk to the doctor , nurse or pharmacist before using
your doctor will determine the dose of topotecan actavis you will receive based on your age and the disease being treated . your doctor will carry out blood tests before you start treatment and regularly during treatment . the usual dose for adults small cell lung cancer : 1 . 5 mg per square metre of body surface area for 5 days . this treatment cycle will be repeated every three weeks . for cervical cancer : 0 . 75 mg per sq metre of surface area , for 3 days . you will start this treatmentcycle on the same day as cervical cancer . your dose will be increased every three months . when used alone , the usual treatment
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious sideeffects : infections ( very common , may affect more than 1 in 10 people ): fever . this is a sign of your general condition . local symptoms include sore throat , burning sensation , severe stomach pain , fever , diarrhoea and bowel inflammation ( neutropenic colitis ). topotecan actavis may reduce your ability to fight infections . lung inflammation ( rare , may affects up to 1 in 1 , 000 people ): difficulty in breathing , cough and fever
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the expiratory date refers to the last day of that month . keep the vials in the outer carton in order to protect from light . after reconstitution and dilution chemical and physical in - use stability has been demonstrated for 24 hours at 25 ± 2 , followed by 24 hours below 2 and then 8 hours below 25 ± 1 , followed respectively by 24 days below 2 , and then 24 hours above 2 and 8 , unless
what topotecan actavis contains the active substance is topotecaan . each vial contains 1 mg or 4 mg topototecin ( as hydrochloride ). after reconstitution , 1 ml of solution contains 1mg topotan . the other ingredients are mannitol ( e421 ), tartaric acid , hydrochloric acid and sodium hydroxide . what topotican actis looks like and contents of the pack topottecan actalis is supplied in glass vials with grey bromobutylic stopper and aluminium seals with plastic flip - off caps . each cart
the active substance of rivastigmine hexal is rivustigmine . rivestigmine belongs to a class of substances called cholinesterase inhibitors . in patients with alzheimer ' s dementia or dementia due to parkinson ' s disease , certain nerve cells die in the brain , resulting in low levels of the neurotransmitter acetylcholine ( a substance that allows nerve cells to communicate with each other ). rivostigmine works by blocking the enzymes that break down acetylchloroline : acetylchelinesterases and butyrylcholinescerase . by
do not take rivastigmine hexal - if you are allergic to rivasta , the active substance in rivostigminehexal , or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have a previous skin reaction ( allergic contact dermatitis ). warnings and precautions talk to your doctor or pharmacist before taking rivstigmine Hexal . if any of these apply to you , tell your doctor before taking the medicine . warnings and risks talk to the doctor or nurse before taking any of your medicines : - if any member of your family
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to start treatment your doctor will tell you what dose of rivastigmine hexal to take . treatment usually starts with a low dose . depending on how you respond to treatment , the highest dose may be 6 . 0 mg twice a day . your doctor may also increase your dose depending on your weight . your dose will depend on your general condition and overall health . taking this medicine take rivasta hexal every day for as long as your health allows . if you have not taken riv
like all medicines , this medicine can cause side effects , although not everybody gets them . you may experience side effects more often when you start your medicine or when your dose is increased . the side effects are usually mild to moderate . very common ( may affect more than 1 in 10 people ) feeling dizzy loss of appetite stomach problems such as feeling sick ( nausea ) or being sick ( vomiting ) diarrhoea common ( might affect up to 1 in every 10 people ): anxiety sweating headache heartburn weight loss stomach pain feeling agitated feeling tired or weak generally feeling unwell trembling or feeling confused decreased appetite nightmares uncommon ( may affects up to1
keep out of the reach and sight of children . do not use rivastigmine hexal after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 30 . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what rivastigmine hexal contains 64 the active substance is rivasterigmine hydrogen tartrate . the other ingredients are : hypromellose , magnesium stearate , microcrystalline cellulose , colloidal anhydrous silica , gelatin , yellow iron oxide red iron oxide ( e172 ), titanium dioxide ( e171 ), shellac . each rivasta hexal 1 . 5 mg capsule contains 1 . 25 mg of rivostigmine . each vial of each ritastigmin hexal 3 mg capsule releases 3 mg of the active ingredient in each riotechnology product .
cabometyx is a cancer medicine that contains the active substance cabozantinib . it is used to treat adult patients with kidney cancer ( renal cell carcinoma ) or liver cancer that has come back after receiving a specific anticancer medicine containing sorafenib . how cabometyx works cabometx blocks the action of proteins called receptor tyrosine kinases , which are involved in the development of new blood vessels . by blocking the action , these proteins can help to stop high amounts in cancer cells . cabomety is used in adults .
do not take cabometyx 45 - if you are allergic to cabozantinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking cabometx : - if your doctor has told you that you have high blood pressure - if the doctor has given you an aneurysm ( enlargement or weakening of a blood vessel wall ) or a tear in a blood valve wall - if diarrhoea has been reported - if a recent occurrence of significant bleeding - if surgery is planned within the last month - if dental surgery is scheduled - if
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will determine the correct dose of this medicine and will adjust your treatment if necessary . if you take more cabometyx than you should if you accidentally take too many tablets , contact your doctor immediately . you may experience serious side effects . your treatment will usually be started by a doctor who is experienced in the treatment of patients with dementia . the recommended dose of cabometx is 60 mg once a day . you should take cabometometyx for 2 hours before or 1 hour after food . swallow the
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with cabometyx and other medicines . tell your doctor straight away if your side effects become serious or if you notice any of the following serious side effects you may need urgent medical treatment : symptoms such as pain in the abdomen ( nausea ), vomiting , constipation and fever ( these may be signs of a gastrointestinal perforation ( a hole that develops in the stomach or intestine ) and severe or uncontrollable bleeding ( these might be symptoms of vomiting blood , black stolls , bloody urine , headache , coughing up blood ,
what cabometyx contains the active substance is cabozantinib ( s )- malate . cabometx 20 mg tablets : each tablet contains cabozatinib_( s ) - malate equivalent to 20 mg cabozetinib . cabobometyx 40 mg tablets: each tablet contain cabozutinib - malates equivalent to 40 mg cabazantinip . cabostyx 60 mg tablets tablets : every tablet contains Cabozanthinib (s ) - talc equivalent to 60 mg cab ozantinibe . the other ingredients are microcrystalline cellulose , lactose
pemetrexed hospira is a medicine used in the treatment of cancer . pemetrexED hospira will be given in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy . pemrexed hospira will also be given to you in combinationwith cisplin for the initial treatment of patients with advanced stage of lung cancer . when pemetreed hospiera is given to patients with lung cancer , it is usually given when your disease
do not use pemetrexed hospira - if you are allergic ( hypersensitive ) to pemetreed or any of the other ingredients of this medicine ( listed in section 6 ). - if breast - feeding is not recommended during treatment with pemetemetrexED hospira . - if your child has recently received or is about to receive a vaccine against yellow fever . warnings and precautions talk to your doctor or pharmacist before using pemetezed hospir if you have or have had problems with your kidneys . before you receive pemetretted hospire , your doctor will check your blood and kidney function . this is
the dose of pemetrexed hospira is 500 mg for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your entire body . your doctor will use this body surface area to work in exactly the right way for you . your dose may be adjusted , or treatment may be delayed depending on your blood cell counts and on your general condition . your healthcare professional will have mixed the pemetreed hospir powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution for injection before it is given to you . pemetretted hospire will
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : fever or infection ( common ): if you have a temperature of 38ºc or greater , sweating or other signs of infection ( since you may have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if you get chest pain ( common ) or a fast heart rate ( common ). if you develop pain , redness , swelling or sores in your mouth ( common ), tell your doctor . allergic reaction : if you notice skin rash
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . reconstituted and infusion solution : chemical and physical in - use stability of the product has been demonstrated for 24 hours at 2ºc to 8ºc . the reconstitution of the recontituted solution should be performed in accordance with local requirements for parenteral medicines . if discolouration is observed
what pemetrexed hospira contains the active substance is pemetre . pemetrixed hospiras 100 mg : each vial contains 100 milligrams of pemetereed ( as pemetretrexed disodium hemipentahydrate ). pemetoxed hospiry 500 mg : one vial of 500 milligram of pememetrexED ( as peemetrexede disodium emipenthydrate ) contains 1 , 000 milligrom of pererexed . after reconstitution , the solution contains 25 mg / ml of petrexed without further dil
ganfort contains two active substances called bimatoprost and timolol which work together to reduce pressure in the eye . bimAToprost belongs to a group of medicines called prostamides , which work by interfering with a prostaglandin analogue . timololine belongs to medicines called beta - blockers . the clear liquid in the back of the eye is a clear , watery liquid that is easily absorbed and can be removed by soft contact lenses . ganfort is used in adults to lower pressure in your eye in the affected eye ( glaucoma ). ganat eye drops are used to
do not use ganfort eye drops : - if you are allergic to bimatoprost , timolol , beta - blockers or any of the other ingredients of this medicine ( listed in section 6 ) - if your doctor has told you that you have respiratory problems such as asthma , severe chronic obstructive bronchitis or severe lung disease ( signs include wheeziness and difficulty in breathing ) - long - standing cough - if any of these apply to you , tell your doctor before using ganf . warnings and precautions talk to your doctor or pharmacist before using this medicine : - coronary heart disease ( symptoms include
always use ganfort exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to use glanfort your doctor will tell you how much ganf you need to use and how long you should continue treatment . the bottle is for single use only . do not put the bottle near your neck . how ganuf is given ganaf is for oral use . how much to use 1 . wash your hands . tilt your head back . 2 . pull down your eyelid , which may open a small pocket . 3 . gently squeeze the bottle . do this until the
like all medicines , ganfort can cause side effects , although not everybody gets them . the drops can cause some side effects . if you use ganart ( multi - dose or single - dose ), you may experience very common side effects ( may affect more than 1 in 10 people ). the eye redness is usually mild . common side effect ( may affects up to 1 in 9 people ) are : uncommon side effects are : 100 - effects in the eye burning , itching , stinging , irritation of the conjunctiva ( the transparent layer at the back of the eye ), sensitivity to light , eye pain , sticky eyes ,
keep this medicine out of the sight and reach of children . do not use ganfort after the expiry date which is stated on the carton and on the label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . do away with ganf after 4 weeks . do this if you notice that the solution is not clear or contains particles . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what ganfort contains - the active substance is bimatoprost ( 0 . 3 mg / ml timolol ). each bottle contains 5 mg of timolole maleate in 6 . 8 ml of solution . - the other ingredients are benzalkonium chloride ( a preservative ), sodium chloride , sodium phosphate dibasic heptahydrate , citric acid monohydrate , purified water , hydrochloric acid and sodium hydroxide . what ganFort looks like and contents of the pack ganart is a clear to slightly yellow , clear , colourless to slightly brown liquid . it is
gefitinib mylan contains the active substance gefitinib . this protein is designed to recognise and kill cancer cells . gefinib melan is used to treat adults with non - small cell lung cancer . this cancer is a disease in which malignant ( cancer ) cells form in the tissues of the lung .
do not take gefitinib mylan if you are allergic to gefitoninib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking gefinib melan if : you have any other lung problems you have some lung problems that have not been treated with gefitalinib yourlan . you have problems with your liver . gefnitinib is not recommended for use in children and adolescents under 18 years of age . other medicines and gefilitinib tell your doctor or pharmacist if you take
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 250 mg tablet once a day . you can take the tablet with or without food . you may take antacids on an empty stomach for 2 to 1 hour before or after food . swallow the tablet whole with a glass of water . you should take gefitinib mylan with or just after food if you have trouble swallowing the tablet . do not take any other liquids . the tablet can be taken with or after water . the maximum recommended dose for adults is 20 mg
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : allergic reaction with symptoms such as swollen face , lips , tongue or throat , difficulty to swallow , hives , nettle rash , difficulty breathing , serious breathlessness , sudden worsening breathlessness with a cough or fever . these may be signs of an inflammation of the lungs called ' interstitial lung disease '. uncommon ( may affect up to 1 in 100 people ) gefitinib may cause severe skin reactions affecting various parts of the body
what gefitinib mylan contains - the active substance is gefinib . each film - coated tablet contains 250 mg of gefginib . - the other ingredients are lactose monohydrate , microcrystalline cellulose , crospovidone ( type a ), povidon ( k30 ), sodium laurilsulfate , magnesium stearate . - coating : polyvinyl alcohol , macrogol 4000 , titanium dioxide ( e171 ), red iron oxide ( e172 ) and yellow iron oxide red ( e 172 ). what gefitoninib melan looks like and contents
reblozyl contains the active substance luspatercept which is used to treat myelodysplastic syndromes ( mds ). mds is a group of many different blood and bone marrow disorders in which red blood cells become abnormal . signs and symptoms include a low red blood cell count ( anaemia ) and cannot be adequately treated with red blood infusion . reblozey is used in adults to treat anaemia in adults with mds who cannot be completely treated with either red blood or erythropoietin therapies ( erythrasaemia ). thalassaemia is a blood problem
do not take reblozyl if you are allergic to luspatercept or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be pregnant ( see pregnancy section ). warnings and precautions talk to your doctor before taking this medicine if you have thalassaemia ( a condition where the spleen removed ) or have had a blood clot . if you need hormone replacement therapy following a previous blood clot , your doctor may recommend preventive measures ( including medicines used to prevent a blood clot ). if you suffer from high blood pressure , your dose of rebluzyl may need to be
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will carry out blood tests to make sure that you are fully protected . how much reblozyl is given the recommended dose of rebl ozyl is one injection under the skin . the dose depends on how much you weigh . the injections should be given in a single dose of 1 . 0 mg / kg of body weight . your dose may be adjusted by your doctor depending on your blood pressure . how often reblzyl is used in patients with myelodysplastic syndrom
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor immediately if you experience difficulty in walking or speaking , dizziness , loss of balance and coordination , numbness or paralysis in the face , leg or arm , or blurred vision . these may be symptoms of a stroke . blood clots swelling in the area around the eyes , face , lips , mouth or tongue throat allergic reactions , rashes 36 reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . very common side effects
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after reconstitution , reblozyl may be stored at room temperature ( up to 8 ) for up to 25 hours when stored at 2 8 . do away with any unused medicinal product or waste material . these measures will help protect the environment .
what reblozyl contains the active substance is luspatercept . each ml of solution contains 25 mg or 75 mg of luspormcept . after reconstitution , each mlof solution contains 50 mg of the active ingredient luspaterscept . the other ingredients are excipients , citric acid monohydrate , sodium citrate 80 , sucrose , hydrochloric acid ( for ph adjustment ), sodium hydroxide ( for pct adjustment ). what rebl ozyl looks like and contents of the pack reblizyl is a white to off - white powder . reblosyl is supplied in v
fotivda contains the active substance tivozanib , which is a protein kinase inhibitor . tiv ozanib works by blocking the action of proteins involved in the growth and spread of the cancer . it stops the growth of cancer cells and new blood vessels forming . fotivada is used in adults with advanced kidney cancer when other treatments ( alpha or interleukin - 2 ) have not helped to stop your disease or have not worked .
do not take fotivda if you are allergic to tivozanib or any of the other ingredients of this medicine ( listed in section 6 ). if you have been told that you have a problem with your heart . if you drink alcohol excessively ( see section 4 ). if your doctor has told you that you are taking st . john ' s wort ( hypericum perforatum , a herbal remedy used to treat depression and anxiety ). warnings and precautions talk to your doctor before taking fotiveda if any of these apply to you : if you suffer from high blood pressure . fotiva may lower your blood
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of fotivda is 1340 mg once a day for 21 days ( 7 days ). this means that you take 1 capsule of capsules once a morning , and 4 capsules once daily . your doctor may increase your dose of the medicine if you take more fotvda than you should if you have experienced unacceptable side effects or if you experience severe side effects during fotrevda therapy . the usual starting dose of each fotiva capsule is 890 mg once daily for 21 weeks
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects high blood pressure is a very common side effect ( may affect more than 1 in 10 people ). if you notice any of the following , talk to your doctor or pharmacist immediately : high blood hypertension may be associated with symptoms such as severe headaches , blurred vision , shortness of breath , changes in your mental state , feeling anxious , confused or disorientated . your doctor may want to monitor your blood pressure more closely while you are taking fotivda . high bloodpressure may be caused by a medicine you are already taking to
what fotivda contains the active substance of fotive is tivozanib . each tablet contains tiv ozanib hydrochloride monohydrate equivalent to 890 mg tivzanib ( as mesilate ). the other ingredients are : capsule content : mannitol ( e421 ), magnesium stearate , gelatin , titanium dioxide ( e171 ), indigo carmine ( e132 ), yellow iron oxide ( e172 ), propylene glycol ( e1520 ) and strong ammonia solution ( e524 ). capsule shell : titanium dioxide , tartrazine aluminium lake ( e133 ), shellac
stribild contains two active substances : elvitegravir ( an antiretroviral medicine known as an integrase inhibitor cobicistat , which is a booster ( pharmacokinetic enhancer ) of elvitesgravira emtricitabine ( an antiviral medicine called a nucleoside reverse transcriptase inhibitor ( nrti ) tenofovir disoproxil ( an antitroviral medication called a nucleotide reverse transcriptases inhibitor ) stribild is given as a single tablet regimen for the treatment of human immunodeficiency virus ( hiv ) infection .
do not take stribild if you are allergic to elvitegravir , cobicistat , emtricitabine , tenofovir , ten ofovir disoproxil or any of the other ingredients of this medicine ( listed in section 6 ). during treatment , you should not take any medicine containing tenofovegravira disoproject . your doctor will monitor your kidney function and may change your dose of these medicines . if you have been told by your doctor that you have alfuzosin ( a type of medicine used to treat an enlarged prostate gland ), amiod
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . adults and adolescents 12 to less than 18 years of age 35 the recommended dose is one tablet taken by mouth once a day . your doctor may change the dose of your medicine depending on how you respond to the treatment . your dose may need to be adjusted by your doctor . you may need medicines ( oral supplements , antacids , laxatives containing minerals such as magnesium , aluminium , calcium , iron , zinc ) to help you remember to take it . take the tablet at least 4 hours before or at least
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of bloodlipids sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . when treating hiv infection , it is not always possible to tell whether the unwanted effects of stribild are caused by the hiva disease itself or by the medicines themselves , but there are some serious side effects that can be serious . tell your doctor immediately if you
what stribild contains the active substances are elvitegravir , cobicistat , emtricitabine and tenofovir disoproxil . each stribil film - coated tablet contains 150 mg elvitesgravira , 150 mg cobicista , 200 mg emtracitabin , 245 mg tenofovegravirin disoprocessil , 300 mg ten ofovir desoproxel fumarate , 136 mg tenorovir . the other ingredients are croscarmellose sodium , hydroxypropyl cellulose , lactose mon
zyprexa contains the active substance olanzapine . zyprexa belongs to a group of medicines called antipsychotics and is used to treat the following conditions : schizophrenia , a disease with symptoms such as hearing , seeing or sensing things which are not there , mistaken beliefs , unusual suspiciousness , and becoming withdrawn . people with this disease may also feel depressed , anxious or tense . moderate to severe manic episodes , a condition with symptoms of excitement or euphoria . zzyprex has been shown to prevent recurrence of these symptoms in patients with bipolar disorder whose manic episode has responded to olan zapine treatment
do not take zyprexa - if you are allergic ( hypersensitive ) to olanzapine or any of the other ingredients of this medicine ( listed in section 6 ). an allergic reaction may be recognised as a rash , itching , a swollen face , swollen lips or shortness of breath . - if your doctor has told you that you have eye problems such as certain kinds of glaucoma ( increased pressure in the eye ). warnings and precautions talk to your doctor or pharmacist before taking zypxa . zypitxa is not recommended for use in elderly patients with dementia because it may have serious side
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . zyprexa tablets should be taken once a day with or without food . your doctor may increase your dose to 5 to 20 mg once a week depending on your symptoms . swallow the tablet whole with a glass of water . do not chew or crush the tablet . you can take zydosexa with or just after food . you should take your zypxa tablets at the same time each day . it is important that you take your tablets at least
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience : unusual movement ( a common side effect that may affect up to 1 in 10 people ) mainly of the face or tongue ; blood clots in the veins ( a side effect which may affect upto 1 in 100 people ) especially in the legs ( symptoms include swelling , pain , and redness in the leg ), which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing . if you notice any of these symptoms seek medical advice immediately ; a combination of fever , faster breathing , sweating ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . zyprexa may pose a risk to the environment . do this by asking your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment
what zyprexa contains - the active substance is olanzapine . each zyprixa tablet contains 2 . 5 mg , 5 mg or 7 . 5mg , 10 mg , 15 mg or 20 mg of olanza . - the other ingredients are lactose monohydrate , hyprolose , crospovidone , microcrystalline cellulose , magnesium stearate , hypromellose , titanium dioxide ( e171 ), carnauba wax . the different zypyxa tablet strengths are marked with the following symbols : - zypoxa 2 .5 mg , 10mg
what prolia is prolia contains denosumab , a protein ( monoclonal antibody ) that attaches to another protein in the body . this protein is important in preventing bone loss in patients with osteoporosis and is important for treatment . prolia helps to make bone stronger and keeps it free of oestrogen . it reduces the amount of bone that makes bones fragile . after the menopause , oestrogens level drops and bones become thin and fragile . what is osteopORosis ? osteoporeosis is caused by the lack of testosterone and glucocorticoids . osteoporiosis has
do not use prolia if you have low calcium levels in the blood ( hypocalcaemia ). if you are allergic to denosumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using prolia . if you think any of these apply to you , or if you get any of them , talk to a doctor or go to the nearest hospital straight away . if any of those apply to your child , talk with your doctor straight away before using this medicine . if your child has any of any of this , talk immediately to your physician or
what prolia is a single injection under the skin ( subcutaneous ) in the thighs or abdomen , preferably in the upper arm . how prolia works prolia comes as a single dose . it is given as a one - time injection . it can be given up to 60 minutes apart or up to 6 hours apart . it may be given as either a single or a single overdose under theskin ( subcuttinganeous ) or in the front of your thighs or upper abdomen ( upper arm ). if you use more prolia than you should if you have used more prolias than you have been told to , tell your doctor or
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking prolia and see a doctor straight away if you develop skin infections ( cellulitis ). if you notice any of these symptoms while taking prolium : swollen , red area of skin , usually in the leg , which feels hot and tender . symptoms may include fever . stop using prolia if you have pain in the mouth and / or jaw , swelling or non - healing of sores in themouth or jaw ( discharge , numbness , feeling of heaviness or loosening of a tooth ), as these could be signs of bone damage in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . keep the vial in the outer carton in order to protect from light . before you use your pre - filled syringe , you should remove the cap from the vials and write down the date of the injection on the outer box . do this at the end of the package leaflet . do away with the cap and the pre -filled syringe after you have used it . do no more
what prolia contains - the active substance is denosumab . each ml of solution contains 1 mg or 60 mg of denosumaab in 60 ml . - the other ingredients are acetic acid , glacial , sodium hydroxide , sorbitol ( e420 ), polysorbate 20 and water for injections . what prolia looks like and contents of the pack prolia is a clear to slightly yellow solution for injection in a pre - filled syringe with a needle guard .
what ambirix is ambirrix is a vaccine used to protect adults and children from 1 to 15 years of age against two diseases : hepatitis a and hepatitis b . infection with the hepatitis a virus causes the liver to become swollen and inflamed . the virus is caused by the virus in faeces , serum or saliva . symptoms usually occur 3 to 6 weeks after infection . you may feel sick ( have a fever ), aches and pains , feel very tired , dark urine , pale faececes or yellowish skin or eyes ( jaundice ). the severity and type of symptoms can vary from person to person .
you must not be given ambirix if you are allergic to ambirax or any of the other ingredients of this vaccine ( listed in section 6 ). signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of your face or tongue . if you have an allergic response to any vaccine . if any of these apply to you , tell your doctor straight away . warnings and precautions talk to your doctor or nurse before you are given ambira if you : have ever had hepatitis a or hepatitis b diseases if you get a severe infection with a high temperature . the vaccine should be given at the same time
your doctor or nurse will give you ambirix as an injection into a muscle in the upper arm . ambirux will be given into a vein . the injection will be injected into the thigh muscle . you will receive a total of two injections . the injections will be administered within 12 months . if you miss an injection , the second injection will come as a single dose . if the injections are missed within 12 weeks , you will be told when to schedule your next injection . the second dose will be between 6 and 12 months after the first injection . extra doses may be given to make up for future booster dosing . if two
like all medicines , this vaccine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects you may need urgent medical treatment : allergic and anaphylactic reactions . the signs may include a rash , itchy , blistering , swelling of the eyes and face , difficulty in breathing or swallowing , a sudden drop in blood pressure and loss of consciousness . other side effects reported in clinical trials with ambirix were : common ( may affect up to 1 in 10 people ): headache loss of appetite feeling tired or irritable pain or redness where
what ambirix contains 26 the active substances are hepatitis a virus ( 1 , 720 micrograms / ml ) and elisa units ( hepatitis b surface antigen ). the other ingredients are 20 microgram ( 0 . 5 milligrams ) of human diploid ( mrc ), cells and aluminium hydroxide , hydrated in 0 . 05 milligram ( milliggram ) of saccharomyces cerevisiae . the other ingredient is aluminium phosphate in 0. 4 milligams , sodium chloride and water for injections . what ambirax looks like and contents of the pack suspension for injection in a pre -
what bexsero is bex serumo is a meningococcal group b vaccine . bex sero is given to adults , adolescents and children from 2 years of age with disease caused by the neisseria meningitidis group b bacteria . these bacteria are responsible for causing infections ( such as meningitis and inflammation of the brain and spinal cord ) and sepsis ( blood poisoning ). the vaccine works by helping the body to make better use of its natural defences . if you have any questions about how bexero works or why this medicine has been prescribed for you , ask your doctor .
do not use bexsero if you are allergic to the active substance or any of the other ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor or nurse before using bex serumo if : you have a severe infection with a high temperature ( over 38 ). vaccination should be postponed until you have recovered from a minor infection such as a cold . your doctor may decide to postpone vaccination if you have haemophilia a or any other problem that may prevent your blood from clotting properly . you are receiving blood thinners ( anticoagulants ) or treatment that suppresses the immune
your doctor or nurse will give you bexsero at the following dose : the recommended dose is 5 ml injected into a muscle ( usually in the thigh or upper arm ). injections will be given at least 2 weeks apart . the first dose will be administered at least 5 weeks apart and the second dose at least three weeks apart after the first . the interval between injections will not be longer than 1 month . the intervals between injections should not be more than 2 months . your doctor will administer a booster at least 12 weeks apart , and the interval will not last longer than 15 days . children and adolescents from 6 months of age the dose
like all vaccines , this vaccine can cause side effects , although not everybody gets them . stop using bexsero and see a doctor immediately if you notice any of the following side effects : very common ( may affect more than 1 in 10 people ): pain / tenderness at the injection site , redness of the skin at the site of injection , swelling of theskin at the place of injection site hardness at the area of injection at the time of injection if any of these side effects occur , stop using this vaccine and tell your doctor immediately . common ( might affect up to 1 in every 10 people ) fever , loss of appetite
what bexsero contains the active substances are recombinant neisseria meningitidis group b nhba fusion protein 1 , 2 , 3 and 50 micrograms recombinant nisseria maningitidi group b noada protein 1 and 2 , 2 and 3 50 micrograms recombinant neoisseria meingitis group b fhbp fusion protein 2 and 2 and 4 , 3 microgrammedially ( approx . 50 microlitres ) recombinant noisseria pleasenitidis type b f hbp fusionprotein 1 , 3 , 4 , 5 , 10 microgrammedially
nitisinone mdk contains the active substance nitisinon . this medicine is used to treat a rare disease called hereditary tyrosinemia ( hty ) in adults , adolescents and children from 1 year of age . because of this disease your body cannot break down the amino acid tyrosine ( amino acids are substances that are naturally present in the body ). nitisinnone helps to break down tyrosinine and the harmful substances it produces . this means that tyrosrine is eliminated from the body by low tyrosines and phenylalanine ( another amino acid ).
do not take nitisinone mdk - if you are allergic to nitisine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking this medicine . pregnancy and breast - feeding nitisinfone md k is not recommended for use in the eyes . during nitisinaone treatment , red eyes may occur . tell your doctor immediately if you have an eye examination . eye problems due to inadequate dietary control may occur ( see section 4 ). your doctor may decide to stop the treatment temporarily or permanently . your doctor will take blood samples during the treatment
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . treatment with this medicine will be started by a doctor who is experienced in the treatment of the disease ( hereditary tyrosinemia type 1 ). the recommended dose is 1 capsule per kg of body weight taken orally once a day . the recommended starting dose is 20 capsules per kg body weight . in this patient population , the recommended daily dose is one capsule per day . swallow the capsules whole with a small amount of water or formula diet . if you take more nitisinone mdk than you should if you
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after first opening , use within 2 hours at a temperature not above 25 . do away with the blister and keep the blister tightly closed . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what nitisinone mdk contains the active substance is nitisino . nitishinone mdky 2 mg : each capsule contains 2 mg nitisine . nisinonemdk 5 mg : one capsule contains 5 mg nisine . each capsule of nitiszinone mdyk 10 mg : two capsules contain 10 mg ninone . the other ingredients are gelatin , titanium dioxide ( e171 ), black iron oxide ( e172 ), shellac glaze . what nitisinnone mdks looks like and contents of the pack nitisinfone md k capsules are 15 . 7 mm long , hard
docetaxel accord contains the active substance docetaxal . docetxel belongs to the group of anti - cancer medicines called taxoids . docelaxel accord has been prescribed by your doctor for the treatment of breast cancer , special forms of lung cancer ( non - small cell lung cancer ), prostate cancer , gastric cancer and head and neck cancer : - for the diagnosis of advanced breast cancer either docetixel or doxorubicin , or trastuzumab , or capecitabine . - for early breast cancer with or without lymph node involvement , docetayel or
do not use docetaxel accord - if you are allergic ( hypersensitive ) to docetxel or any of the other ingredients of docetixel accord ( listed in section 6 ) - if white blood cells are low - if your liver is not working properly - if there is a severe liver disease warnings and precautions before you are given docetAXel accord , you will have blood tests to check that you have enough blood cells and sufficient liver function to receive docetacord . white blood cell disturbances may cause fever and infections . tell your doctor immediately if you experience abdominal pain , tenderness , diarrhoea
docetaxel accord will be given to you by a healthcare professional . the dose will depend on your weight and your general condition . method and route of administration docetaxell accord will usually be given by infusion into one of your veins . the infusion will last approximately one hour . frequency of administration you will usually receive your infusion once every 3 weeks . your doctor will take the number of days off from work and change the dose depending on your blood tests and yourgeneral condition . in particular , docetAXel accord should be given in the presence of diarrhoea , sores in the mouth , feeling of numbness or
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss these with you and will explain the potential risks and benefits of your treatment . the most commonly reported adverse reactions of docetaxel accord are reduction in the number of red blood cells and white blood cells ( alopecia ), nausea , vomiting , sores in the mouth , diarrhoea and tiredness . the severity of adverse events of docelaxel alone may be increased when docetxel is given in combination with other chemotherapeutic agents . during the infusion , allergic reactions ( may affect up to
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . do store below 25 . store in the original package in order to protect from light . do away with the vial once it has been opened . after dilution , the medicine should be transferred from the infusion bag to the infusion vial immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 6 hours
what docetaxel accord contains - the active substance is docetxel . each ml of concentrate for solution for infusion contains 20 mg docetexel . 1 vial of concentrate contains 20mg docetoxel . 4 vials of concentrate contain 80 mg docelaxel . 8 vials ( 0 . 8 ml ) of concentrate containing 160 mg docotaxel - the other ingredients are polysorbate 80 , ethanol anhydrous ( see section 2 " docetacord contains ethanol "), citric acid anhydrated ( see " docel accord contain ethanol "). what docetAXel
intuniv contains the active substance guanfacine . this medicine belongs to a group of medicines that affect the brain . this medicinal product works by reducing the activity of the brain , making it more alert to stimuli . this helps to reduce the effects of impulsive and hyperactive behaviour . this medication is used to treat ' attention deficit hyperactivity disorder ' ( adhd ) in adults who are not adequately controlled with current stimulant medication . it is used when current medication is not controlling adhd symptoms . the medicine is used in addition to a treatment programme consisting of psychological therapy , educational therapy and social therapy . intuniv is
do not take intuniv if you are allergic to guanfacine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking intunive if you have low or high blood pressure . talk to a doctor or nurse if you think you may have heart problems . talk with your doctor if you know you have heart trouble . if you fainted recently or have had thoughts or feelings of suicide . if any of these apply to you , tell your doctor . if your doctor thinks you may be at risk of withdrawal symptoms , such as increased heart rate .
your treatment will be overseen by a doctor experienced in the treatment of adolescent behavioural disorders . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . your doctor will start your treatment with 1 tablet a morning . your dose will be gradually increased depending on how you respond to treatment . the starting dose is 0 . 05 mg / kg of bodyweight once a day for the first week . your weight will be checked at regular intervals during treatment . this will be increased every 1 week . the dose may be adjusted every 7 weeks .
like all medicines , this medicine can cause side effects , although not everybody gets them . if you feel unwell , you should contact your doctor immediately . your doctor may decide to temporarily stop your medicine . serious side effects tell your doctor straight away if you notice any of the following serious sideeffects : feeling drowsy or feeling dizzy ( hypotension ), slow heart beat ( bradycardia ), feeling faint and loss of concentration ( syncope ), a serious withdrawal side effect from high blood pressure . symptoms may include headaches , feeling confused , nervousness , agitation and tremors ( hypertensive encephalopathy ). if any of these
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister pack after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . the tablets should be used within one month after first opening of the blister pack . do this to protect from moisture . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what intuniv contains the active substance is guanfacine hydrochloride . each prolonged - release tablet contains 1 mg of guanFacine . each 2 mg prolonged -release tablet contains guanfuine hydro chloride . each 3 mg prolonged release tablet delivers guanjuine hydroxychloride , each 4 mg prolonged prolonged - releases tablet contains 4 mg of Guanfacin . the other ingredients are hypromellose 2208 , methacrylic acid - ethyl acrylate copolymer , lactose monohydrate , povidone type a , crospovidon type a, microcry
ecalta contains the active substance anidulafungin . it is used in adults and adolescents ( aged 1 to 18 years ) to treat fungal infection in the blood or other internal organs ( invasive candidiasis ). the infection is caused by fungal cells called candida that are cut off and live in the body . ecalta belongs to a group of medicines called echinocandins . these medicines prevent serious fungal infections from spreading and destroy fungal cell walls . ecalda is used when fungalcells have incomplete or defective cell walls , which may make them fragile and unable to grow .
do not use ecalta - if you are allergic to anidulafungin , other echinocandins , caspofungin acetate or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or nurse before using ecaltra . your doctor will check your liver function . if you have liver problems , your doctor may decide to reduce your dose or stop your treatment with anaesthetics . your treatment will be closely monitored by your doctor . if ecaltfa is used in combination with anaesthesia , tell your doctor immediately . if any of these apply
the treatment will be given to you by a doctor or nurse . the recommended dose is 200 mg / 100 mg given once a week . the dose is 1 hour before breakfast . adults ( aged 18 years and over ) the recommended starting dose is 3 . 0 mg / 200 mg given twice a week , followed by 1 . 5 mg /100 mg given three times a week depending on the patient ' s weight . ecalta is given as a slow infusion ( a drip into a vein ) lasting 1 . 4 to 3 hours . the loading dose will depend on the infusion - related effect of ecaltation on thepatient ' s
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following serious side effects : - potentially life - threatening allergic reactions , including difficulty breathing or wheezing or an existing rash . ecalta can cause serious sideeffects , including convulsion ( seizure ), flushing , rash , pruritis ( itching ), hot flush , hives , sudden contraction of the muscles , wheezezing , coughing or difficulty of breathing other side effects very common side effects ( may affect more than 1 in 10 people ): - low blood potassium ( hypokalaemia
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . the reconstituted solution should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 - 8 . the infusion solution should not be stored above 25 for a single period of 48 hours . if refrigerated
what ecalta contains - the active substance is anidulafungin . each vial of powder contains 100 mg of aniduafungan . - the other ingredients are mannitol , polysorbate 80 , tartaric acid , sodium hydroxide , hydrochloric acid and 30 micrograms / ml . what ecaltas looks like and contents of the pack ecaltfa is supplied as a box containing 1 vial containing 100 mg concentrate for solution for infusion . the powder is white to off - white .
adynovi contains the active substance rurioctocog alfa pegol , which is a copy of pegylated human coagulation factor viii ( hcviii ). the human coaggulation factor iii is produced by the human body . factor v iii is necessary for the blood to form clots and stop bleedings . in patients with haemophilia a , factor v viii is not produced . adynovi is used for the treatment and prevention of bleeding in adults and adolescents 12 years of age and older with haemaophilia b , an inherited bleeding disorder caused by lack of factor v
do not use adynovi - if you are allergic to rurioctocog alfa pegol or octocog aluminium or any of the other ingredients of this medicine ( listed in section 6 ) - if your child is allergic to any of these active substances . warnings and precautions talk to your doctor or pharmacist before using adynov : - if the child has had an anaphylactic reaction ( a severe , sudden allergic reaction ) to adyno . allergic reactions may include rash , 95 hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , wheezing
treatment with adynovi will be started by a doctor experienced in the treatment of haemophilia a . your doctor will decide how much adynovovi you need and will determine the dose you need . treatment to prevent bleeding will be initiated by your doctor . your dose of adynova will depend on your condition and the replacement therapy you are receiving . adynoc is a life - long treatment . always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . how much to use prevention of bleeding the recommended dose of adsynovi is 40 mg or 50 mg once every
like all medicines , this medicine can cause side effects , although not everybody gets them . sudden allergic reactions ( anaphylactic ) may occur after the injection . early symptoms of allergic reactions may include rash , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , wheezing , tightness in the chest , feeling of being unwell , dizziness and loss of consciousness . if severe symptoms such as difficulty in breath or fainting occur , prompt emergency treatment is needed . patients who have received previous treatment with factor viii ( more than 150 days of treatment ) inhibitor antibodies ( see
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . the powder vial may be stored at room temperature ( up to 30 ) for a maximum of 3 days . do this medicine if it is stored at a temperature not above 30 and has not been refrigerated for a minimum of 3 weeks . once the vials
what adynovi contains the active substance is rurioctocog alfa pegol ( pegylated human coagulation factor viii produced by recombinant dna technology ). each powder vial contains 250 , 500 , 1000 or 2000 iu of ruricoctocag alfa pepegol . the solvent vial provides 5 ml sterilised water for injections . the other ingredients are mannitol , trehalose dihydrate , histidine , glutathion , sodium chloride , calcium chloride dihydrates , tris ( hydroxymethyl ) aminomethane , polysorb
rekovelle contains follitropin delta , a follicle stimulating hormone that belongs to a group of hormones called gonadotropins . gonadotropicins are involved in female fertility and are present in assisted reproduction programs ( i . e . in vitro fertilisation ( ivf ) and intracytoplasmic sperm injection ). they are produced by the ovaries and are responsible for the creation of many egg sacs .
do not use this medicine if you are suffering from your fertility problems . if you think you may be allergic to follicle stimulating hormone or any of the other ingredients of this medicine ( listed in section 6 ) if you have a tumour in the uterus , ovaries , breasts , pituitary gland or hypothalamus if you develop enlarged ovaries or cysts on your ovaries if you suffer from polycystic ovarian disease ( bleeding from the vagina at an early menopause ) if your family has malformations of the sexual organs ( see section " pregnancy and breast - feeding "). if you or your partner have fib
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the rekovelle dose will be given to you by your doctor during your first treatment cycle . your doctor will decide how much anti - müllerian hormone you need to receive to stimulate your ovaries to produce stimulation with gonadotropins . the dose will depend on your blood weight . your dose will also be calculated from a blood sample taken every 12 months . the number of injections you receive will depend upon your body weight . the duration of treatment will depend mainly on your response to the re
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects caused by hormones that are used to treat infertility have been reported . this medicine may cause a high level of activity in the ovaries ( ovarian hyperstimulation syndrome ). symptoms include pain , discomfort and swelling of the abdomen , nausea , vomiting , diarrhoea , weight gain and difficulty breathing . if you experience any of these symptoms , seek medical advice straight away . a side effect that may affect up to 1 in 10 people : headache nausea ( ovarianhyperstimulation syndrome ) pelvic pain or discomfort ( ovarian origin tiredness (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store below 25 . after reconstitution , the solution may be stored for up to 3 days at room temperature ( up to 28 ) and protected from light . from a microbiological point of view , the product should be used immediately . after the treatment any unused solution must be disposed of in accordance with local requirements . medicines should not be disposed
what rekovelle contains the active substance is follitropin delta . each multidose cartridge contains 12 mg of follitroin delta in 0 . 36 millilitre of solution . after dilution , each ml of solution contains 33 . 3 mg of of folliotropin delta in each millilitere of solution ( corresponding to 0 . 35 ml of the solution ). the other ingredients are phenol , polysorbate 20 , l - methionine , sodium sulphate decahydrate , disodium phosphate dodecahydrates , concentrated phosphoric acid , sodium hydroxide and water
the active substances of revinty ellipta are fluticasone furoate and vilanterol . each inhalation of revindy elliptoe contains flutic asone fureate and 92 mg vilancerol . the 22 mg / 22 mg dose of fluticasaone furyate and 184 mg vilterol is equivalent to 92 / 22 . chronic obstructive pulmonary disease ( copd ) in adults and adolescents ( 12 years of age and older ) weighing 184 kg or more . asthma in adults the 184 mg / 23 mg dose is equivalent of 92 / 42 mg . for chronic obstructative
do not use ellipta if you are allergic to fluticasone furoate , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using ellipta . ellipta has not been studied in patients with liver disease . it is possible that side effects may occur if you have moderate or severe liver disease , but the lower strength of revinty ellipta 92 / 22 mg is used . if you suffer from heart problems , such as high blood pressure , tuberculosis ( tb ) of the lung , or any long standing or untreated
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . asthma the recommended dose for asthma is one inhalation twice a day ( one inhalations each day ) with fluticasone furoate and 22 mg vilanterol . for copd the recommended starting dose for adults is one adult inhalation once a day . for severe asthma , the higher strength inhaler is fluticasaone firoate and the 22 mg dose is one tablet once a morning ( one inhale each day ). for copdn the recommended daily dose
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions to revinty ellipta are rare ( may affect up to 1 in 1 , 000 people ). if you have any of the following symptoms while taking revintchy ellipta stop taking this medicine and contact your doctor immediately : skin rash , hives , redness swelling , especially of the face or mouth ( angioedema ), feeling very wheezy , coughing , difficulty in breathing , feeling weak or light headed ( collapse or loss of consciousness ) immediate breathing difficulties if you experience immediate breathing difficulty while taking the combination of
what revinty ellipta contains the active substances are fluticasone furoate and vilanterol . each 92 micrograms inhalation delivers 92 microlitres of flutic asone firoate and 22 microlitre of vilancerol and trifenatate . each 184 microgram inhalation provides 184 microliters of flilitasonefuroate , 22 microgram of vilterol and 3 trifenedatate respectively . the other ingredients are lactose monohydrate ( see section 2 " revintchy ellipta is sodium "), magnesium stearate . what
atripla contains three active substances that control human immunodeficiency virus ( hiv ) infection : efavirenz , a non - nucleoside reverse transcriptase inhibitor ( nnrti ), emtricitabine , a nucleosides reverse transcriptases inhibitor ( tnrtis ), tenofovir , a nucleotide reverse transcript enzyme inhibitor (nnrtti ). these active substances are all taken together with antiretroviral medicines . they work by interfering with the normal working of an enzyme ( reverse transcriptatase ) that is essential for the virus to multiply . at
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet taken by mouth once a day . atripla should be taken on an empty stomach at least 1 hour before or 2 hours after food . some side effects may be more common , such as dizziness and drowsiness . if you take more atripola than you should if you have taken more atrippla than your doctor tells you to , contact your doctor immediately . if possible , take your tablet with you . atripla can be taken with
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of bloodlipids sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects lactic acidosis ( excess lacticacid in the blood ) rare ( may affect up to 1 in 1 , 000 people ) serious side effect tell your doctor immediately if you notice any of the following serious side side effects : lactic ache (
what atripla contains the active substances are efavirenz , emtricitabine and tenofovir disoproxil . each atripera film - coated tablet contains 600 mg efavenirenz and 200 mg emtripitabin , corresponding to 245 mg tenofoviir disopicroxil ( as fumarate ). the other ingredients are croscarmellose sodium , hyprolose , magnesium stearate , microcrystalline cellulose , sodium laurilsulfate ( see section 2 " atrifla contains sodium "). the tablet
orgalutran contains the active substance ganirelix . it belongs to a group of medicines called anti - gonadotrophin ( gnrh ), which are similar to the natural gonadodotrophins releasing hormone ( ngrh ). gnrh regulates the release of gonadotropins and follicle stimulating hormone ( fsh ). gonadrophins are involved in the growth and development of follicles in the ovaries . follicles are small round sacs that contain the egg cells . they release the immature egg cells in the sacs . they are then collected and given to you by your doctor .
do not use orgalutran - if you are allergic to ganirelix or any of the other ingredients of this medicine ( listed in section 6 ). - if hypersensitive to gonadotrophin releasing hormone ( gnrh ) or any other gonadotropin - releasing hormone , such as a gnrh analogue . - if your child has a moderate or severe kidney or liver disease . - you are pregnant . warnings and precautions talk to your doctor or pharmacist before using orgaluchran allergic reactions may be signs of an active allergic condition . your doctor will do additional monitoring during treatment . allergic reactions if you
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . orgalutran is given to you by a doctor who is experienced in the treatment of assisted reproduction techniques ( i . e . in vitro fertilisation ( ivf ), ovarian stimulation , follicle stimulating hormone ( corifollitropin ), on day 2 or day 3 of each cycle . you will be given orgaluitran under the skin ( subcutaneously ) for 5 to 6 days . your doctor will decide how many cycles you should receive orgaluchran . your dose will be worked
like all medicines , this medicine can cause side effects , although not everybody gets them . a side effect that may affect up to 1 in 10 people is local skin reactions ( redness and swelling ). if the local reaction is severe , it usually disappears ( see section 4 ). uncommon ( may affect 1 in 100 people ) headache nausea ( malaise ) rare ( may affects up to one in 10 , 000 people ) allergic reactions such as rash facial swelling , difficulty breathing ( dyspnoea ) swelling of face , lips , tongue , and / or throat , difficulty in breathing or swallowing ( angioedema or anaphyl
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . syringes should be stored in a refrigerator ( 2 - 8 ). do not freeze . store in the original package in order to protect from light . store the syringules in order for clear , particle - free solutions to be administered immediately . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect
what orgalutran contains - the active substance is ganirelix in 0 . 5 ml solution . - the other ingredients are acetic acid , mannitol , water for injections ( see section 2 ). - the ph is dissolved in sodium hydroxide and acetic acids . what orgaluitran looks like and contents of the pack orgaluchran is a clear , colourless aqueous solution . the solution is clear and colourless . it is supplied in a glass vial for subcutaneous administration . the needle is inserted into the vial . the product is supplied as a clear to slightly
what blitzima is blitzima contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to a specific target in a type in the body called a white blood cell called " b - lymphocyte ". when ritukimab sticks to this target , the cell dies . what blitzima used for blitzima has been used to treat : a ) non - hodgkin ' s lymphoma this is usually a disease of the lymph tissue . the immune system attacks a type a of white blood cells called b - cells . blitzima can be
do not use blitzima - if you are allergic to rituximab , other proteins that are similar to ritonuximib or any of the other ingredients of this medicine ( listed in section 6 ) - if your child has a severe active infection - if he / she has a weak immune system - if the child has severe heart failure or severe uncontrolled heart disease - if any of these apply to your child ( see section " warnings and precautions ") warnings and risks talk to your doctor or pharmacist before using this medicine - if they are children or adolescents ( aged 6 years or older ) - they have a severe
how blitzima is given your doctor will decide how much blitzima you will receive and for how long . always use this treatment exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor may decide to change your dose , or stop you completely , if you experience any side effects . how blitzima will be given blitzima comes as a drip ( intravenous infusion ). it is given to you by a doctor or nurse who is experienced in the use of medicines similar to this . each blitzima administration will be overseen by a healthcare professional . you will be treated with blitzima in
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion you may experience fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what blitzima contains the active substance is rituximab . each 10 ml vial contains 100 mg of ritukimab in 10 ml . each 50 ml vials contains 500 mg of the active ingredient in ritiximab ( 10 mg / ml ). the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what blitzima looks like and contents of the pack blitzima is a clear , colourless solution for infusion . it is supplied in 2 glass vials , each containing 50 ml . pack size of 1 vial .
roactemra contains the active substance toilizumab , a type of monoclonal antibody ( a type in the body that attaches to a specific target in the brain ). it blocks the activity of a protein called interleukin - 6 , which is involved in causing the inflammation in your body . roactemrea can cause symptoms such as pain and swelling in your joints . roactoremra reduces the damage to the cartilage and bone in your bones caused by the disease . roACTemra is used to treat moderate to severe active rheumatoid arthritis , an autoimmune disease that has not responded
do not use roactemra if you are allergic to tocilizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have an active , severe infection . during the infusion with roactemnra , you may experience allergic reactions such as chest tightness , wheezing , severe dizziness , light - headedness , swelling of the lips or skin rash . these reactions usually disappear after a few days . if you develop any signs of infection or infections , tell your doctor immediately . if your body ' s ability to fight infections is reduced , you should tell your physician . if any
the doctor or nurse will give you roactemra by infusion into a vein ( intravenous infusion ). your doctor or a nurse will decide on the dose you need . the intravenous infusion will be given over a period of one hour . the treatment will be started by a doctor or another healthcare professional . the recommended dose of roacterera is 8 mg per kg body weight . the usual dose is 4 mg per kilogram body weight given once a week . the dose of the first dose of a dose of 8 mg is 8mg per kg of body weight , given once every week . your doctor will decide how much
like all medicines , roactemra can cause side effects , although not everybody gets them . the following side effects have been reported in the marketing of roactemnra : very common side effects ( may affect more than 1 in 10 people ) allergic reactions , including difficulty with breathing , chest tightness , light - headedness , rash , itching , hives , swelling of the lips , tongue or face . serious infections , including fever and chills , which may travel through the mouth and skin blisters and stomach ache signs and symptoms of liver toxicity . rare side effects these may affect up to 1 in 1000 people ) tired
keep this medicine out of the sight and reach of children . do not use after the expiry date which is stated on the outer carton and on the vial label after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what roactemra contains the active substance is tocilizumab . each 4 ml vial contains 80 mg of tociluzumab in 20 ml . each 10 ml vials contains 200 mg of of tocizumumab ( 20 mg / ml ). each 20 ml vray contains 400 mg of the active substances in tocilixumab 20 mg . the other ingredients are sucrose , polysorbate 80 , disodium phosphate dodecahydrate , sodium dihydrogen phosphate dihydrate and water for injections . what roactemetra looks like and contents of the pack roact
onbrez breezhaler contains the active substance indacaterol which belongs to a group of medicines called bronchodilators . these relax the muscles in the walls of the small air passages in the lungs . onbrez bronzhalhaler is used to treat breathing difficulties caused by a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten , making breathing difficult . this medicine works by relaxing these muscles in your lungs . this makes it easier for air to get in and out of the lungs , and makes it less likely that you will have to go
do not use onbrez breezhaler - if you are allergic to indacaterol or any of the other ingredients of this medicine ( listed in section 6 ). - if your asthma is not controlled with onbreez breez inhaler . - if any of these apply to you , tell your doctor before using onbrezer . warnings and precautions talk to your doctor or pharmacist before using this medicine : - if there are any signs of heart problems such as epilepsy , thyroid gland problems ( thyrotoxicosis ), or diabetes . treatment with on brez breezerhaler should be stopped immediately if you get tight
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose is one 150 microgram capsule twice a day ( morning and evening ). your doctor may increase your dose to 300 microgram twice a week depending on how you respond to the treatment . you should use your inhaler at least 24 hours after you last inhaled it . onbrez breezhaler is supplied as an inhaler and capsules ( in blisters ) containing the medicine are provided in the pack . the medicine is inhalation powder . the onbreez breez inhaler inhal
what onbrez breezhaler contains - each onbrex breez inhaler 150 micrograms hard capsule contains 150 microlitres of indacaterol ( as indacathol maleate ). - the other ingredients are lactose and the capsule is made of gelatin . - eachonbrez bronzhalER 300 microgram hard capsule contain 300 microlitre of indiacaterol , as indaconaterol maleine . - the ingredients are made of lactose or the capsule contains gelatin . what onbreez breezeler looks like and contents of the pack onbrezy breezer
clopidogrel hcs contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopIDogrel clcs is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombogenesis , which can lead to atherostrombotic events (
do not take clopidogrel hcs - if you are allergic to clopidineogrel or any of the other ingredients of this medicine ( listed in section 6 ). - if your bleeding is currently being treated with a stomach ulcer or bleeding within the brain . - if severe liver disease . if you think any of these apply to you , or if you have any further questions on the use of clopridogrel clcs , ask your doctor or pharmacist . warnings and precautions the following apply to all patients taking clopideogrel ccs : - if bleeding is being treated as a result of a
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel hcs per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clapidogl hcs ( 4 tablets of 75 mg ) once at the start
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what clopidogrel hcs contains the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopide ( as hydrochloride ). the other ingredients are ( see section 2 " clopidaogrel hexamethylene "): tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenated castor oil . film coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide , talc , macrogola
feccroja contains the active substance cefiderocol . it is an antibiotic medicine that belongs to a group of antibiotics called " cephalosporins ". antibiotics are used to fight bacteria that cause infections . fetcroja is used to treat infections caused by bacteria that you have not previously been treated with other antibiotics .
do not use fetcroja if you are allergic to cefiderocol or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before using fetcroj if you have ever had other antibiotics ( e . g . cephalosporins ). if your doctor has told you that you have had a severe allergic reaction to certain antibiotics ( such as penicillins or carbapenems ). if this applies to you , tell your doctor immediately . if you experience severe skin peeling
this medicine is given to you by a doctor or nurse as an infusion ( a drip ) into a vein . it usually takes about 3 to 2 weeks . your doctor will decide how long fetcroja treatment will last . your dose will be decided by your doctor . your first dose will usually be given by a nurse or doctor . if you are given more fetcroj than you should if you think you have been given too much fetcroje , tell your doctor or hospital pharmacist straight away . your infection will be treated as soon as possible . you should not feel any pain during the fetcroja infusion into a blood
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects you may need urgent medical treatment : severe allergic reaction : sudden swelling of your lips , face , throat or tongue , a severe rash or other severe skin reactions , difficulty swallowing or breathing . this reaction may lead to diarrhoea , stools , blood or mucus . treatment may be stopped or medicines may slow bowel movement . other side effects talk to your doctor or pharmacist if you get any of these side effects : very common ( may affect more
what fetcroja contains - the active substance is cefiderocol sulfate tosylate . each vial contains 1 mg cefingerocol . - the other ingredients are sucrose , sodium chloride and sodium hydroxide . what fetcroJA looks like and contents of the pack fetcrojas is a white to off - white powder for concentrate for solution for infusion . it is available in packs containing 10 vials .
depocyte is used to treat adults with lymphomatous meningitis . lymphomatinous meneningitis is a condition in which tumour cells accumulate in the membranes of the brain and spinal cord . depocyte is prepared by biotechnology and is used in adults to prepare lymphoma tumour cell cells .
do not use depocyte - if you are allergic to cytarabine or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has a meningeal infection . warnings and precautions talk to your doctor or pharmacist before using depocyte . severe neurological side effects have been reported with depocyte , with symptoms suggesting problems with the nervous system such as convulsions , pain , numbness , tingling , blindness , visual disturbances . if you experience any of these symptoms , stop using depocytes and contact your doctor immediately . taking any dexamethasone tablets may increase the risk of
your doctor has prescribed depocyte for you because you have cancer . it is stored in a specialised storage area in the lumber sac . depocyte is given as injections of 1 mg or 5 mg of dexamethasone in each vial . each dose is given once a day . your doctor will decide how many injections you need and how often you need to take depocyte . the recommended dose is one 5 mg tablet of dexamine dexamETHasone 5 mg / ml tablet once a week . your physician will decide the correct dose based on your response to each depocyte dose . if you experience any side effects ,
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may occur with your treatment : very common side effects ( affects more than 1 user in 10 ) common side effect ( affects 1 to 10 users in 100 ) uncommon side effects 1 to 1 users in 10 ( affects less than 1 users per 10 ) very common adverse events where depocyte is administered with other chemotherapeutic agents common side ( affects at least 1 user per 10 , but more than1 user in 100 ), nausea , vomiting weakness , confusion fever headaches dizziness shaking uncommon side effect in children ( affects between 1 and
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the exp date refers to the last day of that month . depocyte should be stored in a refrigerator ( 2 - 8 ). do not freeze . depocytes should be used within 4 hours after preparation . do this to protect from light . do do not shake depocyte vigorously as this medicine may cause severe discolouration and a changed appearance . do away with the vials and discard any unused medicine . do discard any medicines that are no
what depocyte contains - the active substance is cytarabine . one ml of suspension contains 10 mg cytarabeine . each 5 ml vial contains 50 mg cytabine ( as cholesterol , triolein ), dioleoylphosphatidylcholine , dipalmitoylophosphatidiylglycerol , sodium chloride and water for injections . what depocyte looks like and contents of the pack depocyte is a solution for injection . it is supplied as 5 ml glass vial with a single injection . depocyte can be divided into two equal doses . each pack contains one
what bemrist breezhaler is bemist breez inhaler contains two active substances , indacaterol and mometasone furoate . indacatorol belongs to a group of medicines called bronchodilators . it relaxes the muscles in the lungs , making it easier for air to get in and out of the lungs . mometsone furyate belongs to the group of medications called corticosteroids . corticoposteroids reduce the swelling and irritation ( inflammation ) in the small airways in the lung , which can lead to breathing problems . cortics reduce attacks
do not use bemrist breezhaler - if you are allergic to indacaterol , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). - if any of these apply to you , tell your doctor before using bemist breez inhaler . - if your doctor thinks you may be allergic . - tell your physician if you have heart problems , such as an irregular or fast heartbeat . - you have thyroid gland problems . - have diabetes , high blood sugar , seizures or low level of potassium in your blood . - suffer from severe liver problems . tell
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . bemrist breezhaler capsules should be swallowed whole with water . you should take the medicine at the same time each day . do not open or chew the capsules . do this to reduce the amount of medicine in your body . if your asthma does not improve or your symptoms get worse , contact your doctor . how bemist breez inhaler is used bemrid breezhhaler is for inhalation use only . you must use it with an inhaler and capsules that contain the
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects can be serious . tell your doctor straight away if you notice any of the following : very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips , or face , skin rash , itching and hives . allergic reaction uncommon ( may effect up to 1 in 100 people ): swelling of either the tongue or lips , face or throat ( angioedema ). other side effects other sideeffects include the following listed below : very commonly ( may affects more than1 in 10 users ):
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special temperature storage conditions . the capsules should be kept in the original blister in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what bemrist breezhaler contains the active substances are indacaterol ( as acetate ) and mometasone furoate . bemist breez inhaler 125 micrograms / 62 . 5 microgram inhaled in a single - use inhalation each capsule contains 173 microgram indacate . each capsule also contains 150 microgram of indacatesol and 80 microgram mometsone furuate . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 125 microg of indaceaterol and 62 . 95 microgramm of
zyllt contains clopidogrel which belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). zyllt is taken to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombogenesis . atherostrombotic events can occur ( such as stroke , heart attack , or death ). zll
do not take zyllt - if you are allergic to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . - if any of these apply to you ( or you are not sure ), talk to your doctor before taking zylltt . warnings and precautions talk to you doctor before you take zllt : - if bleeding is not being controlled - if there is a medicalcondition that puts you at risk of internal bleeding ( such as
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of zyllt per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of zllt ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended daily dose is one one 75
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what zyllt contains the active substance is clopidogrel . each film - coated tablet contains 75 mg of clopridogrel ( as hydrogen sulphate ). the other ingredients are : tablet core : lactose ( see section 2 under ' zylltic contains lactose '), microcrystalline cellulose , pregelatinised maize starch , macrogol 6000 and hydrogenated castor oil in the tablet core and hypromellose ( e464 ), titanium dioxide ( e171 ), red iron oxide ( e172 ), talc and propylene glycol in the film - coating . what zyllts
lamivudine teva contains the active substance lamivudrine . lamivudaine teeva is used to treat long term ( chronic ) hepatitis b infection in adults . lamibudineteva is an antiviral medicine that works by stopping the hepatitis b virus from multiplying . it belongs to a group of medicines called nucleoside analogue reverse transcriptase inhibitors ( nrtis ). hepatitis b is a virus that infects the liver . long term (" chronic " means liver damage ). lamivodine tevas reduces the amount of hepatitis b in your body . this results in a reduction in liver damage . your liver
do not take lamivudine teva - if you are allergic to lamivuda or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions 28 talk to your doctor , pharmacist or nurse before taking lamividine tevas . taking lamidudine with other similar medicines can increase the risk of serious side effects . - if your liver disease is severe ( such as hepatitis c . - you are overweight ). your doctor will do blood tests before you start your medication ( see section 4 ) and regularly while you are taking lamibudine . this is to check that your hepatitis is
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage your doctor lamivudine teva is used to treat your hepatitis b infection . it is important that you continue to take it until your infection is gone . your doctor will regularly monitor your illness to check that it is getting better . if you take more lamivuda teva than you should if you accidentally take too many tablets of lamividine , or if someone else accidentally takes your tablets , contact your doctor immediately . if possible , take lamivuine with another medicine . the recommended
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with lamivudine teva in patients with other conditions linked to hepatitis b . the most serious side effects reported during therapy for hepatitis b are listed below . the side effects that have been observed during lamivudaine clinical trials include tiredness , respiratory tract infections , throat discomfort , headache , stomach discomfort , pain , nausea , vomiting , diarrhoea and increases in liver enzymes . these are signs that the liver is not working properly and may cause problems with the muscles . allergic reaction ( rare , may affect
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . lamivudine teva should be used immediately after dilution . do this if you notice that the solution is not clear or contains particles . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what lamivudine teva contains - the active substance is lamivudaine . each film - coated tablet contains 100 mg of lamivUDine . - the other ingredients are microcrystalline cellulose , sodium starch glycolate , magnesium stearate . tablet film - coating : hypromellose , titanium dioxide ( e171 ), macrogol , polysorbate 80 , iron oxide yellow ( e172 ), iron oxide red ( e 172 ). what lamivudsine teeva looks like and contents of the pack orange , biconvex film - coat : 32 lamividine tevas
nespo is an anti - anaemic ( means that your anaemia is not caused by any other medicine ). anaemia occurs when your blood does not contain enough red blood cells . the symptoms include fatigue , weakness and shortness of breath . nespo works by interfering with the natural hormone erythropoietin . erythroietin works by blocking the action of a substance called erythromycin . this helps your kidneys to produce more red bloodcells . nesterpo is used in adults : - to treat darbepoetin alfa - 2b , which is used to treat chronic
do not use nespo : if you have high blood pressure or are taking other medicines . if you are allergic to nesco ( darbepoetin alfa ) or r - huepo . if this applies to you , tell your doctor . warnings and precautions talk to your doctor before using nespos : if your doctor has high bloodpressure and you are taking medicines to treat sickle cell anaemia . if your child has epileptic fits ( seizures ). if your newborn has convulsions or fits . if he has liver disease . if any of the above apply to you ( or you are
your doctor will carry out blood tests before you start nespo to check your haemoglobin level . the usual starting dose is 10 mg . your doctor will decide the right dose based on a haemboglobin level that is right for you . the dose may be increased or decreased by 10 mg or 12 mg . the pre - filled syringe is for injection into a vein . if you have chronic renal failure , a single injection will be given under the skin or into a veins ( intravenous ). your doctor may decide to change the dose if your anaemia is not controlled . the recommended dose of nespos for your
like all medicines , nespo can cause side effects , although not everybody gets them . the following side effects have been reported with nespos : very common ( may affect more than 471 people ) uncommon ( may affects up to 1 in 100 people ) high blood pressure ( hypertension ) fluid retention ( oedema ) uncommon : ( may effect up to1 in 100 , 000 people ) blood clots ( thrombosis ) pain in the area injected rash , redness and swelling of the skin rare : ( might affect up to one in 10 , 000 patients ) serious allergic reactions sudden life - threatening allergic reactions (
keep out of the reach and sight of children . do not use nespo after the expiry date which is stated on the carton and on the syringe label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep your syringe in the original package in order to protect from light . after first opening of the bottle , nespos may be used within 30 days or up to 7 days . do this at the end of each month . do away with nespen after this time period . medicines should not be disposed of via wastewater
what nespo contains the active substance is darbepoetin alfa . each ml of solution for injection contains 10 , 15 , 20 , 30 , 40 , 50 , 60 , 80 , 100 , 130 , 150 , 300 or 500 iu . the active substances darbasepoetein ala and nespos are sodium phosphate monobasic , sodium phosphate dibasic ( e1200 ), sodium chloride , polysorbate 80 and water for injections . what nespi looks like and contents of the pack nesp is a clear , colourless to slightly pearly
macugen is a solution for the treatment of macular degeneration in adults . this medicine prevents abnormal formation of new blood vessels in the eye . macugen is used for thetreatment of macul degeneration . people with this disease have vision loss caused by damage to a part of the retina called the macula . macula is the thin layer at the back of the eye called the retina . macular is the macular layer that surrounds the eye and is the most sensitive layer in the body . macul is the layer that lines the front of the lens of the coloured eye . the macul makes the eye work smoothly .
do not use macugen : if you are allergic to pegaptanib or any of the other ingredients of this medicine ( listed in section 6 ). if you have an active or suspected infection in the eye . warnings and precautions talk to your doctor or pharmacist before using macugen . if you think you have or have ever had an infection or bleeding in theeye , stop using macug injection and contact your doctor immediately . if any of these apply to you , tell your doctor straight away . if the following symptoms occur , tell the doctor straightaway : eye pain , increased discomfort , worsening eye redness , blurred or decreased vision
mugen will be given to you by a doctor or nurse . injections of macugen are given by injection . macugen is given as a single injection into the eye . it is given every 6 to 9 weeks . the injection will be injected into the vitreous part of the eye ( the front part of your eye ). macugen must be used every day . antibiotic eye drops are also given to help protect your eyes . you will be treated with some local anaesthetic (umbing medicine ) to reduce any pain you may have after the injection . if you are allergic to antibiotic eyedrops , you will not be treated in the eye
like all medicines , this medicine can cause side effects , although not everybody gets them . serious allergic reaction ( anaphylactic reaction or angioedema of which symptoms may include breathing difficulty , wheezing , swollen mouth , face , hands or feet , itching skin , fainting , rapid pulse , stomach cramps , nausea , vomiting and diarrhoea ). the frequency of these side effects is not known . an infection in the internal portion of the eye has been reported rarely in patients receiving macugen treatment . the symptoms are described in section 2 . if you experience any of these symptoms , contact your doctor immediately . other
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do use the medicine immediately if you notice any change in the appearance of the capsules . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what macugen contains - the active substance is pegaptanib . each single dose pre - filled syringe contains 0 . 3 mg of pegaptenib in 90 ml of solution . - the other ingredients are sodium chloride , monobasic sodium phosphate monohydrate , dibasicodium phosphate heptahydrate , sodium hydroxide , hydrochloric acid ( for ph adjustment ) and water for injections . see section 2 . what macugen looks like and contents of the pack macugen solution for injection in a single dose pack is supplied in a pouch . each pack contains a pre -filled syringe of
palifermin belongs to a group of medicines called escherichia coli . palifermin works by stopping the growth of epithelial cells in the mouth and in the digestive tract and tissues of the skin . paliformin is used to treat oral mucositis ( soreness , dryness or inflammation of the mouth ) as an additional side effect that may occur during treatments for your blood cancer . if your bloodcancer is not treated with chemotherapy , radiotherapy or autologous hematopoietic stem cell transplantation ( a procedure where blood cells are collected and given back to you ) it may increase the risk
do not take kepivance if you are allergic to palifermin , escherichia coli derived proteins or any of the other ingredients of this medicine ( listed in section 6 ). children and adolescents do not give this medicine to children and teenagers under 18 years of age . other medicines and kepipivance tell your doctor or pharmacist if you take , have recently taken or might take any other medicines . kepivalance may be taken with heparin . if you have recently been given heparrin , tell your physician . pregnancy and breast - feeding kepvelance is not recommended if you plan to
how kepivance is given the doctor will decide on the dose you need and how long you need to receive cancer treatment . the usual dose of kepvance is 60 mg . your doctor will give you kepvelance in a single dose of one kilogram ( kg ) as an intravenous injection into a vein . how keprevance is administered kepovance will be given to you on three days of chemotherapy ( called radiotherapy ) followed by three days chemotherapy ( including radiotherapy ). you will be treated with chemotherapy andradiotherapy 24 to 48 hours after the chemotherapy . you will also be given
like all medicines , this medicine can cause side effects , although not everybody gets them . common ( may affect up to 1 in 10 people ): side effects include skin rash , itching , redness ( pruritus and erythaema ), an increase in the thickness in the mouth or tongue , change in colour of the mouth and tongue , generalised swelling ( oedema ), swelling of hands , ankles or feet , pain , fever and aching joints ( arthralgia ), altered taste , decrease in lipase and amylase levels , and in levels of digestive enzymes in the blood . the following side effects have
what kepivance contains - the active substance is palifermin . each vial contains 6 . 25 mg of paliferin . - the other ingredients are mannitol , sucrose , l - histidine , polysorbate 20 and diluted hydrochloric acid . what kepvelance looks like and contents of the pack kepiverance is a white powder supplied in a vial . each carton contains 6 vials .
cinacalcet accordpharma contains the active ingredient cinacalcitepine which increases the levels of calcium and phosphorous in the blood . it is used to treat problems with organs called parathyroid glands . parathyroids are four small glands in the neck , which are connected to the thyroid gland . cinaconalcate accordphara is used in adults with secondary hyperparathyroidism to treat serious kidney disease in which dialysis is not possible or where waste products are not possible . to reduce the amount of calcium in the bloodstream ( hypercalcaemia ), parathy thyroid cancer reduces
do not take cinacalcet accordpharma - if you are allergic to cinacealcate or any of the other ingredients of this medicine ( listed in section 6 ). - if there are low levels of calcium in your blood . your doctor will monitor your blood calcium levels regularly while you are taking cinocalcut accordpha . warnings and precautions talk to your doctor or pharmacist before taking crinacal cet accordphiarma : - if any of these apply to you , tell your doctor before taking this medicine . - if your doctor has told you that you have a history of
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . cinacalcet accordpharma must be taken orally with or without food . cinnacalcitpharma should be taken twice a day , with or shortly after breakfast . the tablets should be swallowed whole with water . your doctor will take regular blood samples during treatment to monitor your progress and may adjust your dose if necessary . in patients with secondary hyperparathyroidism the usual starting dose of cinacealcordpharma is 30
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : numbness or tingling around the mouth , muscle aches or cramps , seizures , as these may be signs that your calcium levels are too low ( hypocalcaemia ). swelling of the face , lips , mouth , tongue or throat , which may cause difficulty in swallowing or breathing ( angioedema ). very common ( may affect more than 1 in 10 people ): nausea and vomiting . if you notice any of these side effects seek medical advice immediately . common ( might affect up to 1 in
what cinacalcet accordpharma contains - the active substance is cinacealc . each film - coated tablet contains 30 mg , 60 mg or 90 mg cinaconalcate ( as hydrochloride ). - the other ingredients are cellulose , microcrystalline - crospovidone - magnesium stearate , hypromellose , titanium dioxide ( e171 ), triacetin , indigo carmine aluminum lake ( e132 ), iron oxide yellow ( e172 ). what cinacyalcelcet cordpharma looks like and contents of the pack ciniac
jentadueto contains two active substances , linagliptin and metformin . linaglptin belongs to a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4 inhibitor ) metformina belongs to the class of substances called biguanides . they work together to lower blood sugar levels in adult patients with diabetes called ' type 2 diabetes mellitus '. this medicine works by reducing the amount of insulin produced by the body . this medicine can be used alone or with certain other medicines used to treat diabetes ( such as sulphonylureas or empagliflo
do not take jentadueto - if you are allergic to linagliptin , metformin or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have severely reduced kidney function . - if any of these apply to you , tell your doctor before taking jentadoeto . warnings and precautions talk to your doctor or pharmacist before taking this medicine : - if the patient has severely reduced liver function . if the person has uncontrolled diabetes with severe hyperglycaemia ( high blood glucose ), nausea , vomiting , diarrhoea , rapid weight loss , l
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . jentadueto should be taken with or without food . if you currently take metformin or individual tablets containing linagliptin or metformina , do not take this medication . take this food at the same time each day . if this medicine is not suitable for you , you may have an upset stomach . the recommended dose is one 5 mg linaglptin tablet once a day with food . your doctor may prescribe a higher dose of 2 , 000 mg metformine hydrochloride
like all medicines , this medicine can cause side effects , although not everybody gets them . some symptoms need immediate medical attention . stop taking jentadueto and contact a doctor immediately if you experience any of the following symptoms : low blood sugar ( hypoglycaemia ) trembling , sweating , anxiety , blurred vision , tingling lips , paleness , mood change or confusion . hypoglycasemia is very common ( may affect more than 1 in 10 people ). the most common side effect of jentodueto plus sulphonylurea is when the combination jentadaeto plus insulin is not fully effective . j
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store the blister in the original package in order to protect from light . do this medicine if you notice any visible signs of tampering . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what jentadueto contains - the active substances are linagliptin and metformin hydrochloride . each jentadinueto 2 . 5 mg / 850 mg film - coated tablet contains 2 . 25 mg linaglioptin and 850 mg metformina hydrochloric acid . - each jentinaduet 2 .5 mg / 1 , 000 mg film film - coating contains 2. 5 mg linagoptin and 1 , 500 mg metin hydroxychloric Acid . - the other ingredients are arginine , copovidone , magnesium stearate , maize starch , silica
edurant contains the active substance rilpivirine . edurant is used to treat human immunodeficiency virus ( hiv ) infection in adults , adolescents and children aged 12 years and older who are already taking hiv medicines called non - nucleoside reverse transcriptase inhibitors ( nnrtis ). edurants does not cure hiv . it is used in combination with hiv medicine in adults and adolescents 12 years of age and older , who are infected with h hiv and who have not taken hiv vaccines before . your doctor will discuss with you which combination of medicines is best for you
do not take edurant if you are allergic to rilpivirine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking edurants if you : are taking any of any of following medicines : carbamazepine , oxcarbazepine ( e . g . phenobarbital ), phenytoin ( medicines used to treat epilepsy and prevent seizures ) rifampicin , rifapentine ( medicines to treat some bacterial infections such as tuberculosis ) omeprazole , esomeprazole (
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . adults and adolescents ( 18 years of age and older ) the recommended dose of edurant is 1 tablet of rifabutin ( a medicine used to treat some bacterial infections ). edurants does not contain rifabeutin . if you take more edurent than you should if you accidentally take too many tablets , contact your doctor immediately . if possible , take your tablets with a glass of water . do not open or crush the tablets . if any of the above apply to you (
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you have : headache , nausea , difficulty falling asleep , insomnia , dizziness , or changes in your routine liver tests ( transaminase ), increase in cholesterol and pancreatic amylase in your blood , abnormal dreams , rash , stomach pain , depression , tiredness , vomiting , drowsiness , decreased appetite , sleep disorders , stomach discomfort , depressed mood , dry mouth 36 low white blood cell and / or platelet count , decrease in haemoglobin in your body ( triglycerides , lipase , bilirub
what edurant contains the active substance is rilpivirine . each tablet contains rilpaline hydrochloride . each film - coated tablet contains eduririne hydroxychloride equivalent to 25 mg of ril pivirrine . the film - coating tablet core contains lactose monohydrate , croscarmellose sodium , povidone k30 , polysorbate 20 , silicified microcrystalline cellulose , magnesium stearate . the other ingredients are lactosemonohydrate , hypromellose 2910 ( e464 ), talc ( e553b ),
avandamet tablets are a combination of two different medicines called rosiglitazone and metformin . these two medicines are used to treat type 2 diabetes . people with type 2abetes either don ' t make enough insulin or their body does not make enough of a sugar - lowering insulin to control their blood sugar levels . rosigslitazONE and met formin work together by helping the insulin in your body to work better . this helps your blood sugar to lower . avandamter is also used as a sulphonylurea ( a type of diabetes medicine ) in adults .
follow all your doctor ' s instructions carefully , even if they differ from the general information contained in this leaflet . check with your doctor if you are not sure . your doctor may need to change your dose of avandamet . do not take avandamanet if you : are allergic ( hypersensitive ) to rosiglitazone , metformin or any of the other ingredients of avANDamet ( listed in section 6 ) have had a heart attack have severe angina have heart failure have had heart failure in the past have severe breathing difficulties have liver disease have diabetic ketoacidosis ( a complication
always take avandamet tablets exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended starting dose is 2 mg rosiglitazone ( equivalent to 1000 mg metformin ). this dose is achieved gradually over 1 to 8 weeks . the maximum dose is reached gradually over 4 weeks . your doctor will decide how much rosigslitazONE ( equivalentto 1000 mg of metformina ). thisdose is achieved slowly over 1 or 8 weeks , but the maximum dosage should be reached gradually through 4 weeks and should not exceed 4 mg ro
like all medicines , avandamet can cause side effects , although not everybody gets them . allergic reactions to avandamanet may include raised and itchy rash ( hives ) swelling mainly of the face or mouth , angioedema ( difficulty in breathing collapse ). if you get any of these symptoms , stop taking avandandamnet and seek medical advice straight away . lactic acidosis ( build up of lacticacid ) can occur in some patients , particularly when treatment with metformin is contraindicated . if you have severe kidney disease , symptoms of lact acidosis include rapid breathing , cold
keep out of the reach and sight of children . do not use avandamet after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do this if you notice any change in the appearance of the tablets . do away with the blister or the desiccant after you have taken them . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what avandamet contains the active substances are rosiglitazone and metformin . avandamanet tablets come in different strengths . each tablet contains 1 mg rosigllitazon , 500 mg metforma , and 2 mg rosciglitasone , 500mg metforman . each 2 mg tablet contains rosigslitazione , 1000 mg met formin . each 4 mg tablet contain rosIGlitazion , 1000mg met formformin , and each 4mg tablet contains similose ( e464 ). the other ingredients are : sodium starch glycollate ,
clopidogrel mylan contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopIDogrelmylan is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombogenesis , which can lead to atherostrombotic events (
do not take clopidogrel mylan 31 if you are allergic to clopiprel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , tell your doctor before taking clopridogrelmylan . warnings and precautions talk to your doctor or pharmacist before taking any of your medicines : if you think any of this applies to you ( or you are not sure ), talk to the doctor or nurse
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel mylan per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clapidogl mylan ( 4 tablets of 75 mg ) once at the start
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what clopidogrel mylan contains the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopidaogrel ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 , hydrogenated castor oil ( see section 2 " clopideogrel Mylan contains hydrogenatedcastor oil "), polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide , talc , macrogl 3000
doptelet belongs to a group of medicines called thrombopoietin receptor agonists . doptelet is used to treat chronic liver disease ( low platelet count ) in adults ( thromboocytopenia ) who may need a medical procedure to stop bleeding . it works by reducing the number of platelets . platelets are blood cells that are needed in the blood to clot and prevent bleeding .
do not use doptelet : - if you are allergic to avatrombopag or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor thinks that you may have a risk of blood clots in the veins or arteries . if you have a history of bloodclots , as this medicine may increase the risk of having blood cl clots . - if any of these apply to you ( or you are not sure ), talk to your doctor or pharmacist before using doptelelet . warnings and precautions talk to you doctor or nurse before using this medicine : - before you start
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose for your procedure is one 5 mg tablet once a day . your doctor may increase your dose to one 8 mg tablet twice a day depending on your response to doptelet . your dose of doptelets may be increased by 20 mg , 40 mg or 60 mg once a week for up to 5 weeks . your platelet counts may be reduced by taking this medicine at least 10 to 13 days before your planned medical procedure . swallow the tablet whole with a glass of water . do not chew
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with doptelet : very common ( may affect more than 1 in 10 people ): feeling tired uncommon ( may effect up to 1 in 100 people ): low red blood cell count ( anaemia ) blood clot in the portal vein ( a blood vessel that transports blood from the liver to the intestines ) upper abdominal pain , swelling bone pain , muscle aches and fever reporting of side effects if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this
what doptelet contains - the active substance is avatrombopag . each film - coated tablet contains avatormboprag maleate equivalent to 20 mg of avatrambopg . - the other ingredients are lactose monohydrate ( see section 2 " doptelets contains lactose "), microcrystalline cellulose , crospovidone type b [ e ], silica , colloidal anhydrous , magnesium stearate . - coating : vinyl alcohol , talc , macrogol 3350 , titanium dioxide ( e171 ), iron oxide yellow ( e172 ). what dop
rapiscan belongs to a group of medicines called ' coronary vasodilators '. these are used to monitor the heart arteries ( heart rate ) and the muscles in the heart . rapiscan is used for the purpose of performing a type of heart scan called ' myocardial perfusion imaging '. the scan contains a radioactive substance called a ' radiopharmaceutical '. these images are taken using a machine that scans the muscles of the heart using a readmill . a scan contains only a small amount of radiopharma and is injected into the body through a vein . it is given by your doctor or nurse . it can be
do not use rapiscan if you have slow heart rate , high degree heart block , sinus node disease , or a pacemaker that does not work properly . if you experience chest pain ( unstable angina ) during treatment , especially if you suffer from low blood pressure ( hypotension ) or heart failure . if your doctor thinks you may be allergic to regadenoson or any of the other ingredients of rapiscin ( listed in section 6 ). warnings and precautions talk to your doctor before using rapiscen if any of these apply to you : if you are not sure , talk to a doctor or pharmacist before using
rapiscan will be given to you by a doctor or nurse who is experienced in the treatment of your heart and blood pressure . it will be injected into a vein ( intravenously ) over a period of approximately 400 minutes . the recommended dose is a 5 ml solution the injection will be administered over a minimum of 5 to 10 minutes depending on your weight . the dose may be administered as an injection of sodium chloride 9 mg / ml ( 0 . 9 %) solution for injection ( intravenous ) over approximately 5 minutes . if you are given a radioactive substance ( radiopharmaceutical ), the dose of rapiscan is calculated by
like all medicines , rapiscan can cause side effects , although not everybody gets them . the side effects are usually mild to moderate and usually disappear after the rapiscin injection has been given 30 minutes after any treatment . tell your doctor immediately if you notice any of the following side effects : sudden stopping of the heart , which may be signs of damage to the heart ( heart block ), a disorder of theheart ' s electrical signal , rapid heart beat low blood pressure , fainting , ministrokes , weakness of the face , inability to speak . if you have any of these , stop taking rapiscen and tell your
viagra contains the active substance sildenafil which belongs to a group of medicines called phosphodiesterase type 5 ( pde5 ) inhibitors . it works by helping the blood vessels in your penis relax , allowing blood to flow into your penis when you get sexually excited . viagra will only help you to get an erection if you are sexually stimulated . viagagra is a treatment for adult men with erectile dysfunction or impotence . this is when a man cannot get , or keep a hard , erect penis suitable for sexual activity .
do not take viagra - if you are allergic to sildenafil or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has prescribed medicines containing nitrates , which could lead to a dangerous fall in your blood pressure . these medicines are used to treat angina pectoris ( " chest pain "). if you have not been prescribed any of these medicines , please contact your doctor . - if the doctor has recently prescribed nitric oxide donors such as amyl nitrite , which may lead to an increase in your risk of a dangerous drop in yourblood pressure . - when taking
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 50 mg once a day . viagra film - coated tablets are suitable for taking with or without food . viagagra orodispersible tablets are for oral use . swallow the tablets whole with a glass of water . do not crush or chew the tablets . taking viagra with food viagra will help you to get an erection if you get sexually stimulated . if you take more viagra than you should if you accidentally take too many tablets , contact your doctor straight away . if
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects are usually mild to moderate . stop taking viagra and see a doctor straight away if you notice any of the following serious side effects after taking viaga : an allergic reaction ( may affect up to 1 in 100 people ). symptoms include sudden wheeziness , difficulty in breathing , dizziness , swelling of the eyelids , face , lips or throat . chest pains may be severe and may require immediate medical attention . you may be in a semi - sitting position . you should use nitrates to relieve your chest pain . prolonged and sometimes
what viagra contains - the active substance is sildenafil . each tablet contains 25 mg of sildenedafil ( as the citrate salt ). - the other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , magnesium stearate . tablet coating : hypromellose , titanium dioxide ( e171 ), lactose monohydrate , triacetin , indigo carmine aluminium lake ( e132 ). what viagra looks like and contents of the pack viagra film - coated tablets have a rounded - diamond shape and are
sifrol contains the active substance pramipexole and belongs to a group of medicines known as dopamine agonists , which stimulate dopamine receptors in the brain . stimulation of the dopamine receptors triggers nerve impulses in thebrain that help to control the symptoms of primary parkinson ' s disease . it is used in combination with levodopa to treat parkinson '. sifrol is used to treat the symptoms in adults with moderate to severe primary restless legs syndrome .
do not take sifrol - if you are allergic to pramipexole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking sifol . tell your doctor if you have or have had any medical conditions or symptoms , including kidney disease . hallucinations ( seeing , hearing or feeling things that are not there ). most hallucinations are visual . dyskinesia ( e . g . abnormal , uncontrolled movements of the limbs ). if you suffer from advanced parkinson ' s disease , you may be given levodopa to treat dysk
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of sifrol for parkinson ' s disease is 3 tablets taken once a day . during the first week , take 1 tablet of sufrol 0 . 088 mg ( 0 . 264 mg / day ). after 1 week , your doctor will increase your dose to sifol 0 .088 mg ( 1 . 264mg / day ) once a week . this will be until your symptoms are controlled . the usual starting dose is two tablets taken twice a day , once in the morning
like all medicines , this medicine can cause side effects , although not everybody gets them . evaluation of these side effects is based on the following frequencies : very common : may affect more than 1 in 10 people common : might affect up to 1 in 100 people uncommon : may affects up to1 in 1 , 000 people rare : may effect up to one in 10 , 000 patients with parkinson ' s disease the following side effects have been reported : - dyskinesia ( abnormal , uncontrolled movements of the limbs ), dizziness , nausea ( sickness ), urge to behave in an unusual way - hallucinations ( seeing , hearing or feeling things that
what sifrol contains the active substance is pramipexole . each tablet contains 0 . 088 mg , 0 . 18 mg , or 0 . 35 mg , in 0 . 7 ml of solution . the other ingredients are pramipxole 0 . 125 mg , 1 mg , 2 mg , 3 mg , and 1 mg pramiperxole dihydrochloride monohydrate . the ingredients are mannitol , maize starch , anhydrous colloidal silica , povidone k 25 , magnesium stearate . what sifroll looks like and contents of the pack sifol
emadine is a medicine used for the treatment of seasonal allergic conjunctivitis of the eye . allergic conditions occur when the body has a build - up of substances in the eye that can cause the allergic reaction . allergic conjustivitis may occur when some materials ( allergens ) become present in the body . allergic reactions may include itching , redness and swelling on the surface of your eye . if you notice any of these , tell your doctor immediately . if any of the reactions gets worse , tell the doctor .
do not use emadine - if you are allergic to emedastine or any of the other ingredients of this medicine ( listed in section 6 ). - if your child is more than 3 years old . warnings and precautions talk to your doctor or pharmacist before using benzalkonium chloride . emadrine contains benzalkone in the active substance in emadines . see section 6 . clinical trials should be performed before and during treatment with emadin . if you have kidney or liver problems , your doctor may decide to reduce the dose of emadina . other medicines and emadmine tell your doctor if you
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use adults use in adults use for 3 weeks . use in children and adolescents use in the eye only . this medicine is for use in both eyes . use within 3 weeks of the first dose . use at least 1 hour before or 2 hours after the first drop . do not use more than 1 hour after the second dose . do this if you notice that the emadine bottle is damaged . wash your hands thoroughly after using the medicine . do the following : remove the bottle from the bottle
like all medicines , this medicine can cause side effects , although not everybody gets them . the drops can cause them to stop working properly . common side effects ( may affect up to 10 in 10 people ) effects in the eye : eye pain , itchy eye and eye redness . uncommon side effects : ( may effect up to 1 in 100 people )effects in the back of the eye ( corneal disorder ): abnormal eye sensation , increased tear production , tired eyes , eye irritation , blurred vision , corneel staining and dry eye . general side effects include headache , difficulty sleeping , sinus headache , bad taste , rash
keep out of the reach and sight of children . do not use emadine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . do this to protect from moisture and infections . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what emadine contains the active substance is emadastine in 0 . 5 ml solution . the other ingredients are difumarate , benzalkonium chloride , trometamol , sodium chloride , hypromellose , purified water , hydrochloric acid , sodium hydroxide to maintain acidity levels and ph levels . what emadrine looks like and contents of the pack emadINE is a liquid ( a solution ) supplied in a 5 ml or 10 ml plastic ( drop -tainer ) bottle with a screw cap .
levetiracetam is an antiepileptic medicine ( a medicine used to treat seizures in epilepsy ). levetiratam actavis is used : on its own in adults and adolescents from 16 years of age with newly diagnosed epilepsy , to treat a certain form of epilepsy . epilepsy is a condition where the patients have repeated fits ( seizures ). leveiracetamine is used for the epilepsy form in which the fits initially affect only one side of the brain , but could thereafter extend to larger areas on both sides of the body ( partial onset seizure with or without secondary generalisation ). leetiracetamer has been
do not take levetiracetam actavis - if you are allergic to levetiraacetam , pyrrolidone derivatives or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking leveturacetamactavis - tell your doctor if you have kidney problems - tell the doctor if any slow down in the growth or unexpected puberty development of your child has been reported in patients treated with anti - epileptics . levetiaracetam actsavis may cause thoughts of harming or killing themselves . tell your physician if you or your child
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet of levetiracetam actavis in the morning and one tablet in the evening . monotherapy dose in adults and adolescents from 16 years of age and older : one tablet ( 1 , 000 mg ) three times a day ( equivalent to 3 , 000 micrograms ) one tablet (" oral ") of levevetiratam acta in the afternoon and one half a tablet ( 2 , 000 iu ) in the night . therapy dose in children and adolescents
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor or the nearest emergency department immediately if you experience : weakness , feel light - headed or dizzy or have difficulty breathing , as these may be signs of a serious allergic ( anaphylactic ) reaction . swelling of the face , lips , tongue and throat ( quincke ' s oedema ), flu - like symptoms , a rash on the face with an extended rash and a high temperature . increased levels of liver enzymes seen in blood tests ( increase in a type of white blood cell ) 56 in patients with eosin
what levetiracetam actavis contains the active substance is levetiraacetam . levetaracetamactavis 250 mg : each tablet contains 250 mg of levetoracetam ( as levetilacetam ). levetieracetam actingavis 500 mg : one tablet contains 500 mg of the active ingredient levetiroacetam. leveteracetam actedavis 750 mg : two tablets contain 750 mg of of levevetir acetam (as levetviracetam ) each tablet is available in a pack containing 1 , 000 tablets . the other ingredients are : tablet core : cro
cecurse ellipta contains the active substance umeclidinium bromide which belongs to a group of bronchodilators . incruse ellipte is used to treat adults with chronic obstructive pulmonary disease ( copd ). copd is a long - term condition in which the airways in the lungs become blocked . this leads to breathing difficulties . people with copd have difficulties in breathing because of tightening of the muscles around the airway . this medicine blocks the tightening of these muscles in the air passages , making it easier for air to get in and out of the lungs . this helps to control your
do not use incruse ellipta 27 - if you are allergic to umeclidinium or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine if you have asthma . incruruse ellipta should not be used in patients with asthma . talk to a doctor or nurse before using incrusey ellipta if you : - have heart problems - have an eye problem called narrow - angle glaucoma ( an enlarged prostate , difficulty passing urine , or a blockage in your bladder ) - have severe liver problems
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours at the same time each day . do not use more incruse ellipta than your doctor tells you to . if you use more than the recommended dosage of incruense ellipta , contact your doctor immediately . symptoms of using too much of this medicine may include a sudden attack of breathlessness or wheezing . if this attack occurs , you may need to use a quick - acting reliever inhaler
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions are uncommon ( may affect up to 1 in 100 people ). if you experience any of the following symptoms while taking incruse ellipta stop taking this medicine and seek medical help immediately : itching skin rash , hives and redness 29 common side effects ( may effect up to1 in 10 people ): faster heart beat painful and frequent urination . these may be signs of a urinary tract infection . common cold infection of nose , throat cough feeling of pressure or pain in the cheeks and forehead . these could be signs for inflammation of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the inhaler after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the inhalcer in the sealed tray in order to protect from light . after first opening of the tray , the inhalard should be used within 6 months . once the tray has been opened , the active substance of the medicine should be removed from the tray and used immediately . do this if the inhaluer has
what incruse ellipta contains - the active substance is umeclidinium bromide . each single inhalation provides a delivered dose of 55 micrograms umecylidinia ( equivalent to 65 microgramrams of umecleidinIUM bromides ). - the other ingredients are lactose monohydrate ( see section 2 under ' incrusemipta contains lactose '), magnesium stearate . what incrusey ellipta looks like and contents of the pack incrusea ellipta is an inhalation powder . the ellipta inhaler consists of a grey plastic body , a
what nucala is nucal contains the active substance mepolizumab , a monoclonal antibody . this type of protein is used to treat severe asthma in adults , adolescents and children aged 6 years and older . severe asthma affects many eosinophils ( a type of white blood cell that helps the airways to open ) and affects the lungs . eosinaophilic asthma is the most common form of asthma nucalo is used in asthma attacks when you are taking medicines called high dose inhalers . it helps control your asthma by helping you breathe more easily . these medicines are usually medicines called
do not use nucala if you are allergic to mepolizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine if you have worsening asthma 58 patients have experienced asthma - related side effects when using nucal . if your asthma is not controlled with nucalan , your doctor may decide to reduce the dose or stop nucla treatment . if you think you may be allergic , ask your doctor for advice . injection site reactions medicines of this type ( monoclonal antibodies ) cause severe allergic reactions to other parts
nucala is given under the skin ( subcutaneous injection ). adults and adolescents 12 years of age and older : the recommended dose is 100 mg once a day . the recommended starting dose is 1 mg once daily . you should use the pre - filled pen at the same time each day . do not inject nucala yourself . your doctor will decide how long you should continue treatment with nucal . if you use more nucale than you should if you have used more nuala than you have been told to , tell your doctor or go to a hospital straight away . if possible , stop the treatment and contact
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with nucala : allergic reactions allergic or allergic - like reactions may occur ( may affect up to 1 in 10 people ) at the site of the injection . sometimes symptoms can be severe . symptoms can include chest tightness , cough , difficulty breathing fainting , dizziness , feeling lightheaded ( due to a drop in blood pressure ), swelling of eyelids , face , lips , tongue or mouth hives rash tell your doctor immediately if you have a reaction similar reaction to nucal . other side effects very
keep out of the reach and sight of children . do not use nucala after the expiry date which is stated on the carton and on the pre - filled pen after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre pre -filled pen in the outer carton in order to protect from light . after first opening , the pen may be stored for up to 7 days in the refrigerator ( 3 8 ). discard the pre filled pen if it has not been used within 7 days . do away with the pre … filled pen once
what nucala contains - the active substance is mepolizumab . each 1 ml ampoule contains 100 mg of mepolixumab ( as besilate ). - the other ingredients are sucrose , sodium phosphate dibasic heptahydrate , citric acid monohydrate , polysorbate 80 , edta disodium dihydrate and water for injections . what nucal looks like and contents of the pack nucale is supplied as a pack containing 1 ampoules , a multipack containing 3 ampouls and 1 vial . not all pack sizes may be marketed
what ninlaro is ninlar is a cancer medicine that contains the active substance ixazomib , a ' proteasome inhibitor '. what it is used for ninlara is used to treat a cancer of the bone marrow called multiple myeloma . ixezomib works by stopping cell survival and slowing down the growth of myelomas cells . it works by blocking a lot of proteins called proteasomes . how ninlalo works when used in adults , it is given to you by your doctor . how it works in multiple myelo , the active ingredient in ninlare is lenalidom
do not take ninlaro if you are allergic to ixazomib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking ninlar if you : - have bleeding , persistent nausea , vomiting , diarrhoea , nerve problems , tingling , numbness , swelling or a persistent rash - have liver or kidney problems . your doctor may decide to stop treatment with ninlara if you have problems with your kidneys . your dose may need to be adjusted . your treatment may need a lot of blood tests to check that you have enough
instructions for use in adults and adolescents for use of multiple myeloma are given at the end of this leaflet . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of ninlaro is lenalidomide ( a medicine that contains dexamethasone ), an anti - inflammatory medicine . how to take ninlar take lenalidomeide once a day for the first 4 weeks . you will take lenlaro once a morning on the same day of the week . the first 3 weeks are
like all medicines , this medicine can cause side effects , although not everybody gets them . very common serious side effects ( may affect more than 1 in 10 people ): low platelet counts ( thrombocytopenia ) nose bleeds that can easily bruise nausea , vomiting , diarrhoea numbness or tingling or burning of the hands or feet ( peripheral neuropathy ) swelling of the legs or feet (> peripheral oedema ) skin rash ( itchy , often on the entire body ). rare side effects may affect up to 1 in 1 , 000 people : severe skin rashes with red to purple bumps (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the blister and carton after exp . the exp date refers to the last day of that month . do store above 30 . store in the original package in order to protect from moisture . once the capsule has been removed from the blister , use it immediately . do this if you notice any damage to medicine packaging . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what ninlaro contains the active substance of ninlar is ixazomib . each capsule contains 2 . 3 mg ixasomib and 3 . 3mg ixabomib citrate . the other ingredients are microcrystalline cellulose , magnesium stearate , talc . the capsule shell contains gelatin , titanium dioxide ( e171 ), red iron oxide ( e172 ), shellac , propylene glycol , potassium hydroxide , black iron oxide . the printing ink contains : - ixar 3 mg : ix azomib 3 mg hard capsules : izar 4 .
do not use palforzia if you are allergic to peanuts ( arachis hypogaea ). warnings and precautions talk to your doctor or pharmacist before using palfourzia . children and adolescents from 4 to 17 years of age should not receive treatment for peanut allergy because the medicine contains traces of peanut ( desensitisation ). palfiorzia is not intended to cause allergic reactions . palfORzia should not be used in children and young people with food allergies . talk to a doctor or nurse before using this medicine . pforzial is not recommended for children and children under the
do not take palforzia if you are allergic to peanut or soya or any of the other ingredients of palfourzia ( listed in section 6 ). if you have severe asthma . if your asthma has a problem swallowing . if you suffer from long term problems with your digestive system . if any of these apply to you , tell your doctor . if the patient has a severe mast cell disorder . if he / she has severe or life - threatening anaphylaxis . if this happens within 60 days of treatment with palfiorzia . warnings and precautions talk to your doctor or pharmacist before taking p
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if you have been diagnosed with allergy , your doctor will decide if you should take palforzia . allergic reactions ( anaphylaxis ) may occur within 3 months of starting treatment with palfourzia , and initial doseescalation should be initiated . these treatment steps should be repeated every three weeks . the initial dose escalation and up - dosing steps should continue for as long as prescribed by your doctor . if necessary , your physician may adjust the dose of palfORzia according
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with palforzia : severe allergic reactions : if you have any of the following symptoms , stop taking palfourzia and seek medical help immediately : - signs of the reaction include trouble breathing , throat tightness , feeling offulness , trouble swallowing or speaking - changes in voice , dizziness or fainting - severe stomach cramps , pain , vomiting , diarrhoea , severe flushing or itching of the skin palfORzia may cause problems with the stomach and digestive system (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial label after exp . the exp date refers to the last day of that month . do store below 25 . do this medicine if you notice any hard lumps of powder or if the liquid is discoloured . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what palforzia contains the active substance is palfoforz . each 0 . 5 mg capsule contains 1 , 10 or 20 mg of the active substances . the other ingredients are : capsule content : microcrystalline cellulose , colloidal anhydrous silica and magnesium stearate palforbzia 100 mg oral powder in capsules with opening microcrycrystallinine celluloses , colloid anhydrated silica , and magnesium unstearatepalforza 300 mg oralpowder in sachet microcry crystalline cellulos , collir anhydrate silica ( and magnesiumst
zerne belongs to a group of substances called benzodiazepine - related medicinal products . it contains hypnotic actions . zerene is used to treat sleeping problems in adults . it is used in adults who have not responded to treatment or who have had treatment before . it should be used in those who have problems sleeping .
do not take zerene : if you have hypersensitivity ( an allergy ) to zaleplon or any of the other ingredients of zerenea sleep apnoea syndrome ( which may occur for short periods ) if you suffer from severe kidney or liver problems if you are suffering from myasthenia gravis ( which causes very weak and tired muscles , severe breathing and chest problems ). warnings and precautions talk to your doctor or pharmacist before taking zeren . the undesirable effects may occur if you take any medicine , including any medicines that increase physical dependence . treatment may cause withdrawal symptoms such as headaches , muscle pain
always take zerene exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 10 mg once a day . if you have difficulty falling asleep , you should take the capsule with you . if your doctor tells you to stop taking zeren , you may need to take the capsules at least one hour before or one hour after your regular dose . if the doctor tells your doctor to stop , you can take the dose at any time of the day . do not take more than the recommended dosage . if a person is 65 years of age or older , the dose
like all medicines , zerene can cause side effects , although not everybody gets them . tell your doctor if you notice any other changes in your health . the frequency of possible side effects listed below is defined using the following convention : 36 very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) very rare ( affects less than 1 users in 10 , 000 ). very rare : very rare , affects lessthan 1 user per 10 ,000 . not known ( frequency cannot be estimated from the available data ). very common : may affect
what zerene contains - the active substance is zaleplon 5 mg . - the other ingredients are microcrystalline cellulose , pregelatinised starch , silicon dioxide ( e171 ), sodium lauryl sulphate , magnesium stearate , lactose monohydrate , indigo carmine ( e132 ), titanium dioxide ( c171 ), gelatin , titanium dioxide , red iron oxide ( e172 ), yellow iron oxide , black iron oxide (< e172 ) and sodium laurel sulphates ( e133 ), silicon dioxide . ( s - 13050 ), shellac , lecithin , simethicone
